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Evolutionarily Conserved Function of Huntingtin in Cellular Dynamics Related to Cell 
Adhesion and the Cytoskeleton 
Abstract 
 Huntington’s disease (HD) is a rare, dominantly inherited neurodegenerative disorder 
characterized by progressive chorea, emotional and behavioral disturbances, and cognitive 
decline. The single, causative mutation is an expanded trinucleotide repeat of cytosine, 
adenosine, and guanine (CAG) of more than 37 residues in the HD gene (currently referred to 
as HTT). Genetic evidence suggests that the CAG repeat expansion results in a gain of 
huntingtin function. While huntingtin and its numerous interactors have been implicated in a 
variety of essential cellular processes, the role of the full-length, endogenous protein remains 
unclear. Multiple studies have implicated huntingtin in processes related to cytoskeletal 
structure and dynamics in HD patients and model organisms. However, alterations in cellular 
dynamics related to the cytoskeleton – including cell adhesion – have not been characterized in 
a comprehensive, rigorous manner. Using Mus musculus genetic models of the HD mutation 
and/or deficiency and a Dictyostelium discoideum genetic deficiency model, I have undertaken 
an investigation of evolutionarily conserved huntingtin function in the cytoskeleton and cell 
adhesion. The results of these studies support a role for huntingtin in cell-cell and cell-substrate 
adhesion, as well as maintaining actin cytoskeletal structure. Furthermore, my thesis research 
sets the stage for future work to elucidate the molecular mechanism by which huntingtin is 
acting and determine the effect of the CAG repeat expansion on huntingtin function.  
Evolutionary conservation affords an invaluable tool to identify crucial function(s) of the 
huntingtin molecule and the effect of the pathogenic HD mutation on function, enabling 
therapeutic development while providing novel insights into cytoskeletal biology and cell 
adhesion. 
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Chapter 1: 
Introduction 
The genetic basis of Huntington’s disease 
 Huntington’s disease (HD) is a fatal, late-onset neurodegenerative disorder affecting 
approximately 1 in 10,000 individuals [1]. Although age of onset of symptoms varies, patients 
are most likely to experience diagnosed symptoms in mid-life – including uncontrolled, choreic 
movement and progressive decline of cognitive, behavioral, and motor function [2]. Unlike many 
other complex genetic neurodegenerative diseases, HD pathogenesis is due to a single 
causative mutation in the HD gene (recently renamed HTT)2, which is dominantly inherited [3]. 
The pathogenic mutation results in an expanded version of a normally polymorphic 
polyglutamine (polyQ) tract in the huntingtin protein [4]. The HD mutation was identified by 
genomic mapping without prior understanding of underlying biology [5]. However, knowledge of 
huntingtin normal function is essential to developing targeted therapeutics for intervention at the 
earliest stages of HD because of the need to both fully understand the HD initiating process and 
to inform strategies aimed at decreasing huntingtin levels, such as RNA interference (RNAi) 
                                                
2 An effort was made to keep HD gene and protein nomenclature consistent throughout this 
manuscript. However, it is important to note that the name of the HD gene was recently 
changed to HTT. The cellular and whole organism models generated in our lab were named 
under the previous guidelines and therefore reflect the original HD (Huntington’s disease) or 
Hdh (HD homolog) gene names. These original lab strain names have been retained in this 
manuscript. Except in rare instances, the protein name huntingtin has been spelled out in its 
entirety throughout the manuscript to indicate reference to the full-length protein. All of the 
model organisms described in this manuscript express a form of full-length huntingtin. 
 
Organism Official nomenclature Alternate nomenclature Gene Protein 
Homo sapiens HTT HTT HD, IT15 
Mus musculus Htt Htt Hdh 
Dictyostelium discoideum htt htt hd 
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technology which is the strategy currently on track to be the first disease modifying HD 
therapeutic to be assessed in clinical trials. [6, 7]. 
Genotype-phenotype studies of HD patients have produced a set of genetic criteria that 
characterize the disease. First, mutant huntingtin displays dominance over the wild-type protein 
[8, 9]. Second, though age at onset of clinical HD symptoms varies widely, there is an inverse 
relationship between the CAG repeat length and age at onset, such that over half of the 
variance can be explained by length of the CAG expansion (Figure 1.1) [9]. However, there 
remains significant variation in age at onset even in individuals with the same CAG repeat 
length (Figure 1.1, gray shading). This variation appears to be highly heritable, suggesting that 
other genetic factors act to modulate HD pathogenesis [10, 11]. Third, the disease-causing 
mutation leads to progressive neuronal death in a variety of brain regions, but particularly acute 
and selective loss of medium spiny neurons in the striatum [6]. 
 
  
The pathogenic mechanism of HD is not primarily due to loss of huntingtin activity 
because heterozygous HTT inactivation, via rare translocations, has been reported in humans 
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Figure 1.1 CAG repeat length-dependence of age at clinical onset of HD. Each red data point 
represents the average age at clinical onset for patients with a given HD CAG repeat length. 
Gray shading indicates the variation in age at onset of clinical symptoms in patients with a given 
HD CAG repeat length. (Figure courtesy of Dr. Marcy MacDonald) 
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and these individuals do not display phenotypic abnormalities [12, 13]. Similarly, mice 
hemizygous for Htt are phenotypically normal and do not develop HD-like phenotypes [12-14]. A 
complete dominant-negative inhibition of huntingtin function is also unlikely because although 
human patients homozygous for the HD mutation are indistinguishable from heterozygous 
siblings [15, 16], homozygous inactivation of the mouse Htt gene results in early embryonic 
lethality at approximately E7.5 [14]. At this time the most parsimonious genetic explanation for 
the HD trigger is that the polymorphic CAG repeat region confers enhanced huntingtin 
molecular function. 
Huntingtin normal function and its relation to structure and CAG repeat length 
Despite two decades of research, the normal function of huntingtin has remained elusive 
due to a variety of challenges related to the protein’s unique structural and physical properties. 
Huntingtin is a large, 3,144 amino acid (~350 kDa) protein that is expressed ubiquitously 
throughout all tissues [17]. Based upon sequence prediction and biochemical analysis of 
purified full-length recombinant huntingtin, the protein is a hinged α-helical solenoid spanned by 
HEAT (Huntingtin, elongation factor 2, protein phosphatase 2A PR65/A subunit, and target of 
rapamycin) repeats [18, 19]. Figure 1.2 is a representation of our current understanding of the 
conserved structural domains of huntingtin created by sequence-based prediction software [20]. 
Proteins predominantly comprised of HEAT domains – such as importin-β and protein 
phosphatase 2A PR65/A [21, 22] – are flexible molecules that facilitate macromolecular 
complexes and contribute to an array of cell signaling pathways [19, 23]. Over 100 distinct 
conformations of recombinant full-length huntingtin were identified by negative stain electron 
microscopy [20] and epitopes of endogenous huntingtin display differential accessibility [6]. 
These data imply structural flexibility of huntingtin that may allow the protein to organize 
members of dynamic complexes, similar to other canonical HEAT proteins. Consistent with this 
hypothesis, huntingtin participates in more than 70 putative protein interactions [19, 24, 25] and 
can directly bind DNA and RNA [26], implicating it in a wide variety of cellular processes – 
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including transcriptional regulation and DNA maintenance, cytoskeletal and transport processes, 
cell signaling and fate, protein synthesis and turnover, and cellular metabolism [24, 27-37]. 
Genetic models to study evolutionarily conserved huntingtin structure/function 
Murine genetic models 
 To narrow down the vast number of putative huntingtin interactors and identify the 
essential activities of huntingtin, genetic strategies are indispensable because they hold the 
potential to reveal the unexpected and dissect causal relationships. Our lab generated precise 
genetic models that replicate the human HD mutation or produce huntingtin deficiency. In the 
allelic series of knock-in (KI) mouse models, a portion of exon 1 of the murine Htt was replaced 
with a human HTT exon 1 of varying CAG (Q) repeat length (HdhQ7, HdhQ20, HdhQ91, HdhQ111), 
such that the chimeric mouse:human exon 1 (or humanized exon 1) is expressed from the 
endogenous murine Htt promoter along with the rest of the 66 exons encoding the full-length 
huntingtin protein [38]. Furthermore, mice homozygous or heterozygous (HdhQ7/7, HdhQ20/7, 
HdhQ91/Q7, HdhQ111/Q7) for the HD mutation were generated to enable investigation of possible 
dominant negative effects; striatal cell lines were isolated and immortalized [8] and embryonic 
stem (ES) cell lines were derived [39]. A homozygous deficiency mutant model was also created 
where exons 4 and 5 of the mouse Htt gene were replaced with a neomycin (Neo) resistance 
cassette (Hdhex4/5/ex4/5) [14]. This genetic strain has a detectable mRNA product, but no 
huntingtin protein expression. Mice homozygous for Htt inactivation were embryonic lethal at 
approximately E7.5, showing that huntingtin is needed for proper development. Huntingtin is not 
required for cell growth in culture since ES cells were isolated and viable [39]. 
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Dictyostelium discoideum huntingtin deficiency model 
Given the difficulties in identifying crucial normal functions of full-length huntingtin and 
the fact that structural properties of huntingtin are highly conserved through multicellular 
evolution, interest in non-mammalian models to study conserved function of huntingtin has 
increased and resulted in a number of experimental organisms in nematode worms 
(Caenorhabditis elegans) [40, 41], fruit flies (Drosophila melanogaster) [42, 43], zebrafish 
(Danio rerio) [44], and slime mold (Dictyostelium discoideum) [45-47]. All of these possess the 
benefits of reducing the cost and time course of experimentation [17]. D. discoideum is 
particularly intriguing based on a few distinct properties: 1) D. discoideum is the most 
evolutionarily ancient organism known to possess a huntingtin ortholog; 2) While D. 
discoideum can be induced to undergo a diploid phase, they primarily exist in a haploid state 
throughout their development and in laboratory culture, providing for ease of genetic 
manipulation; 3) Given the known importance of huntingtin in developmental processes, D. 
discoideum possess a primitive form of multicellular development and cellular differentiation 
that is well characterized, relatively simpler than mammalian systems, and can be interrogated 
for potentially conserved huntingtin function.  
Translation to human disease 
Translation back to mammalian and ideally human systems is necessary to evaluate 
the relevance of phenotypes and conserved function(s), identified in non-mammalian 
experimental systems, to HD pathogenesis. Our lab possesses a large repository of human 
fibroblast and lymphoblast cell lines from patients with various CAG repeat length HTT 
mutations. Furthermore, recent advances in stem cell technology allow new, patient-specific 
cellular resources to be generated by reprogramming adult, differentiated cells to induced 
pluripotent stem (iPS) cells [48]. Colleagues in the lab are developing differentiation protocols 
to take cells from iPS pluripotency to neuronal progenitors and an array of differentiated 
neuronal subtypes, including cells that phenotypically resemble primary striatal cultures. Thus, 
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studies in murine and D. discoideum cellular models presented here are ripe for parallel 
investigations in human models to verify their relevance to disease and determine the effect of 
CAG repeat length on the huntingtin function(s) identified. 
Huntingtin in cell adhesion and the cytoskeleton 
 Mounting evidence supports the hypothesis that huntingtin plays a subtle, but vital 
functional role in cytoskeletal structure and function, including cell adhesion. The molecular 
machinery of cytoskeletal and cell adhesion biology is highly conserved and, where direct 
conservation of specific molecular players is lacking, there remain some unifying mechanistic 
principles across model organisms [49]. 
HD patient phenotypes 
 In human patients, levels of the actin binding protein profilin – a key regulator of actin 
polymerization and crucial player in neuronal differentiation and synaptic plasticity [50] – are 
reduced progressively with stage of disease in the cortical brain region of presymptomatic, 
early stage, and late stage HD patients compared to age-matched controls [51]. Furthermore, 
coimmunoprecipitation of huntingtin and β-tubulin has been achieved from human patient 
lymphocytes and rat brain [52]. These studies suggest an interaction between huntingtin and β-
tubulin. The association of huntingtin with the microtubule cytoskeleton through interaction of 
huntingtin with tubulin allows for efficient trafficking of the protein to the cell nucleus. Thus, 
huntingtin has been strongly implicated as a player in both the actin and microtubule 
cytoskeletal systems, although its exact role remains unclear. 
Phenotypes in murine genetic models 
A number of preliminary studies using murine Htt deficiency models and Htt polyQ 
expansion models that replicate the precise genetic mutation in HD, suggested that aspects of 
cytoskeletal and adhesion dynamics are subtly altered both by lack of huntingtin and by the 
presence of mutant huntingtin. Huntingtin deficient ES cells – as well as zebrafish – have 
revealed a role for the protein in homotypic adhesion of neuroepithelial cells by modulating 
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activity of the metalloprotease ADAM10 and cleavage of N-cadherin [47]. Additionally, 
huntingtin is a well-established enhancer of vesicular transport facilitated by its microtubule-
based associations with HAP1, dynactin, and p150glued [27, 53-55]. Actin cytoskeletal effects 
are also apparent in immortalized striatal murine cells, including colocalization of huntingtin 
with cofilin-actin stress rods in the cell nucleus and defective actin remodeling [56]. 
Phenotypes in Dictyostelium discoideum deficiency model 
 Due to the high degree of evolutionary conservation of many of the key molecules 
involved in cytoskeletal biology, D. discoideum is increasingly being recognized as an excellent 
tool for dissecting actin-related human diseases, including Alzheimer’s disease and spastic 
paraplegia [57]. Similarly, cell adhesion machinery is highly conserved [58] and two of the main 
developmentally-regulated cell adhesion molecules, cad1 and csA, are putative orthologs of 
human cadherin and neuronal cell adhesion molecule, respectively [59]. Figure 1.3 provides a 
representation of the D. discoideum life cycle, which occurs in a 24-hour period upon starvation 
and is known to be regulated by three adhesion molecules – cad1, csA, and lagC – whose 
expression peaks successively. Recently, two novel models of huntingtin deficiency have been 
independently made in D. discoideum [45, 46]. Initial phenotypes in the D. discoideum 
huntingtin deficiency model, detailed in Chapter 4, were reminiscent of mammalian models and 
mirrored known phenotypes of cytoskeletal and cell adhesion mutants, prompting further 
investigation and in-depth characterization. 
 9 
 
Figure 1.3. Schematic of D. discoideum development. The developmental life cycle progresses upon 
starvation to completion within a 24-hour cycle. Cell adhesion is critical to the complex intracellular and 
intercellular coordination and movement necessary to accomplish this feat. Cad1, csA, and lagC are the 
three canonical adhesion molecules known to govern adhesion during development and their 
expression peaks successively (indicated by solid bars). (Figure modified from [59]) 
 
 
 My thesis aimed to further characterize and define evolutionarily conserved functions of 
huntingtin in cellular dynamics related to the cytoskeleton and cell adhesion. Chapter 2 details 
the published characterization of cell adhesion and the actin cytoskeleton in the murine striatal 
genetic knock-in models of HD [60]. Chapter 3 describes optimization of growth conditions and 
characterization of the murine ES knock-out and knock-in genetic models [39]. Chapter 4 
discusses an evolutionarily conserved role for huntingtin in cell adhesion in huntingtin deficient 
D. discoideum [45]. This adhesion phenotype was first described in the original publication 
characterizing the newly created D. discoideum model [45] and Chapter 4 represents a 
manuscript in preparation that further elucidates the adhesion defect. 
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 The work in this chapter is a collaborative project conducted in the MacDonald lab, 
primarily with colleagues Dr. Surya Reis and Dr. Ihn Sik Seong. I conducted the research on 
actin cytoskeletal phenotypes in the immortalized striatal cell models detailed in Figure 2.5. I 
identified a novel cofilin phenotype in the striatal cells that was included in the manuscript 
(Appendix A). Dr. Reis conducted the whole organism and primary striatal cell culture studies, 
as well as initially identifying the aberrant phalloidin immunofluorescence staining in the 
immortalized striatal cell system, which I went on to further characterize and quantify. Dr. 
Seong performed the majority of the biochemical experiments detailed in the manuscript. 
Abstract 
The expanded HD CAG repeat that causes striatal cell vulnerability in Huntington’s 
disease (HD) encodes a polyglutamine tract in full-length huntingtin that is correlated with 
cellular [ATP] and [ATP/ADP]. Since striatal neurons are vulnerable to energy deficit, we have 
investigated – in Hdh CAG knock-in mice and striatal cells – the hypothesis that decreased 
energetics may affect N-cadherin, a candidate energy-sensitive adhesion protein that may 
contribute to HD striatal cell sensitivity. In vivo N-cadherin was sensitive to ischemia and to the 
effects of full-length mutant huntingtin, progressively decreasing in HdhQ111 striatum with age. 
In cultured striatal cells, N-cadherin was decreased by ATP-depletion and STHdhQ111 striatal 
cells exhibited dramatically decreased N-cadherin, due to decreased Cad2 mRNA and 
enhanced N-cadherin turnover, which was partially normalized by adenine supplementation, to 
increase [ATP] and [ATP/ADP]. Consistent with decreased N-cadherin function, STHdhQ111 
striatal cells displayed profound deficits in calcium-dependent N-cadherin-mediated cell 
clustering and cell-substratum adhesion, and primary HdhQ111 striatal neuronal cells exhibited 
decreased N-cadherin and an abundance of immature neurites, featuring diffuse, rather than 
clustered, staining for N-cadherin and synaptic vesicle markers, that was partially rescued by 
adenine treatment. Thus, mutant full-length huntingtin, via energetic deficit, contributes to 
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decreased N-cadherin levels in striatal neurons, with detrimental effects on neurite maturation, 
strongly suggesting that N-cadherin mediated signaling merits investigation early in the HD 
pathogenic disease process. 
Introduction 
The CAG expansion mutation that causes Huntington’s disease (HD) elongates a 
polymorphic polyglutamine segment in the huntingtin protein. Full-length huntingtin with a 
polyglutamine region of more than about 37 residues initiates a disease process that 
culminates in the loss of neurons, especially in the striatum, and the onset of the motor, 
psychiatric and cognitive symptoms [61, 62]. Understanding the rate-limiting events that 
contribute to the early vulnerability of striatal neurons would guide efforts to track the natural 
history of the disease and may provide new avenues for therapeutic development. 
Studies investigating the earliest consequences of full-length mutant huntingtin, in HD 
patient cells and tissues – and in accurate genetic Hdh CAG knock-in mouse cells and tissues 
– have revealed perturbations in membrane vesicle trafficking, gene transcription, intracellular 
signaling pathways [55, 63, 64], as well as altered energetics, characterized by decreased 
[ATP] and [ATP/ADP], that is correlated with size of the polyglutamine-repeat [65-67]. We have 
been studying the effects of altered energetics, as the correlation of energetic measures with 
polyglutamine-repeat in full-length huntingtin implies a dominant effect that conforms to the 
genetic features of the HD trigger mechanism, and energetic defects, thought to be important 
to striatal cells, may be evident through the lifetime of the cell, perhaps from birth [65-67]. 
Certainly, early weight loss in HD patients and a systemic metabolic defect in branched chain 
amino acids (BCAA), are consistent with a systemic attempt to compensate for an early energy 
deficit [68]. 
Neuronal (N)-cadherin, which is intimately involved in neuronal cell adhesion signaling, 
differentiation and synapse function [69, 70], is a prime candidate for being affected by energy 
deficit. Members of the cadherin family exhibit selective degradation in response to renal 
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ischemia/ATP depletion [71-73], and in normal rat kidney cells via cleavage by membrane-type 
1-matrix metalloprotease (MT-MMP) [74]. However, N-cadherin has not been studied either in 
acute neuronal ischemia/ATP depletion or in the response to the HD mutation, which elicits a 
chronic energy deficit in a process that culminates in neurodegeneration. 
N-cadherin is a transmembrane cell adhesion glycoprotein comprised of an extracellular 
domain, a single pass transmembrane region, and a cytoplasmic tail [75]. N-cadherin 
molecules make calcium-dependent homophilic bonds between their extracellular domains 
[76]. The cytoplasmic domain contains two main binding regions, the C-terminal domain (CTD) 
and the juxtamembrane domain (JMD). The CTD domain binds β- and γ- catenin, which in turn 
associates with the actin cytoskeleton to modulate cell adhesion and mobility via α-catenin [77, 
78]. The JMD interacts with p120-catenin and with presenilin 1 (PS1), which has emerged as a 
potential regulator of cell adhesion and neuronal physiology [79, 80]. 
Here, we have assessed the candidacy of N-cadherin as an energy-sensitive 
contributor to the striatal cell vulnerability that ensues from the HD mutation. Specifically, we 
have investigated N-cadherin in HdhQ111 CAG knock-in mouse striatum and cultured STHdhQ111 
striatal neuronal cells, which express endogenous full-length 111-glutamine mutant huntingtin. 
We first tested whether N-cadherin was sensitive to acute ATP depletion/ischemia and to the 
chronic effects of full-length mutant huntingtin protein and then we evaluated immortalized 
STHdhQ111 and primary HdhQ111 striatal neurons to explore N-cadherin ATP-sensitivity and the 
phenotypic consequences of decreased N-cadherin function. Our findings reveal that N-
cadherin is an ATP-sensitive protein that is associated with altered HD CAG striatal cell 
adhesion and neuritogenesis.  
Results 
Striatal N-cadherin was sensitive to acute ischemia and to the HD CAG mutation 
To assess whether N-cadherin might be affected in a mild ischemic brain injury 
paradigm, where the striatum displays early vulnerability, we performed transient middle 
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cerebral artery occlusion (MCA-O) with 12-month-old wild-type and mutant HdhQ111/Q111 knock-
in mice. For both genotypes, immunoblot of protein extracts at 24 hours after reperfusion 
(Figure 2.1 A and 2.1 B) revealed robustly decreased N-cadherin in the ischemic, compared to 
the contralateral, striatal hemispheres. By contrast, full-length wild-type 7-glutamine huntingtin 
and 111-glutamine mutant huntingtin, cleaved by calpains in response to severe ischemia [81], 
and α-catenin and β-catenin, were not decreased, though p120 was slightly reduced by 
ischemia, attesting to the mildness of the lesion and demonstrating the exquisite sensitivity of 
N-cadherin in striatum to ischemia/ATP-depletion. 
The immunoblot results also revealed reduced N-cadherin in contralateral HdhQ111/Q111 
striata, compared to the wild-type striata, suggesting an effect of the CAG mutation. This was 
confirmed by immunoblot analysis of wild-type and HdhQ111/Q111 striatal tissues at different ages, 
which revealed a progressive decrease in N-cadherin (normalized to α -tubulin) from 3 months 
to 5 months of age that reached statistical significance by 12 months of age (Figure 2.2). 
Notably, Cad2 mRNA levels were not reduced, in total striatal tissue, following ischemic 
reperfusion or in response to the CAG mutation (data not shown), implying that cell-specific 
and/or multiple mechanisms may contribute to energy-dependent N-cadherin decrease in vivo. 
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Figure 2.1. ATP-sensitive N-cadherin stability. A) A representative coronal section of wild-type 
HdhQ7/Q7 mouse brain, following MCA occlusion/reperfusion, stained with 2,3,5-triphenyltetrazolium 
chloride (TTC), to demonstrate the infarct region (white area) in the left hemisphere (L), as well as the 
contralateral right hemisphere (R). The infarct sizes (mm3 and mean ± standard errors) were 
measured from mice brains of both genotypes at 30 and 60 min MCA occlusion as 33.9 ± 3.64 and 
35.2 ± 3.55 for wild-type brain at 30 and 60 min and 41.5 ± 5.97 and 43.1 ± 6.81 for mutant brain and 
showed no significant differences by genotypes and times (n=3), consistent with the previous report 
(23). B) Immunoblot showing bands of N-cadherin, β-catenin, α-catenin and p120 detected in protein 
extracts of striata from the MCA-occluded hemisphere (L) and contralateral hemisphere (R) for wild-
type HdhQ7/Q7 (Hdh7/7) and mutant HdhQ111/Q111 (Hdh111/111) mice, with 30 min MCA occlusion (30”) 
or 60 min MCA occlusion (60”), demonstrating decreased N-cadherin on the lesion side, relative to the 
α-tubulin loading control band. However, the reduction in N-cadherin was not statistically different 
between two genotypes or two occlusion times (n=3). C) Immunoblot showing bands of N-cadherin, β-
catenin, α-catenin and p120 detected in protein extracts of wild-type STHdhQ7/Q7 (ST7/7) and mutant 
STHdhQ111/Q111 (ST111/111) cells, at time 0 (cont), and 0.5, 1 and 2 h in ATP-depletion medium. The 
adjacent graph plots the relative band intensity of N-cadherin normalized to α-tubulin in the same lane 
(Y-axis), with the time in ATP-depleting medium (X-axis), illustrating decreased N-cadherin in mutant 
cells at baseline and ATP-sensitive degradation of N-cadherin in cells of both genotypes. Bars denote 
the standard deviation from three independent experiments. D) Immunoblot showing N-cadherin in 
extracts of STHdhQ111/Q111 cells, after incubation in medium supplemented with 10 µM adenine for 0, 2, 
4 and 6 days (D), relative to the α-tubulin band. The adjacent bar graph plots the relative N-cadherin 
intensities normalized to the α-tubulin band intensities (Y-axis) for the time points analyzed (X-axis). 
Relative to the untreated control, N-cadherin levels were significantly elevated by day 4 (*P<0.05, 
n=3). 
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Figure 2.2. N-cadherin was decreased with age in striata of HdhQ111/Q111 mice.  Immunoblot showing 
bands of N-cadherin for striata from three HdhQ7/Q7 (Hdh7/7) and three HdhQ111/Q111 (Hdh111/111) 
littermates, demonstrating progressively decreased N-cadherin at 3, 5, and 12 months of age. The 
bar graph below shows relative N-cadherin band-intensity normalized to the α-tubulin band-intensity 
and expressed relative to the wild-type ratio (Relative N-cad/tub), which was significantly decreased 
at 12 months in HdhQ111/Q111striatum (*P<0.05, n=3). Error bars represent standard deviation (±SD). 
 
Striatal cell N-cadherin was sensitive to ATP-depletion and the HD CAG mutation 
 We then assessed whether N-cadherin might be sensitive to ATP-depletion and to the 
CAG mutation in cultured STHdhQ7/7 and STHdhQ111/Q111 striatal neuronal cells, expressing wild- 
type (7-glutamine) and mutant (111-glutamine) full-length huntingtin, respectively. Cells were 
treated with 2-deoxyglucose and antimycin A, to inhibit both glycolysis and mitochondrial 
respiration, and nucleotides in cellular extracts were measured by HPLC analysis. As reported 
previously [65, 67], the baseline [ATP/ADP] was significantly lower in mutant compared to wild-
type, striatal cells, and for both genotypes, [ATP/ADP] was dramatically decreased within two 
hours of energy-depletion (Figure 2.3 A) although cell viability was not significantly changed 
(Figure 2.3 B). 
 Immunoblot analysis revealed that N-cadherin was decreased at baseline in mutant 
striatal cell extracts compared to wild-type, with a progressive reduction over the time-course of 
ATP-depletion for both genotypes (Figure 2.1 C). By contrast, α-catenin, β-catenin, and p120 
levels were similar for cells of either genotype and were not changed by ATP-depletion (Figure 
2.1 C). Thus, N-cadherin level was reduced concomitant with decreased [ATP/ADP], both due 
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to purposeful energy depletion and in response to ATP-deficit due to full-length mutant 
huntingtin. 
Figure 2.3. ATP/ADP and MTS measurement for 
ATP-depletion and adenine supplementation. A) 
The bar graph summarizes HPLC measurements, 
showing progressively decreased [ATP/ADP], 
relative to no treatment of wild-type cells (Y-axis), 
for wild-type STHdhQ7/Q7 (ST7/7) and mutant 
HdhQ111/Q111 (ST111/111) striatal cell extracts, with 
time in ATP-depletion media (X-axis). The baseline 
[ATP/ADP] of mutant striatal cells was significantly 
decreased compared to wild-type striatal cells 
(*P<0.005, n=3), as previously reported, and was 
not as affected by ATP-depletion conditions as the 
wild-type. B) The bar graph plots the results of 
MTS cell viability (Y-axis), with time in ATP-
depletion media (X-axis), revealing no change of 
wild-type (ST7/7) or mutant striatal cell 
(ST111/111) viability. C) The bar graph 
summarizes HPLC measurements, showing 
progressively increased (*P<0.05, n=3) [ATP/ADP] 
ratios (Y-axis) for HdhQ111/Q111 (ST111/111) striatal 
cell extracts, with time in adenine supplemented 
media (X-axis). Error bars represent standard 
deviation (±SD). 
 
 
 
 
 
Further analyses demonstrated that decreased N-cadherin in mutant, compared to wild-
type, striatal cells, reflected decreased Cdh2 mRNA, as demonstrated by the results of RT-
PCR analysis (Figure 2.4 A), as well as increased turnover rate of the protein, which had a half-
life of about two hours in STHdhQ111/Q111 cells compared to a half-life of more than four hours in 
wild-type cells (Figure 2.4 B).  
To explore the energy-sensitivity of these measures, mutant striatal cell culture medium 
was supplemented with adenine, a precursor of high-energy nucleotides. By two days, 
[ATP/ADP] was mildly but significantly elevated (Figure 2.3 C) and by four days of treatment N-
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cadherin was modestly but consistently increased (Figure 2.1 D), though Cad2 mRNA levels 
were not altered over the entire six day time course (data not shown). These results suggested 
that enhanced N-cadherin protein turnover in the mutant striatal cells may involve an energy-
sensitive process, while altered Cad2 mRNA may reflect a different underlying process. 
However, assays to explore the involvement of metalloproteases, activated in ischemia, failed 
to disclose elevated MT-MMP and MT-MMP inhibition with GM-6001 did not alter the half-life of 
N-cadherin in mutant striatal cells (data not shown). 
 
Figure 2.4. N-cadherin expression, turnover, ATP-depletion and N-cadherin overexpression.  
A) The bar graph presents the results of quantitative RT-PCR analysis of Cdh2 mRNA normalized to 
β-actin (Y-axis) for mRNA extracted from wild-type HdhQ7/Q7 (ST7/7) and HdhQ111/Q111 mutant 
(ST111/111) striatal cells incubated in ATP-depletion media for 0 or 2 hours (X-axis). Cdh2 mRNA 
was significantly decreased in mutant cells (*P < 0.005, n = 3), but was not affected by ATP-
depletion. B) Immunoblot showing bands of N-cadherin and a-tubulin for STHdhQ7/Q7 (ST7/7) and 
STHdhQ111/Q111 (ST111/111) striatal cell extracts, after cells were incubated in cyclohexamide for 0-4 
hours to follow the rate of N-cadherin degradation (turnover). The graph below plots the half-life of N-
cadherin (Y-axis degradation rate) by time in cyclohexamide (X-axis), calculated by taking the N-
cadherin/a-tubulin band intensity ratio relative to the ratio at time=0, for wild-type (open square) and 
mutant (closed square) striatal cells, showing the short half-life of N-cadherin in mutant striatal cells 
(about 2 h) compared to wild-type striatal cells (longer than 4 h). Results represent three independent 
experiments and error bars represent standard deviation (±SD). C) Immunoblot showing bands of N-
cadherin and a-tubulin in extracts of wild-type (ST7/7) and mutant (ST111/111) striatal cells 
transfected with 4 µg of control vector (pcDNA3.1) or 2-6 µg of N-cadherin expression vector (phN-
cad), demonstrating increased N-cadherin in mutant striatal cells transfected with phN-cad. 
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STHdhQ111/Q111 cells exhibited deficits in N-cadherin mediated cell-cell adhesion 
The potential functional consequences of decreased N-cadherin in mutant striatal cells 
were then evaluated, beginning with confocal microscopy to investigate N-cadherin sub-cellular 
localization. The wild-type STHdhQ7/Q7 cells exhibited prominent N-cadherin immunostain at 
cell-cell contacts, whereas mutant striatal cells displayed decreased N-cadherin signal that was 
not prominent at cell-cell contacts (Figure 2.5 A), strongly implying a defect in calcium 
dependent N-cadherin mediated cell-cell adhesion [82, 83]. To assess this possibility, wild-type 
STHdhQ7/Q7 and mutant STHdhQ111/Q111 cells were evaluated in a cell-clustering assay, which 
measured the time taken for detached single cells to form clusters (Figure 2.5 B). Within 30 
minutes of dispersal to single cells, 70% of the wild-type cells, but only 30% of the mutant 
striatal cells, formed clusters in Ca2+-containing media, though cells of both genotypes 
exhibited similar Ca2+-independent (in EGTA) cell-clustering. This phenotype was N-cadherin 
dependent, as exogenous expression of N-cadherin, after transfection, raised N-cadherin 
levels to about 50% of wild-type levels (Figure 2.4 C) and partially rescued the mutant cell 
deficit in Ca2+-dependent cluster formation. At 30 minutes after being dispersed, about 20% 
more N-cadherin transfected mutant striatal cells formed clusters in Ca2+ media, compared to 
mutant cells transfected with the control vector (Figure 2.5 C). In the absence of Ca2+ (in 
EGTA), the transfection of N-cadherin had no effect on cell-cell adhesion. 
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Figure 2.5. STHdhQ111/Q111 striatal cells exhibited decreased N-cadherin function. A) Confocal images 
of the N-cadherin immunostain signal (red) in wild-type STHdhQ7/Q7 (ST7/7) and STHdhQ111/Q111 
(ST111/111) striatal cells, indicating decreased N-cadherin signal at STHdhQ111/Q111 cell–cell contacts. 
B) Plot summarizing the results of three independent cell-clustering assays, showing the proportion of 
single cells compared with time zero (Nt/N0) (Y-axis) relative to time of clustering (X-axis) for 
STHdhQ7/Q7 (square) and STHdhQ111/Q111 (circle) striatal cells, in the absence (open symbols) and 
presence (closed symbols) of Ca2+, illustrating that mutant striatal cells exhibit impaired calcium-
dependent clustering. Error bars denote the standard deviation. C) Plot summarizing the results of 
three independent STHdhQ111/Q111 cell-clustering assays for cells transfected with the phN-cad human 
N-cadherin expression vector (squares) or with the control vector (circles), performed in the absence 
(open symbols) and presence (closed symbols) of Ca2+. Error bars denote the standard deviation. D) 
Fluorescence images of STHdhQ7/Q7 (ST7/7) and STHdhQ111/Q111 (ST111/111) striatal cells, showing 
the pattern of DAPI (blue) nuclei, TRITC–phalloidin (red) F-actin signal and anti-cofilin (green) 
immunostain, illustrating decreased nuclear size, paucity of actin stress fibers and bright perinuclear 
cofilin stain of the mutant cells, consistent with an elongated rounded-up (less flat) morphology. The 
adjacent bar graph shows the average phalloidin signal and the total or nuclear area cofilin 
intensities. The average intensity of the phalloidin signal was significantly reduced in mutant striatal 
cells (*P<0.001) and the inset was taken at different exposure conditions to examine the pattern of 
the phalloidin signal in mutant cells. The average intensity of the total cofilin signal was not altered but 
its localization was shifted to the nuclear and perinuclear region (**P<0.001). Error bars represent 
standard errors. 
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STHdhQ111/Q111 cells exhibited deficits in cell-substratum adhesion 
N-cadherin is known to regulate cell-substratum adhesion [84] and actin cytoskeleton 
dynamics [85, 86]. Consequently, co-stained striatal cells were monitored by confocal 
microscopy, to detect DAPI-stained nuclei and F-actin cytoskeleton binding proteins (Figure 2.5 
D). Compared to wild-type STHdhQ7/Q7 cells, the mutant STHdhQ111/Q111 striatal cells appeared 
smaller with elongated shapes, and decreased stress fiber-like rhodamine-phalloidin signal, 
though in flattened cells the pattern of phalloidin-signal resembled that of wild-type cells (Figure 
2.5 D). Consistent with the elongated (less flat) morphology, mutant striatal cells exhibited 
smaller DAPI-stained nuclei and the significant intense cofilin-stain of the mutant cells was 
localized to the nuclear and perinuclear region, although quantification demonstrated that the 
total cofilin signal in mutant and wild-type cells was similar (Figure 2.5 D). The mutant striatal 
cells also exhibited a similar nuclear/perinuclear immunostaining pattern for profilin, another F-
actin-binding protein, which, like cofilin, is involved in actin filament structure and dynamics [87] 
(data not shown). Notably, immunoblot revealed similar levels of F-actin and the actin 
monomer (G-actin) in extracts of mutant and wild-type striatal cells (data not shown). Thus, 
rather than lacking an actin cytoskeleton, the altered subcellular patterns of actin-associated 
proteins, along with decreased N-cadherin, were consistent with the elongated less-flat 
morphology of the striatal cells expressing full-length mutant huntingtin and strongly implied 
deficits in cell-substrate adhesion, as well as cell-cell adhesion. 
HdhQ111/Q111 primary striatal neuronal cells exhibited decreased N-cadherin and immature 
neurites 
N-cadherin mediated cell-substrate adhesion promotes neurite outgrowth [84] and N-
cadherin is required for proper vesicle clustering essential for neurite formation and maturation 
[88-91]. To evaluate the potential impact of full-length mutant huntingtin on N-cadherin function 
in developing striatal neurons, we examined primary neuronal cell cultures from the striatum of 
E14 control and HdhQ111/Q111 knock-in mouse embryos. At day 10 of differentiation (div10), F-
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actin rhodamine-phalloidin binding was assessed by confocal microscopy, as a surrogate for 
proper actin cytoskeleton/cell substratum adhesion, and cultures were immunostained to detect 
MAP2, a neuronal cell microtubule associated protein, to evaluate the developing neuronal cell 
projections. Compared to wild-type primary striatal neuronal cells, the primary HdhQ111/Q111 cells 
exhibited decreased rhodamine-phalloidin stain and an abnormally robust network of fine 
MAP2-stained projections, which confirmed neuronal cell differentiation, while implying altered 
adhesion and development (Figure 2.6). 
 
Figure 2.6. Primary HdhQ111/Q111 striatal neurons exhibit altered cytoskeletal elements. Confocal 
images of primary HdhQ7/Q7 (Hdh7/7) and HdhQ111/Q111 (Hdh111/111) striatal cell cultures at 10 days 
(div10), showing the pattern of rhodamine–phalloidin F-actin signal (left) and anti-MAP2 microtubule 
immunostain (right), illustrating decreased phalloidin signal and an abundance of fine MAP2-positive 
projections of the mutant neuronal cells, consistent with impaired adhesion and altered neuronal cell 
development. The bar graph below plots the fold intensity of the signal in mutant cells relative to wild-
type cells (*P<0.001). Error bars represent standard errors. 
 
Consistent with decreased N-cadherin function, co-staining revealed dramatically 
decreased N-cadherin signal, detected in β-III-tubulin-positive HdhQ111/Q111 striatal neuronal 
cells, compared to the signal intense signal of wild-type striatal cells (Figure 2.7 A), with only 
weak diffuse-stain along cellular the projections instead of the bright punctate pattern of wild-
type cells (Figure 2.7 A inset, quantified in Figure 2.8 A and B). This observation implied that 
 23 
the synaptic vesicles that transport N-cadherin were not clustered, as expected of matured 
neurites, but instead were distributed along the processes in the diffuse pattern characteristic 
of immature neurons [92]. 
 
Figure 2.7. Primary HdhQ111/Q111 striatal neurons displayed decreased N-cadherin signal and 
abnormally extensive neurite networks. A) Confocal images of primary HdhQ7/Q7 (Hdh7/7) and 
HdhQ111/Q111 (Hdh111/111) striatal cell cultures, at 10 days (div10), showing the pattern of N-cadherin 
immunostain (green), β-III-tubulin microtubule immunostain (red) and DAPI-signal marking nuclei 
(blue), with an overlay of all layers (merge), showing in mutant cells decreased N-cadherin signal 
intensity and paucity of bright puncta (inset), concomitant with an extensive network of β-III-tubulin-
positive extensions (neurites). B) Bar graph plotting the total β-III-tubulin-positive neurite length per 
cell, which was significantly increased in the div10 primary HdhQ111/Q111 (Hdh111/111) striatal neuronal 
cells compared with the wild-type HdhQ7/Q7 (Hdh7/7) cells (*P<0.005). Error bars represent standard 
errors. C) As a consequence of HD mutation, several markers of synaptic development showed 
decreased signal intensity, such as N-cadherin (green) and presynaptic markers, synapsin 1 (red in 
the left column) and synaptophysin (red in the right column). Along with a decrease in the markers for 
synaptic development in the HdhQ111/Q111 neurons, there was also a diffuse staining pattern in contrast 
to a punctuated pattern in the wild-type processes. 
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Figure 2.8. Quantification of N-cadherin localization and β-III tubulin-positive neurites. A) The bar 
graph shows the relative amounts of N-cadherin immunosignal compared to mutant neurites (Y-axis) 
for primary wild-type HdhQ7/Q7 (Hdh7/7) and HdhQ111/Q111 (Hdh111/111) neuronal cultures (X-axis), in 
cell bodies (solid color) or in projections, here called neurites (hatched), demonstrating significantly 
decreased N-cadherin signal in primary mutant striatal neuronal cells, in the cell bodies (P<0.01) as 
well as the neurites (P<0.01). B) The bar graph plots the number of N-cadherin-signal puncta or 
‘particles’ (Y-axis) along neurites, as counted in 6 different signal-intensity bins (categories) (X-axis) 
for wild-type HdhQ7/Q7 (blue) and HdhQ111/Q111 (red) striatal neuronal primary cell cultures, illustrating 
that most wild-type neurite particles are of high signal-intensity, while most of the particles in mutant 
striatal neuronal cells are of low-signal intensity, consistent with impaired N-cadherin vesicle 
clustering. C) The montage of images demonstrates the procedure used to determine primary striatal 
cell β-tubulin-positive neurite length in a given field; the β-III-tubulin image was used to define the 
neurite-signal above background-signal (left). The image of the skeletonized neurites was converted 
into a graph where each β-III-tubulin positive neurite was assigned a width of 1 pixel, to equate thick 
and thin neurites (middle), and the sum of all neurites within a field was then calculated by adding 
total assigned neurite pixels. The overlay between the original β-III-tubulin signal and the skeletonized 
neurites is provided (right), to demonstrate that this approach accurately captures the neuronal cell 
neurites. 
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To explore the potential developmental deficits, the β-III tubulin positive neuronal cell 
processes (here called neurites) of day 10 primary neuronal cells were quantified. Automated 
image analysis revealed that mutant cells exhibited a three-fold increase in total length of β-III 
tubulin positive neurites, compared to wild-type striatal neuronal cells (Figure 2.7 B, 
quantification in Figure 2.8), implying delayed maturation of the neurite network. Moreover, co-
staining to detect N-cadherin and markers of synaptic vesicles, synapsin and synaptophysin, 
confirmed this interpretation. The decreased N-cadherin signal, as well as the synapsin and 
synaptophysin vesicle-signals were distributed diffusely within the processes of the mutant 
HdhQ111/Q111 striatal neuronal cells, rather than assuming the bright punctuate matured 
appearance of these markers in wild-type HdhQ7/Q7 striatal cells (Figure 2.7 C). This immature 
pattern, which prominently featured decreased N-cadherin [92], was consistent with decreased 
N-cadherin function and delayed maturation of the network of developing neurites and 
synapses elaborated by the mutant primary neuronal cells. 
HdhQ111/Q111 primary striatal developmental deficit was partially rescued with adenine 
As adenine treatment of mutant STHdhQ111 immortalized striatal cells partially elevated 
[ATP/ADP] (Figure 2.3 C) and partially normalized N-cadherin level (Figure 2.1 D), we 
determined whether adenine treatment might modulate the propensity of primary div 10 E14 
HdhQ111/Q111 striatal neurons to form abnormally extensive neurite networks. As shown in Figure 
2.9, after treatment with adenine for 10 days the div 10 HdhQ111/Q111 striatal cultures exhibited 
MAP2 positive neuronal cells with fewer neurites per cell body, compared to DMSO vehicle 
treated cultures, though the number of cell bodies was not appreciably altered, as shown by 
DAPI nuclear staining. Consistent with the ameliorative effect of adenine on energy measures 
and N-cadherin levels, demonstrated in STHdhQ111 cells, these findings suggest that the 
delayed development of mutant primary neuronal cells may, at least in part, reflect decreased 
function of the ATP-sensitive N-cadherin adhesion molecule.  
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Figure 2.9. Adenine ameliorated altered HdhQ111/Q111 primary striatal neuron neuritogenesis. Confocal 
images of primary HdhQ111/Q111 striatal cell cultures at 10 days (div10), after culture in media 
supplemented with vehicle (DMSO) or with adenine (Adenine), showing MAP2-immunostained 
microtubules (red) and DAPI-stained nuclei (blue) and overlapped images (merge), illustrating that 
adenine-treated neuronal cells displayed a less branched neurite network than vehicle-treated cells. 
The bar graph below shows that adenine supplementation significantly decreased the total length of 
neurites/cell by 25% (*P<0.001), while a similar number of DAPI-stained nuclei confirmed that 
adenine did not result in toxicity or loss of cells. Error bars represent standard errors. 
 
Discussion 
Huntington’s disease is a progressive neurodegenerative disorder, with marked loss of 
the major population of neurons in the striatum (medium size spiny neurons), which are 
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vulnerable to acute energetic challenge. The neuronal specificity of HD stems from the effects 
of the HD CAG repeat, encoding a polyglutamine repeat in the full-length huntingtin protein of 
more than about 37 residues. Multiple groups including our own have discovered that the 
polyglutamine repeat modulates the, as yet unknown, role of full-length huntingtin in negatively 
regulating measures of energy metabolism in human cells and in genetically accurate CAG 
knock-in mice and striatal cells [65, 66, 93]. In the current study, in order to guide in vivo 
investigations of striatal cell vulnerability, we have explored the hypothesis that chronically 
decreased energetics, due to endogenous full-length mutant huntingtin, may affect critical 
aspects of the biology of cultured striatal neuronal cells. 
In a candidate approach, we have evaluated N-cadherin, an integrator of adhesion and 
cytoskeleton signaling required for proper neuronal cell development and synaptic function. N-
cadherin was sensitive to acute ATP-depletion, in striatal tissue and cultured striatal neuronal 
cells, and was strikingly sensitive to the effects of full-length mutant huntingtin. N-cadherin was 
progressively reduced with age in HdhQ111 knock-in mouse striatum and, consistent with a 
defect from birth, was dramatically decreased in cultured STHdhQ111 immortalized neuronal 
cells, generated from embryonic HdhQ111 striatal primordia [94], and in primary cultures of 
embryonic HdhQ111 striatal neurons. 
The molecular basis of decreased N-cadherin in response to full-length mutant 
huntingtin is not yet clear, but in HdhQ111 striatal cells appears to involve regulation of Cad2 
mRNA, as well as N-cadherin protein stability. Chronic energy deficit appears to contribute to 
the latter, but not the former, as adenine nucleotide was able to elevate both [ATP/ADP] and N-
cadherin levels and the rate of N-cadherin turnover was increased, with decreasing ATP and 
[ATP/ADP], while these manipulations did not affect Cad2 mRNA levels, which instead may 
reflect a role for full-length huntingtin in mediating some aspect of Cad2 gene expression or 
mRNA stability. Enhanced N-cadherin turnover in STHdhQ111 striatal cells did not appear to 
involve metalloproteinase-1 (MMP-1, which mediates ischemia-induced turnover of cadherin 
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[73, 74]. MMP-1 levels were not increased in mutant STHdhQ111 striatal cells and N-cadherin 
turnover was unaffected by GM-6001, a specific MMP inhibitor (data not shown). Rather, 
elevated N-cadherin instability may entail altered GTPase regulated N-cadherin 
phosphorylation [8, 95], consistent with decreased STHdhQ111 striatal cell GTP and [GTP/GDP], 
as well as ATP and [ATP/ADP] [65]. However, there are other possibilities: altered calcium-
dependent ligand or catenin binding and internalization, consistent with full-length 
huntingtin/syntaxin 1A regulation of N-type calcium channels [96], or abnormal N-cadherin 
trafficking and/or glycosylation, as implied by the findings that STHdhQ111 and primary HdhQ111 
neuronal cells demonstrated a paucity of clustered N-cadherin and synaptic marker-positive 
vesicles. Certainly, HdhQ111 striatal cells display diverse membrane trafficking defects, involving 
endocytic vesicles [97, 98], autophagic vacuole cargo engulfment [99], and the ER/Golgi 
network [94], attesting to the impact of the polyglutamine repeat on full-length huntingtin 
function in regulating membrane trafficking [94, 98, 100].  
N-cadherin mediated calcium-dependent adhesion-cytoskeletal organization and 
signaling is especially needed for normal neuronal cell development and functionality, for 
example to achieve proper neurite outgrowth, synaptic vesicle clustering in maturing neurons, 
and synapse formation, maturation and dynamics [84, 86, 101-103]. HdhQ111 striatal cells 
exhibited impaired cell-cell, as well as cell-substrate adhesion, deficits in N-cadherin, 
synaptophysin and synapsin vesicle clustering, and immature neurite networks, strongly 
suggesting delayed developmental maturation. In part, chronic energetic deficit contributed to 
impaired N-cadherin function, perhaps via decreased N-cadherin half-life. Adenine, which 
partially normalized STHdhQ111 striatal cell ATP and N-cadherin levels, significantly rescued 
primary HdhQ111 striatal cell neurite development, consistent with the hypothesis that energetic 
state may be a prominent factor in determining N-cadherin levels and function, in cells 
expressing full-length mutant huntingtin. 
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HD is typically assumed to be due to a disease process that begins later in life. 
However, our observation of decreased N-cadherin and delayed development of embryonic 
HdhQ111 striatal neurons in vitro offers a possible explanation for impaired development of the 
striatum in E13.5-15.5 HdhQ111 embryos [104], and for decreased measures of brain 
neurodevelopment in humans with expanded CAG repeats [105], which demonstrate effects of 
the HD CAG repeat that become manifest even before birth. Later in life, N-cadherin was 
progressively decreased, with age, in HdhQ111 striatum, implying chronic synaptic dysfunction, 
as N-cadherin orchestrates activity-modulated CNS synapses [92]. Indeed decreased N-
cadherin may contribute to impaired actin polymerization and long-term potentiation detected in 
HdhQ92 mice [106, 107]. 
Accumulated evidence now supports CAG-dependent energetic deficits in human cells 
and tissues, before onset of overt clinical symptoms, as well as in the brains of symptomatic 
individuals [67, 68, 108-110]. Therefore, it will be of interest to determine whether decreased 
levels of N-cadherin may contribute to the HD pathogenic process, either by contributing to 
subtly altered development that may sensitize striatal cells to the disease process or by 
representing a rate-limiting step in the disease process that is initiated by the impact of the 
polyglutamine-repeat on full-length huntingtin. 
Materials and Methods 
Mice and striatal neuronal cell cultures 
HdhQ111/Q111 knock-in mice have been described previously [111]. Striata were dissected 
from genotyped homozygous mutant HdhQ111/Q111 and wild-type HdhQ7/Q7 littermates from 
heterozygous HdhQ111/Q7 matings, at various ages. Conditionally immortalized wild-type 
STHdhQ7/Q7 striatal cells and homozygous mutant STHdhQ111/Q111 striatal cells, 
generated from HdhQ111/Q111 and HdhQ7/Q7 littermate embryos were described previously [94]. 
The striatal cells were grown at 33°C in Dulbecco’s modified Eagle’s medium supplemented 
with 10% fetal bovine serum, 1% nonessential amino acids, 2 mM L-glutamine, and 400 mg/mL 
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G418 (geneticin; Invitrogen). Primary neuronal cell cultures were set up from striata dissected 
from E14 wild-type HdhQ7/Q7 and mutant HdhQ111/Q111 embryos, from heterozygous HdhQ111/Q7 
matings. 
The striata were dissociated with trypsin (0.5%), trypsin inhibitor (0.1%) and DNAse 
[228 U/mL] treatments for 1 minute each in a 37°C warm water bath. Dissociated cells were 
plated onto poly-L-lysin [0.1 mg/mL] and laminin [50 µg/mL] (Sigma) double-coated coverslips 
in neurobasal medium (GIBCO) supplemented with 2% B27 and 1% 
penicillin/streptomycin/gentamycin. Cells were cultured for 10 days (DIV 10) at 37°C and 5% 
CO2. 
Focal ischemia 
All focal ischemia experiments were conducted in accordance with National Institutes of 
Health, and Massachusetts General Hospital institutional guidelines on animal 
experimentation. 
Three wild-type HdhQ7/Q7 and three HdhQ111/Q111 mice (12 months of age) mice were 
anesthetized with 2% halothane in 70% N2O and 30% O2, and then maintained on 1% 
halothane in a similar gaseous mixture. Transient focal cerebral ischemia was performed using 
an 8-0 nylon monofilament coated with silicone, which was introduced into the internal carotid 
artery via the external carotid artery and then advanced 10 mm distal to the carotid bifurcation 
to occlude the middle cerebral artery (MCA) as described [112]. Laser Doppler flowmetry 
(PF2B; Perimed Stockholm) of relative cerebral blood fluid (CBF) was used to verify successful 
occlusion (<20% baseline value). The MCA was occluded for 0.5 and 1 hour followed by 
withdrawal of filament and reperfusion for 24 hours. Relative CBF returned to >95% of baseline 
values, indicating almost complete reperfusion without residual occlusion. After reperfusion, 
right (control hemisphere) and left (infarct hemisphere) striata from each mouse brain were 
dissected for tissue extraction and immunoblot analysis. 
MTT assay 
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The metabolic activity of mitochondria as indicator of cell viability was estimated by 
MTT assay, based on the conversion of yellow MTT tetrazolium salt to blue insoluble MTT 
formazan product by mitochondrial succinic dehydrogenase. After incubation under ATP 
depletion conditions, the cells were washed twice with PBS and MTT (0.5 mg/mL in PBS) was 
added to each well and incubated for two hours at 33°C. The medium was carefully removed 
and 200 µl of acidified isopropyl alcohol was added to solubilize the colored formazan product. 
Absorbance was read at 550 nm on a multi-well spectrophotometer (Molecular Devices). 
Immunoblot analysis 
Whole cell protein extracts were prepared from harvested striata and striatal cells by 
lysis on ice for 30 minutes in a buffer containing 20 mM HEPES (pH 7.6), 1 mM EDTA, 0.5% 
Triton X-100, protease inhibitor mixture (Roche, Indianapolis, IN), and 1 mM PMSF 
(phenylmethyl sulfonyl fluoride), mixing by tapping every 10 minutes. The total lysates were 
cleared by centrifugation at 14,000g for 30 minutes and the supernatants were collected. The 
protein concentration was determined by using Bio-Rad (detergent compatible) protein assay. 
25 µg of protein extract was mixed with 4X SDS sample buffer, boiled for 2 minutes, and 
subjected to 6 or 10% SDS-PAGE. After electrophoresis, the proteins were transferred to 
nitrocellulose membranes (Schleicher & Schuell) and incubated for 30 minutes in blocking 
solution containing 5% nonfat powered milk in TBS-T (50 mM Tris-HCl, 150 mM NaCl, pH 7.4, 
0.1% Tween 20). The blots were probed overnight at 4°C with primary antibodies: MAB2166 
for huntingtin (Chemicon), N-cadherin (BD-bioscience), α-catenin (Chemicon), β-catenin 
(Sigma), p120 (Sigma), and α-tubulin (Sigma). After four washes of 10 minutes each, in TBS-T, 
the blots were incubated for one hour at room temperature with horseradish peroxidase-
conjugated anti-mouse or anti-rabbit antisera. After a 30-minute wash, the membranes were 
processed using an ECL chemiluminiscence substrate kit (New England Biolabs, Beverly, MA) 
and exposed to autoradiographic film (Hyperfilm ECL; Amersham Bioscience). Quantification of 
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the immunoreactive bands was performed by scanning and analysis using the GS-800 
Calibrated Densitometer and the Quantity One software (BioRad, Hercules, CA). 
Immunocytochemistry 
Wild-type STHdhQ7/Q7 and homozygous mutant STHdhQ111/Q111 cells were grown on four-
chamber glass slides at a density of 2*105 cells/well. The cells were fixed in 4% 
paraformaldehyde for 20 minutes, permeabilized for five minutes in 0.1% Triton X-100 in PBS, 
treated for 30 minutes in blocking buffer (2% bovine serum albumin in PBS) and incubated for 
two hours in blocking solution containing anti-N-cadherin. After several washes in PBS (3 X 5 
min), cells were then incubated for one hour in blocking solution containing anti-mouse 
fluorescent secondary antibody. 
Cells were imaged with a laser confocal microscope (Bio Rad, Hercules, CA) using a 
60X oil objective. Primary cells were fixed with 4% formaldehyde for 10 min followed by 20 min 
of 100% MeOH for permeabilization. Single or double incubation of neurons with various 
primary antibodies was performed overnight at 4°C. The primary antibodies in this study were 
N-cadherin antibody (Abcam; 1:200), β-III-tubulin (Chemicon; 1:500), Cofilin (Sigma: 1:1000), 
Synapsin-1 (Synaptic Systems: 1:1000), Synaptophysin-1 (Synaptic Systems 1:200), and 
MAP2 (EnCor Biotechnology Inc: 1:10,000). For visualization, one-hour treatment with Alexa-
488 and Alexa-568 secondary antibodies (both Molecular Probes, 1:500) was performed. 
Phalloidin-TRITC (Sigma: 1:1000) signal was visualized without secondary antibody. 
Coverslips were fixed onto object glasses using ProLong Gold antifade reagent containing 
DAPI (Invitrogen) for subsequent laser confocal microscopy (Leica). 
Cell-clustering assay 
Sub-confluent striatal cell cultures were incubated for 10 minutes in cold PBS and the 
cells were then collected with a scraper. After washing twice with PBS containing 10 mM 
HEPES-NaOH (pH 7.4), cells were resuspended in PBS containing 10 mM HEPES-NaOH (pH 
7.4), 1 mg/mL BSA, 1 mM EGTA and maintained at 4°C. Before the start of clustering assays, 
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cells were carefully resuspended to ensure single cell suspensions and viability of cells (>90%) 
was confirmed by trypan blue exclusion. Clustering assays, which were performed at 33°C with 
rotation in non-tissue culture 24 well Falcon dishes to prevent cell-dish attachment, were 
started by addition of 50 µl cell suspension (5 Í 106 cells/mL) to 500 µl pre-warmed (33°C) PBS 
containing 1 mg/mL BSA, 10 mM HEPES-NaOH (pH 7.4) and either 2 mM CaCl2 or 2 mM 
EGTA. Incubations were terminated by addition of 500 µl of 5% glutaraldehyde in PBS and 
particle numbers were determined on a Coulter Counter Model Z2 (Beckman Coulter, Fullerton, 
CA). Clustering is expressed as the fractional loss of particle number, Nt/N0, where N0 is the 
particle number at time 0 and Nt the particle number after any given time point. 
RNA extraction and quantitative RT-PCR  
Harvested striatal cells or dissected striata were extracted with TRIzol reagent 
(Invitrogen) and total RNA was extracted according to the manufacturer’s instructions. 
Synthesis of cDNA was performed using Oligo(dT)15 primer and Reverse Transcription 
System (Promega) according to the manufacturer’s instructions. Amplification by PCR was 
performed with 10 µl aliquots of cDNA in a total volume of 50 µl using iQTM SYBR Green 
Supermix (Bio Rad) with a Bio-Rad iCycler (Hercules, CA). Expression of Cdh2 was specifically 
detected using two primers; Cdh2 forward, 5’-AGAGGCCTATCCATGCTGAG-3’ and Cdh2 
reverse, 5’-AGCAGCTTTAAGGCCCTCAT-3’. The thermocycling program used was 30 cycles 
of 95°C 
for 15 seconds, 56°C for 20 seconds, 72°C for 15 seconds, preceded by incubation at 95°C for 
1 minute. A primer set of β-actin, forward, 5’-GACGGCCAGGTCATCACTAT-3’; reverse, 5’- 
ATGCCACAGGATTCCATACC-3’, was used as a positive control to ensure the integrity and 
quantity of RNA. PCR amplification was performed for β-actin under the following conditions: 
95°C for 1 minute; 30 cycles of 95°C for 15 seconds, 54°C for 20 seconds, 72°C for 20 
seconds. 
ΔΔCT method was used to calculate gene expression levels from quantitative RT-RCR [113]. 
 34 
N-cadherin half-life 
STHdhQ7/Q7 and STHdhQ111/Q111 cells plated on 6-well dishes were incubated in growth 
medium containing cyclohexamide at a final concentration of 30 µg/mL for 0, 1, 2, and 4 hours. 
At each time point the cells were washed once with ice-cold phosphate-buffered saline and 
lysed by incubation for 30 minutes in a buffer containing 20 mM HEPES (pH 7.6), 1 mM EDTA, 
0.5% Triton X-100, protease inhibitor mixture (Roche, Indianapolis, IN), and 1 mM PMSF, 
followed by tapping every 10 minutes. The total lysates were then cleared by centrifugation at 
14,000g for 30 minutes and the supernatants were collected. The protein concentration was 
determined using the Bio-Rad (detergent compatible) protein assay and equal amounts of 
protein from each lysate were resolved by 10% SDS PAGE. The proteins were transferred to 
nitrocellulose membranes, blocked in 5% nonfat milk TBS-T, and incubated overnight at 4°C 
with a monoclonal anti N-cadherin antibody. The immunoblot was then probed with horseradish 
peroxidase-conjugated secondary antibody and visualized by ECL reagents. 
ATP depletion 
STHdhQ7/Q7 and STHdhQ111/Q111 cells plated on 6-well dishes were washed twice with 
phosphate-buffered saline (PBS) and then were incubated at 33°C in either normal growth 
medium (control cells) or glucose-free DMEM containing 10 mM 2-deoxyglucose and 10 µM 
antimycin A to yield ATP-depleted cells. After incubation for 0.5, 1, 2 hours, cells were collected 
with a scraper and extracts were generated for immunoblot analysis. 
After ATP-depletion, cells were washed three times with PBS and viability was 
assessed by the MTS assay kit (Promega, Madison, WI). MTS (3-(4,5-dimethylthiazol-2-yl)-5-
(3- 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) solution was added to 
each well, followed by incubation at 33°C for 2 hours. Absorbance was measured at 490 nm on 
a multi-well spectrophotometer (Molecular Devices). For measuring altered ATP nucleotide in 
cells after ATP depletion, HPLC analysis was performed as described previously [67]. 
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Image analysis of primary cultures 
Quantification of immunostain was performed using ImageJ, image analysis software 
available through the NIH website (http://rsb.info.nih.gov/ij/). To determine the area for cells 
(cell bodies and neurites separately) the number of β-III-positive pixels were counted within a 
field of view. For cell bodies, β-III-tubulin staining defined the edges of the cell body, so that the 
total area of the cell body could be determined. Four different fields per genotype were 
analyzed. For quantification of N-cadherin, intensity histograms of N-cadherin in β-III-tubulin 
defined neurites and cell bodies were measured. To obtain the amounts of N-cadherin-signal 
for a specific genotype and the respective cell part, the products of each intensity over a 
threshold value multiplied by the percentage of the area covered by that intensity were added 
up: 
i = maximum intensity 
i = minimum intensity   intensityi * pixeli/total pixel number 
To compare the four different amounts to one another (wild-type cell body, wild-type 
neurites, mutant cell body, mutant cell neurites), the signal-amount in mutant neurites was 
defined as one, and the other three signal amounts were expressed in ratio to this. The number 
of N-cadherin signal particles was determined by using the Analyze particle plug-in of ImageJ. 
30 images of neurites per genotype were analyzed. Images were thresholded 6 times for 
different signal intensity intervals (intensity 30-90, 40-90, 50-90 etc. till 80-90) For each 
thresholded image, the number of particles was calculated (i.e. I30-90, I40-90, I50-90, … I80-90). To 
obtain the number of particles with a specific highest intensity (40, 50, … 90), the number of 
particles within one intensity interval was subtracted from the one of the next lower interval (i.e. 
N30-40 = I30-90 – I40-90). The number of particles was also normalized to the length of neurites. In 
order to determine the total neurite length, in four fields of view per genotype of β-III-tubulin 
images, the cell bodies were removed. The resulting images were skeletonized and the length 
Σ 
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of the skeleton was measured and subsequently divided by the number of DAPI-positive nuclei 
in the appropriate field. 
Statistical analysis 
All cell images were quantified in 10 randomly chosen groups comprising at least 100 
cells and other experiments, such as immunoblot and ATP/ADP measurement, in three 
independent experiments. The mean, standard deviation (SD) and standard error (SE) were 
calculated and statistical significance analyzed using an unpaired two-sample t-test. 
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Chapter 3: 
Characterization of murine embryonic stem cell model of Huntington’s disease4 
 
Attribution 
 Colleagues in the MacDonald lab created the ES cell genetic models of huntingtin 
deficiency and the HD genetic mutation [39]. When I undertook my graduate work, these cell 
systems had fallen out of use. I revived and re-optimized the growth conditions for these cells 
to return them to optimal morphology and pluripotency. I began a preliminary characterization 
of the cytoskeletal structure in the ES models and found initial evidence of a defect in cellular 
adhesion. We quickly decided that neuronal differentiation would be essential to in-depth 
analyses of the cytoskeleton and cell adhesion. Colleagues in the lab began pursuing 
optimization of neuronal differentiation protocols and have, to date, succeeded in deriving 
neuronal progenitor and mature neuronal populations. 
I contributed cellular resources and data to a publication (Appendix B) on gene 
expression profiling of the knock-out and knock-in ES cell models (Figure 3.1) [39]. I also 
supported the training of new lab members in murine ES culturing. In collaboration with my 
colleague, Dr. Marta Biagoli, I contributed cell resources to a characterization of the ES model 
– including pluripotency markers and epigenetic state – under different growth conditions. Dr. 
Biagoli is chiefly responsible for optimizing the neuronal differentiation protocols which can now 
be employed to conduct a more thorough characterization of cytoskeletal phenotypes and 
validate huntingtin conserved function(s) identified in the D. discoideum model. Dr. Randy 
Singh has collaborated with me to investigate cell adhesion phenotypes in the ES cells based 
upon results from the murine striatal cell and D. discoideum models. His work has yielded a 
                                                
4 This chapter contains data that contributed to the following publication and is reprinted here 
with permission: Jacobsen, J.C., et al., HD CAG-correlated gene expression changes support a 
simple dominant gain of function. Hum Mol Genet, 2011. 20(14): p. 2846-60. 
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cell-substrate adhesion assay in the ES cell system that has been optimized for screening with 
small molecules and RNAi. 
Abstract 
 We sought a model cellular system in which effects of huntingtin deficiency, as well as 
the CAG repeat expansion, could be studied to elucidate huntingtin function in the cytoskeleton 
and cell adhesion and its relation to HD. Growth conditions have been optimized for 
maintenance of pluripotent potential and stem cell state on gelatin and mouse embryonic 
fibroblast feeder cells. Preliminary results, suggested that there might be a cell adhesion defect 
related to CAG repeat expansion in ES cells. 
Results and discussion 
An allelic series of heterozygous knock-in (KI) ES cells with varying polyQ lengths, as 
well as a knock-out (dKO) ES cell line have been generated in our lab [14, 38, 39, 114, 115]. I 
undertook an optimization of growth conditions for the murine ES cells WT (HdhQ7/7), dKO 
(Hdhex4/5/ex4/4), KI (HdhQ20/7, HdhQ50/7, HdhQ91/7, HdhQ111/7) (Figure 3.1).  
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Figure 3.1. Characterization of the isogenic ES cell panel. 
A) The images demonstrate the morphology of colonies 
of wild-type parental ES cells (WT), double knock-out 
huntingtin null Hdhex4/5/ex4/5 ES cells (dKO), and Hdh20/7, 
Hdh50/7, Hdh91/7and Hdh111/7 CAG knock-in ES cells 
(Q20/7, Q50/7, Q91/7 and Q111/7, respectively), grown 
in LIF on gelatin-coated dishes. B) Bar plot illustrating 
comparable levels of expression of ES cell stem cell 
marker genes, across the ES cell panel members, 
relating the gene name (x-axis) and microarray probe 
intensity (y-axis). 
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Figure 3.1 (continued). Characterization of the isogenic ES cell panel. C) The images demonstrate 
the morphology of day 4 embryoid bodies, following withdrawal of LIF, for wild-type parental ES cells 
(Q7/7), double knock-out huntingtin null Hdhex4/5/ex4/5 ES cells (dKO), and Hdh20/7, Hdh50/7, Hdh91/7 and 
Hdh111/7 CAG knock-in ES cells (Q20/7, Q50/7, Q91/7 and Q111/7, respectively). D) Composite 
images of bands of RT-PCR amplification products, summarizing the results of analysis of day 4 
embryoid bodies, from members of the ES cell panel, for the expression of endoderm, mesoderm and 
ectoderm marker genes, demonstrating differentiation into the three primary germ layers. Endoderm 
markers:  Afp = alpha-fetoprotein, Pdx1 = pancreatic and duodenal homeobox 1; Mesoderm markers:  
Actc = alpha cardiac actinin, Bry = Brachyury and Ectoderm markers:  Ncam1 = neural cell adhesion 
molecule, Pax6 = paired box gene 6. The results for Hdh91/7 EBs are not shown but confirm formation 
of primary germ layers. Figure reprinted with permission from [39]. 
 
Microarray profiling followed by pathway analysis, revealed that the comparison of 
genome-wide expression changes across the polyQ series and the comparison of deficiency 
versus WT produces two different gene sets with minimal overlap [39]. However, upon pathway 
analysis, there were 13 shared pathways, indicating that the effects of huntingtin deficiency are 
distinct from, but related to, the effects of polyQ expansion. The cytoskeleton and adhesion as 
well as pathways related to cytoskeletal function – including lipid metabolism, energy 
metabolism, reproduction/development/growth, signal transduction, nucleotide metabolism, 
and amino acid/peptide/protein metabolism – were amongst the top pathways to emerge from 
the analysis. 
I conducted a preliminary investigation of cytoskeletal structure in the undifferentiated 
ES cells. Possible changes in the cell/colony morphology exist between the genotypes WT, 
Hdhex4/5/ex4/5, and HdhQ111/7 ES cells on gelatin substrate (Figure 3.2). Most notably, 
immunofluorescence data as well as observations while culturing the cells and differentiating 
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them to embryoid bodies suggest that CAG repeat expansion has an effect on cell adhesion, 
with HdhQ111/7 cells failing to form tight colonies on gelatin. 
WT Hdhex4/5/ex4/5 HdhQ111/Q111 
DAPI Cofilin Phalloidin  
Figure 3.2. Comparison of staining for F-actin (phalloidin, red), cofilin (green), and nucleus (DAPI, 
blue) in WT, HdhQ7/7.and HdhQ111/111 mouse ES cells. Cells were cultured on gelatin for at least three 
passages and then replated on laminin-coated glass coverslips and allowed to settle overnight. The 
next day cells were fixed with 4% formaldehyde and permeabilized with 1% Triton-100, followed by 
co-immunostaining with cofilin and phalloidin antibodies. Coverslips were mounted with Prolong Gold 
reagent containing DAPI. Images are representative of three experiments. 20X magnification. 
 
The localization of cytoskeletal markers is hard to assess given the relative lack of 
cytoskeletal architecture in undifferentiated ES cells. Therefore, I repeated the experiment with 
retinoic acid (RA) differentiated ES cells and assessed the following markers: phalloidin, cofilin, 
N-cadherin, Ezh2, cortactin (data not shown). RA differentiation had a high degree of cell 
toxicity resulting in variable cell density and morphology, which may be related to different 
adhesion properties of the cells with different huntingtin genotypes. Therefore, the localizations 
of cytoskeletal markers were variable and it was difficult to determine trends. A neuronal 
differentiation protocol has now been optimized in the lab that will allow investigation of 
cytoskeletal structure and cell adhesion to be carried out in neuronal progenitors and terminally 
HdhQ 1/7 
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differentiated neurons derived from the knock-out and knock-in ES cells. Moreover, 
encouraged by observations of apparently different adhesion properties of the knock-in 
neurons differentiated from the ES cells, as well as the STHdhQ111 striatal cells (Chapter 2), my 
colleague Dr. Randy Singh has now generated cell adhesion assays that distinguish human 
neuronal progenitor cell lines (from iPS cell lines) with different CAG repeat alleles [48]. 
Meanwhile, I became interested in gaining greater insight into evolutionarily conserved 
cytoskeletal and adhesion functions of huntingtin in the hopes that ancient roles of the protein 
will be crucial to its normal function, help to guide studies of the functional consequences of the 
CAG repeat expansion of the protein in HD, and more quickly yield mechanistic insights which 
can be validated in the optimized mammalian cell systems. 
Methods: 
Modified from: Embryonic Stem Cells: Methods and Procotols. Ed. Turksen, K. Methods in Mol. 
Bio. v.185. Humana Press, 2002. 
Preparation of media 
1. Store media at 4°C until used and discard after 14 days. 
2. Combine reagents and filter through 0.2 µm filter units. 
3. ES cells are sensitive to pH change. When a bottle is half full, filter remaining medium into 
a smaller bottle to minimize air space in the bottle that causes the pH to rise as air gases 
and medium reach equilibrium. 
4. Mouse ES cell medium 
a. Ingredients 
i. KO-DMEM (Invitrogen Cat no. 10829-018, 500 mL) 
ii. 15% ES-qualified FBS (Hyclone) 
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iii. 0.2 mM GlutaMax (Invitrogen) 
iv. 0.1 mM MEM nonessential amino acids (NEAA, 100X; Sigma) 
v. 0.1 mM 2-mercaptoethanol (BME; Sigma) 
vi. 1000 units/mL leukemia inhibitory factor (LIF; Millipore) 
vii. 50 U/mL penicillin/50 µg/mL streptomycin (100X; Cellgro) 
5. Mouse embryonic fibroblast (MEF) medium (same as above without LIF) 
Preparation of gelatin-coated plates 
1. Store and use gelatin solution (ES-qualified, Millipore) at room temperature. 
2. Transfer enough 0.1% gelatin solution to cover the bottom of the dish or well. 
Dish size Volume gelatin (mL) 
4-well 0.5 
24-well 0.5 
12-well 1.0 
6-well 2.0 
6 cm (60 mm) 3.0 
10 cm (100 mm) 6.0 
3. Incubate at room temperature for 30 minutes under the tissue culture hood. 
4. Remove excess gelatin solution and use dishes immediately. Do not allow the gelatin to air 
dry. 
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Preparation of feeder layers 
1. To prepare a fresh 10 cm MEF feeder plate: 
a. Quickly thaw MEF cells. Transfer to 9 mL MEF media in a 15 mL tube and spin to wash. 
Discard supernatant. Resuspend in fresh MEF media and plate. Allow cells to settle 
overnight before use. 
b. Discard feeder cells after 7-10 days. 
c. Prior to plating ES cells on MEFs, aspirate media and wash once with fresh ESC 
media. 
Maintenance of ES cells 
1. Thawing 
a. Remove a vial of cells from the liquid nitrogen freezer and thaw in a 37°C water bath. 
Agitate the vial until the frozen suspension becomes slurry. 
b. Sterilize the vial with 70% ethanol and transfer to the tissue culture hood. 
c. Transfer contents of the vial to a prepared feeder plate containing fresh ES cell 
medium. Vials should have enough cells to evenly plate a 10 cm dish with colonies (~ 
4-6*106 cells). 
d. Gently swirl the plate to distribute cells over the entire surface. 
e. Label the plate with date, cell line, and passage number before returning to incubator. 
2. Daily feeding 
a. Examine the condition of cells and colony formation daily and record observations. 
b. Remove media by aspirating slowly and replace with fresh ES cell media gently by 
adding media to side of plate at least every other day or daily. 
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c. Media volume given dish type 
Dish size Media volume (mL) Cell count 
4-well 0.5 Embryos 
24-well 1.0 2.0 *104 
12-well 2.0 3.0 *105 
6-well 5.0 4.0 *105 
3.5 cm (35 mm) 3.0 4.0 *105 
6 cm (60 mm) 5.0 6.0 *105 
10 cm (100 mm) 15.0 2.0 *106 
4-chamber slide 1.0 1.4 *105 
8-chamber slide 0.5 6.0 *104 
 
3. Subculturing 
a. Examine colony morphology, density, and size to estimate the ratio at which you wish to 
split cells and prepare the number of feeder plates needed. 
i. Decide the ratio to split cultures based on size and distribution of ES cell colonies. 
Growth rate of different cell lines often differs and should be determined for each 
strain. 
ii. Even distribution of colonies averaging in size from 200-400 µm diameter and 
spaced 400 µm apart in a 10 cm plate will have ~ 1-1.5*107 total cells 
iii. Typically split cultures at ratios from 1:6 – 1:8 resulting in ~ 1.5-2.0*106 cells to be 
plated to each new 10 cm plate. Avoid overcrowding and undercrowding. 
b. Remove media and wash with 10 mL PBS. 
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c. Remove PBS and add trypsin 
i. Amount trypsin given dish size 
Dish size Volume gelatin (mL) 
24-well 4 drops/well 
12-well 0.5 
6-well 0.5 
6 cm (60 mm) 1.5 
10 cm (100 mm) 2.0 
 
d. Incubate 1-2 minutes, monitoring the detachment of cells every 30 seconds by gently 
tapping it against your palm. 
e. Once cells are no longer attached, add 8 mL (for 10 cm plate) ES cell media to the 
trypsin cell suspension. Transfer to 15 mL tube and pipette up and down vigorously to 
dissociate cells. 
f. Plate approximately 2*106 cells in each prepared 10 cm plate. You can cryopreserve 
remaining cells as described below. 
4. Freezing (10 cm plate = 4-5 vials with ~ 3-6*106 cells/vial) 
a. Freezing medium 
i. 90% ES cell media 
ii. 10% DMSO 
b. Transfer the cell suspension to a 15 mL tube and pellet cells by low speed 
centrifugation at 100 g for 5 minutes. 
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c. Remove supernatant without disturbing the cell pellet. 
d. Add 1 mL freezing medium for each frozen vial depending on cell number. Pipette up 
and down to dissociated ES cells and transfer 1 mL of cell suspension into each 
cryotube. 
e. Put cryotubes in a Nalgene controlled-rate freezer box and then put the box in the -
80°C freezer overnight. 
f. Transfer the vials of frozen ES cells into liquid nitrogen for long-term storage. 
Subcloning and expanding ES cell colonies 
1. Prepare 24-well plates with a MEF feeder layer as described above at least one day in 
advance. 
2. To pick colonies: 
a. Remove media from each well of 24-well plate and replace with fresh ES cell media. 
b. Select and mark colonies under microscope. Pick colonies that are ~300 µm in 
diameter using a sterile pipette tip. 
c. Transfer colony to a well of a 24-well dish and pipette repeatedly to disrupt cells. Draw 
media from the well up and down in the pipette to transfer all ES cells into the well. 
d. Distribute a single colony per well. 
3. To expand picked colonies: 
a. In the days after you pick colonies, examine each well for the presence of ES cells. 
Record average size and morphology of surviving colonies. 
b. When colonies are ~300 µm in diameter dissociate them. If colonies are smaller, gently 
change the media and leave the cells alone until the next day. 
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i. Remove old media from wells and wash with 0.5 mL PBS. 
ii. Add 4 drops trypsin/well and incubate 1-2 minutes. 
iii. After incubation, vigorously tap dish against palm of hand to dislodge cells 
iv. Once cells are completely dissociated, add 2 mL ES cell media to each well. 
v. The next day, examine each well and record observations of colony morphology 
and number. Change media in wells with 1.5 mL fresh ES cell media. 
vi. To maintain ES cells undifferentiated they must be dissociated usually every other 
day and the media changed daily or every other day. 
vii. Dissociation and/or media changes may need to be done several times in a 24-well 
dish before there are enough ES cells to split 1:2 (half for freezing, half for replating 
and other uses). 
viii. Not all clones grow at the same rate. Each should be handled as a different cell line. 
ix. When there are enough colonies (200-400 µm in diameter) to cover dishes/wells 
while still being spaced approximately 200-400 µm apart, they are ready to split. 
c. To split: 
i. Prepare 12-well dishes with MEF feeder layers as described above. 
ii. Examine each well and mark colonies that will be dissociated and left in the 24-well 
dish and colonies that are ready to split 1:2. Record clone numbers. 
iii. Remove media from each well and wash with PBS 
iv. Add 4 drops trypsin per well and incubate 1-2 min at 37°C 
v. Vigorously tap dish to dissociate all cells 
vi. For wells that are just being dissociated: add 2 mL media to each well 
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vii. For each well to be split 1:2: aspirate 3 mL of media into a 5 mL pipette. Transfer 1 
mL of this media into 1 well of a trypsinized 24-well dish and transfer to a 12-well 
dish. Pipette up and down several times to ensure all cells are completely 
dissociated. Transfer 1.5 mL cell suspension into appropriate pre-labeled cryotube. 
Leaving remaining cell suspension in the 12-well dish to continue growing. 
viii. Pellet cells in cryotubes at 100 g for 5 min. Pour off supernatant and add 0.5 mL 
freezing medium to each vial. Vigorously shake all the vials and place in a 
controlled-rate freezer at -80°C. 
ix. When all clones are transferred into the 12-well dish, fill each well with ES cell 
media to a total of 3 mL. 
x. The next day, transfer vials to a liquid nitrogen freezer for long-term storage. 
Important notes: 
1. Use aseptic technique at all times. Never re-enter a bottle with the same pipette 
2. Use ES-qualified products 
3. ES lines from different strains react differently to serum in the media. When working with 
cell lines from different strains use ALL strains in tests of different serum lots. This is even 
necessary for ES-qualified serum. 
4. ES cells grow more slowly following freeze-thaw and need time to recover. It is not unusual 
to dissociate cells within the same dish or split 1:2. 
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Chapter 4: 
Calcium partially restores EDTA-resistant homotypic cell adhesion in huntingtin 
deficient Dictyostelium discoideum5 
Morgan N. Thompson, James F. Gusella, Marcy E. MacDonald, Michael A. Myre 
 
Attribution 
 I performed the entire body of research on the D. discoideum EDTA-resistant cell 
adhesion defect in huntingtin deficient cells that is presented in this chapter and a manuscript 
regarding this work is in preparation for publication. The adhesion defect that I identified was 
first reported in the original publication characterizing the D. discoideum model of huntingtin 
deficiency, which is also addressed in the introduction to this chapter and included as Appendix 
C [45].  
Abstract 
Huntington’s disease (HD) results from a single causative mutation in the HTT gene 
consisting of an expanded version of a polymorphic polyglutamine tract in the huntingtin 
protein. As the earliest known organism to possess a huntingtin ortholog, D. discoideum is a 
powerful system to study conserved, normal function of huntingtin. We have previously 
demonstrated that huntingtin null (hd-) D. discoideum cells wholly fail to acquire EDTA-resistant 
cell adhesion in shaking starvation culture. Contact site A (csA) is the molecular player 
considered to be primarily responsible for EDTA-resistant adhesion in D. discoideum. Protein, 
but not mRNA, levels of csA are dramatically reduced in hd- cells, yet introduction of csA via an 
overexpression construct fails to rescue the adhesion defect. Interestingly, exogenous calcium 
supplementation is capable of partially restoring EDTA-resistant adhesion in hd- cells in the 
                                                
5 This chapter includes data from a manuscript in preparation as well as already published data 
which is included here and in Appendix C with permission from: Myre, M.A., et al., Deficiency of 
huntingtin has pleiotropic effects in the social amoeba Dictyostelium discoideum. PLoS Genet. 
7(4): p. e1002052. 
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appropriate developmental timeframe and results in normal levels of csA. No defects were 
found in localization or glycosylation of the protein, suggesting that csA protein synthesis or 
turnover is defective in hd- cells. Yet, upon addition of calcium, we demonstrate that hd- cells 
possess all of the necessary machinery to produce csA at normal levels and developmental 
timing. These results spurred an examination of the effects of calcium on EDTA-resistant 
adhesion in csA- cells. Exogenous calcium is able to partially rescue EDTA-resistant adhesion 
in the absence of csA. Together our data suggest that calcium alone is capable of partially 
ameliorating the requirement for csA. Therefore, a novel compensatory pathway that supports 
EDTA-resistant adhesion in the early adhesion phase of D. discoideum development must 
exist independent of csA and huntingtin. 
Introduction 
Huntingtin is a large, multifunctional protein first identified because of the severe 
neurodegenerative human genetic disorder Huntington’s disease, which results from an CAG 
triplet repeat expansion in the HTT gene [5]. Despite two decades of research, the normal 
function(s) of the huntingtin protein remain(s) unknown. Huntingtin is expressed ubiquitously, 
associates with a variety of cellular organelles, interacts with more than 50 proteins, and has 
been implicated in a many essential cellular processes, including transcription, vesicular 
transport, cell adhesion, apoptosis, metabolism, autophagy, and microRNA regulation [6]. In 
mammalian models, polyglutamine expansion of huntingtin alters cellular function long before 
disease symptoms present, suggesting that the mutation may act to initiate the disease 
process via some opportunity afforded by the normal function of the full-length huntingtin 
protein [116]. The difficulty in identifying the normal function of huntingtin in mammalian models 
encourages the use of lower organism models, including recently developed D. discoideum 
huntingtin deficient cells [45, 46].  
Huntingtin appears to have arisen coincidently with multicellularity in evolution. As the 
most ancient organism known to possess a huntingtin ortholog, D. discoideum offers an 
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exceptional model for investigations of evolutionarily conserved huntingtin function. While the 
expansion of the polyglutamine tract first appears in deuterostomes [17, 47], the overall 
structure of huntingtin remains predominately alpha-helical across species [45], lending 
plausibility to the hypothesis that functional conservation will exist. Although the exact 
molecular players may differ, investigation of evolutionarily conserved huntingtin function may 
provide critical insights into essential roles for this protein that can be studied in parallel with 
mammalian experimental systems. 
We previously characterized that loss of huntingtin in D. discoideum results in 
pleiotropic defects in multiple cellular processes throughout different phases of the organisms’ 
lifecycle [45]. Interestingly, D. discoideum hd- cells revealed cytoskeletal and cell adhesion 
defects reminiscent of phenotypes uncovered in mammalian cells that possess the precise 
genetic mutation observed in HD patients [45, 47, 60]. Cellular morphology appears normal in 
nutrient medium, but exposure to starvation conditions immediately causes cell rounding in 
huntingtin deficient cells (Figure 4.1 B, [45]). Phalloidin staining was examined as a direct result 
of parallel lines of experimentation in immortalized striatal cells – detailed in Chapter 2 – and 
revealed aberrant localization of F-actin in cells lacking huntingtin under starvation conditions 
(Figure 4.1 D). Also suggestive of an actin cytoskeletal phenotype is the altered spore shape in 
the absence of huntingtin (Figure 4.2 A), which is reminiscent of D. discoideum actin 
cytoskeletal mutants [117]. 
In addition to the cytoskeletal abnormalities, hd- cells display defective cell adhesion as 
revealed by a number of developmental assays. Upon starvation, D. discoideum cells enter a 
complex developmental program, involving polarized motility, multicellularity, and differentiation 
that culminates in the formation of a fruiting body [59]. The developmental cycle is governed by 
cyclic AMP (cAMP) pulsing that in turn activates a host of other factors, including cell adhesion 
proteins [118]. On starvation agar, WT cells migrate in streams to form mounds by six hours 
(Figure 4.3 A). However, hd- cells fail to stream and instead form mounds by accretion (Figure 
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4.3 B). Furthermore, hd- cells submerged under starvation buffer entirely fail to stream. High 
cell density allowed the hd- cells to form mounds with irregular shape, but did not rescue the 
streaming defect (Figure 4.3 E and F). However, exogenous supplementation with 1mM CaCl2 
is capable of restoring normal development in hd- cells (Figure 4.3 G and H). 
 
 
Figure 4.1. Removal of nutrients caused rounding of hd− cells and affects F-actin localization. A) The 
morphology of hd− cells (right panel) grown and photographed as an adherent culture in HL-5 was 
similar to wild-type cells (left panel). Scale bars (20 µm) are shown on the bottom right. B) Removal of 
nutrients (HL-5) and replacement with starvation buffer (KK2) caused rounding of hd− cells. Cells were 
photographed 20 minutes after the addition of starvation buffer. Wild-type cells (left panel) displayed 
morphology similar to that observed for cells in HL-5 whereas all hd− cells immediately adopted a 
rounded morphology (right panel). Scale bars (20 µm) are shown on the bottom right. C) Aberrant 
localization of F-actin in starved hd− cells. Vegetative wild-type cells (left panel) and hd− cells (right 
panel) collected from axenic medium (HL-5) were deposited into Lab-tek chambered cover glass (8 
well) at 1×105 cells/cm2 and allowed to grow overnight in HL-5 at 21°C. For F-actin staining, the cells 
were fixed with 4% formaldehyde in PDF buffer and then stained with Texas red-phalloidin. Arrows 
indicate membrane extensions enriched with F-actin. D) Localization of F-actin in cells submerged in 
starvation buffer (KK2). One hour after starvation in KK2, wild-type cells retained their normal 
amoeboid morphology (left panel); hd− cells remained rounded and exhibited a redistribution of F-
actin away from the cell cortex as it concentrated in the cytosol (right panel). Nuclei were stained with 
Hoechst 33342. Scale bars (5 µm) are shown on the bottom right. Scale bar 10 µm. Figure 
reproduced here with permission from [45]. 
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Figure 9 
Figure 9 
 
Figure 4.2. hd- cells produced round, calcofluor positive spores with reduced viability. A) Wild-type 
(left panel) and hd- (right panel) spores were collected from 48-72 hour fruiting bodies and viewed 
using brightfield microscopy. Wild-type spores were refractile with an elliptical morphology; hd- fruiting 
bodies produced spores with a dark, round morphology. B) Wild-type (left panel) and hd- spores (right 
panel) were stained with 0.01% calcofluor in spore buffer and viewed by fluorescent microscopy. 
Scale bar 20 mM. C) The viability of wild-type (black bars) and hd- (grey bars) spores was assessed. 
Untreated spores were heated to 45°C for 10 minutes or incubated with 0.5% NP40 detergent for 5 
minutes and aliquots of 100 spores were plated in triplicate onto SM-5 agar plates in a suspension of 
bacteria and grown for 7 days at 21°C. The relative viability of hd- spores was assessed by counting 
the number of clear plaques on the bacterial lawns. Results are representative of three independent 
experiments. Figure reproduced here with permission from [45]. 
 
 
Figure 4.3. hd− cells displayed aggregation defects and failed to stream under submerged culture. 
Wild-type and hd− cells (1×106 cells/mL) were deposited on non-nutrient KK2 agar plates and 
visualized by brightfield microscopy. Images are top view. A) Wild-type cells migrated in streams 
(arrows) to form aggregation territories (m) by ~6 hours. B) hd− cells did not form well-defined 
streams, but rather clusters of cells that formed aggregation centers largely by accretion. Scale bar 
100 µm. C) Wild-type and D) hd− cells (1×105 cells/cm2) were submerged under KK2 and allowed to 
develop for 6 hours. Streams (arrows) of wild-type cells moving into an aggregation center (m) were 
readily apparent (left panel) whereas hd− cells failed to stream (right panel). E) Wild-type and F) hd− 
cells were submerged under buffer at high density (5×106 cells/cm2) and imaged after 20 hours. 
Under these conditions, wild-type cells readily formed distinct organized mounds; high density 
partially restored the ability of hd− cells to form aggregation territories but with an irregular polarized 
shape. (G) Wild-type and (H) hd− cells (1×105 cells/cm2) were submerged under KK2 in the presence 
of 1 mM CaCl2 and imaged after 20 hours; under these conditions exogenous calcium rescues early 
development of hd− cells. Scale bar 100 µm. Figure reproduced here with permission from [45]. 
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Cell adhesion in the early aggregation phase of Dictyostelium development is known to 
be facilitated by two glycoproteins whose expression peaks successively, cad1 and csA [59] 
(Figure 1.3 and 4.5), and can be monitored using an assay that takes advantage of the unique 
ability of Dictyostelium cells to acquire EDTA-resistant adhesion within four hours of initiation of 
development by starvation, in shaking suspension culture [119]. Using this assay I explored the 
homotypic cell adhesion properties of hd- cells in comparison to WT. I discovered that the hd- 
cells wholly failed to acquire EDTA-resistant homotypic adhesion (Figure 4.4) [45]. This 
phenotype mimics the well-characterized adhesion defect of csA- cells. 
 
 
Figure 4.4. Loss of EDTA-resistant adhesion in hd- cells. Wild-type and hd- cells (5×106 cells/mL) 
were developed in Soerensen's buffer at 150 rpm and 21°C. Samples were collected at the start of 
the assay and at one hour time points over a period of 6 hours. For each collection point, cells were 
dissociated by vortexing and then incubated in the presence or absence of 10 mM EDTA for 30 
minutes, fixed with 2% glutaraldehyde (10 min.) and single cells were counted in duplicate using a 
hemocytometer. All experiments were performed in duplicate at least three times and the mean value 
for single cells in duplicate samples, expressed as percentage of total cells, was plotted over time. 
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Figure 4.5. Signaling events in the early aggregation stages of Dictyostelium development. Starving 
amoebae secrete glycoprotein factors, including prestarvation factor and conditioned medium factor, 
that trigger the onset of multicellular development by inducing full expression of early genes and a low 
rate of expression of aggregation genes, including car1 and acA, which in turn initiate pulsatile cAMP 
signaling. cAMP in the cellular and extracellular environment is rapidly hydrolyzed by 
phosphodiesterases to allow for transient pulsing. Cad1 is expressed at basal levels in amoebae and 
is the first adhesion molecule whose expression is upregulated during development to form weak, 
homophilic, EDTA-sensitive interactions. Cad1 is unique in that it is soluble, secreted via the non-
canonical contractile vacuole system, and comprises part of the extracellular matrix. As development 
continues, csA accumulates and is responsible for the acquisition of EDTA-resistant homotypic cell 
adhesion. CsA associates with the plasma membrane via a ceramide-like linkage and indirectly 
associates with the actin binding protein ponticulin. Abbreviations: Cyclic AMP (cAMP), Cyclic GMP 
(cGMP), Calcium-dependent ADhesion Molecule-1(cad1), Contact Site A protein (csA), Loose 
AGregate C (lagC), cAMP Receptor- 1 (car1), Cytosolic Regulator of Adenylate Cyclase (CRAC), 
Adenylate Cyclase of Aggregation Stage (acA), Phosholipase C (PLC), cAMP-dependent Protein 
Kinase A (PKA)  
 
Our current study provides evidence that hd- cells fail to produce the csA protein, 
although normal levels of csA mRNA are present. However, lack of csA alone is not 
responsible for the inability of hd- cells to acquire EDTA-resistant adhesion since we 
 56 
demonstrate that constitutive overexpression of csA is unable to rescue the defect, despite the 
fact that the overexpressed protein is properly localized. Supplementation with calcium or 
magnesium is capable of partially restoring EDTA-resistant adhesion and restores normal csA 
protein levels. Interestingly, the EDTA-resistant adhesion defect of csA- cells is also partially 
rescued by calcium supplementation. These data suggest that calcium is interacting with 
another novel factor independent of csA or huntingtin to facilitate EDTA-resistant adhesion. 
Results 
Huntingtin null cells fail to accumulate csA protein upon starvation 
 Previous studies indicate that the csA protein chiefly governs the maintenance of 
EDTA-resistant homotypic cell adhesion [120, 121]. Therefore, we examined levels of csA in 
hd- cells to determine whether the defect in cell adhesion we observe is due to the csA protein 
(Figure 4.6). As expected, csA protein is present at barely detectable basal levels prior to 
starvation, but accumulates dramatically by six hours of starvation in WT cells. By contrast, hd- 
cells fail to accumulate csA protein in the normal developmental timeframe (Figure 4.6 B). To 
determine if the failure to accumulate csA protein was due to improper gene expression, csA 
levels were assessed by RT-PCR (Figure 4.6 C). CsA mRNA levels in hd- cells mirrored WT, 
indicating that the homotypic cell adhesion defect resulting from huntingtin deficiency was 
instead at the level of either protein translation or stability. Despite the artificiality of the EDTA-
resistant adhesion assay, this experimental method is an effective way of interrogating aspects 
of real biology since disruption of cell-cell contact in early adhesion – in this case, due to 
absence of huntingtin – has developmental consequences when cells are plated on an agar-
based starvation substrate and allowed to develop normally (Figure 4.6 D). 
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Figure 4.6. Huntingtin deficient cells fail to acquire EDTA-resistant homotypic cell adhesion in shaking 
starvation culture. A) hd- cells fail to acquire EDTA resistant cell adhesion in the presence of EDTA 
as measured by relative % single cells. * p-value = 0.0001 ** p-value – 2.6*10-13 Error bars = standard 
deviation of cell counts; N=7. B) Protein levels of csA (80 kD) at 0, 3, and 6 hours of development in 
shaking starvation culture in WT, hd-, csA-, hd- csA OE (overexpression), and cad1- cells probed with 
1:100 csA antibody. C) RT-PCR of csA at 3 and 6 hours of development in shaking starvation culture. 
RT +/- indicates presence or absence of reverse transcriptase. D) Defective cell-cell adhesion results 
in disruption of developmental potential of hd- cells plated on starvation agar after 0-6 hours of 
starvation in liquid shaking culture. 
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Cad1 protein levels and localization are normal in huntingtin deficient cells 
 The defect in cell adhesion could be due to the upstream molecule Cad1 which has 
been proposed to influence csA levels by an unknown mechanism [59]. I established that 
cad1 levels were not significantly altered in the hd- cells (Figure 4.7 A). Therefore, I sought to 
address by immunofluorescence microscopy whether cad1 localization was affected (Figure 
4.7 B). In WT cells at six hours of starvation, cad1 signal concentrated near the plasma 
membrane or in distinct puncta, appearing to decorate contractile vacuoles known to traffic 
cad1 [122, 123]. No significant differences were observed in hd- cells except for a decrease in 
signal at contractile vacuoles (Figure 2 B), which is expected given prior evidence that the 
contractile vacuole system is severely affected by loss of huntingtin [45]. 
 Figure 4.7. Protein levels and localization of 
cad1 in hd- cells compared to WT. A) Western 
blot of cad1 (24 kD) at 0, 3, and 6 hours of 
development in shaking starvation culture. 
Probed with 1:10,000 cad1 antibody and alpha-
tubulin loading control. Representative blot of 
three experiments. B) Cad1 localization unaltered 
in hd- cells in starvation media adherent cultures 
for 0 and 6 hours. Images representative of four 
fields of view. N=1. 
 
 
Overexpression of csA fails to rescue the homotypic adhesion defect in huntingtin deficient cells 
 Constitutive overexpression of csA has been previously demonstrated to rescue the 
absence of EDTA-resistant adhesion in csA- cells [124]. We obtained and introduced this 
expression construct into hd- cells and evaluated EDTA resistant adhesion. Overexpression of 
csA was achieved (Figure 4.6 B and C), but failed to rescue EDTA-resistant adhesion (Fig. 4.8 
A) despite proper localization of the overexpressed protein (Figure 4.8 B).
A B 
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Figure 4.8. A) Overexpression of csA in hd- cells fails to rescue EDTA-resistant adhesion. Error bars 
= standard deviation of cell counts; N=3. B) Localization of csA in WT, hd-, and hd- cells 
overexpressing csA (csA OE) after one hour in starvation medium with (+) and without (-) exogenous 
1mM CaCl2. Representative images from four fields of view. 
A 
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Homotypic cell adhesion in huntingtin deficient cells is not rescued by cAMP pulsing 
 Proper timing and progression of development is governed by cAMP pulsing which is 
suggested to affect csA levels by an unknown mechanism [59]. Huntingtin deficient cells grown 
on a substrate have a characterized defect in synchronicity of cAMP pulsing, which can be 
overcome by exogenous cAMP pulsing [45]. Therefore, I examined whether the defective 
homotypic adhesion of the hd- cells was due to improper extracellular cAMP pulsing by 
providing pulses of 75 nM cAMP every seven minutes for the duration of the adhesion assay 
(Figure 4.9). In WT cells, supplementation with 75 nM cAMP speeds up development such that 
when six hour-starved cells are plated on glass slides, they immediately enter the 
developmental program and begin to stream and develop faster than non-pulsed WT cells 
(Figure 4.9 A). By contrast, hd- cells fail to acquire EDTA resistant adhesion even with cAMP 
pulsing in the adhesion assay (Figure 4.9 B) and remain unable to stream on glass slides 
(Figure 4.9 A). Failure of extracellular cAMP to rescue the hd- adhesion defect suggests that the 
defect is not at the level of synchronicity of pulsing. To determine whether cells lacking 
huntingtin respond appropriately to the extracellular cAMP signal, we measured levels of 
adenylyl cyclase A (acA) expression. As a downstream effector critical for upregulation of 
intracellular cAMP production, acA expression is an indirect readout of the ability of cAMP to 
bind and activate the cAMP receptor (car1) and the intervening cAMP signal relay and transport 
machinery. However, acA mRNA expression was unchanged in hd- cells at six hours 
suggesting that there are no gross abnormalities in cAMP response (Figure 4.9 C). 
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Figure 4.9 Pulsing of cAMP fails to rescue the hd- homotypic cell adhesion defect in starvation media. 
A) Streaming behavior is initiated immediately upon plating of 6h starved cells on glass slides and is 
accelerated in cells pulsed with 75 nM cAMP. By contrast, hd-cells never enter normal streaming 
behavior and are unaffected by cAMP pulsing. 4X magnification, brightfield image. B) 75 nM pulses of 
cAMP were added every 7 min. Error bars = standard deviation of cell counts; N=1. C) RT-PCR of 
acA at 0, 3, and 6 hours of starvation in WT and hd-cells. 
 
Calcium supplementation restores csA levels in huntingtin deficient cells 
 Calcium signaling has well-established roles in cell adhesion and cAMP-dependent 
development [125-127]. Furthermore, the divalent cations magnesium and calcium were 
previously shown to rescue a developmental streaming defect in hd- cells [45]. Therefore, I 
examined whether supplementation with 1 mM CaCl2 affects the adhesion of hd- cells. As seen 
in Figure 4.10 A, supplementation with calcium restored EDTA-resistant cell adhesion as 
measured by percentage of single cells in the normal six-hour developmental window (six hour 
pvalue with EDTA = 0.27 and without EDTA = 0.77). Furthermore, csA protein levels returned to 
normal in hd- cells with calcium supplementation (Fig 4.10 B) and the protein was localized 
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properly (Figure 4.8 B). Calcium was capable of rescuing the % single cell measure of EDTA-
resistant adhesion at concentrations as low as 0.1 mM (data not shown). 
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Figure 4.10. Supplementation with calcium partially rescues EDTA-resistant adhesion in hd- cells and 
enables csA protein synthesis. A) Rescue of hd- homotypic cell adhesion defect with 1mM CaCl2 
supplementation in starvation media. Error bars = standard deviation of cell counts; N=2. B) Western 
blot of csA levels with CaCl2 supplementation, probed with csA antibody and reprobed with cad1 
antibody as a loading control. Loaded in triplicate. Representative blot of three experiments. 
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We sought to more finely characterize the EDTA-resistant adhesion phenotype by 
examining more subtle measures of the aggregation phenotype, including aggregate size and 
morphology. Brightfield microscopy of cells taken from the adhesion assay at the six-hour time 
point reveals that while calcium supplementation restores hd- cell adhesion, as measured by 
percent single cells in the presence of EDTA, the size of aggregates is dramatically reduced 
with no large aggregates, similar to the csA- cells in the presence of EDTA (Figure 4.11). 
However, in presence of calcium without EDTA treatment hd- cells are capable of normal 
aggregate formation. By contrast csA- cells, in the absence of EDTA form aggregates, but the 
aggregate morphology is irregular and much less compact that hd- or WT cells. These data, 
combined with the fact that restoring csA levels in hd- cells by overexpression fails to restore 
EDTA-resistant adhesion, suggest that huntingtin is playing an additional novel role in 
homotypic cell adhesion independent of its effect on csA protein levels.
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Inability to produce csA points to a translation defect in the absence of huntingtin 
 Failure to produce csA in the absence of huntingtin could result from increased turnover 
or decreased synthesis. Glycosylation of csA is known to affect localization and stability of the 
protein [128]. Tunicamycin treatment inhibits N-glycosylation and reveals the 50 kDa and 68 
kDa precursors of csA, as well as the 80 kDa mature, fully-glycosylated, membrane-bound 
isoform [128]. Cells were treated with 0.4 µg/mL tunicamycin at 3 hours of starvation and protein 
extraction was performed at 6 hours of starvation (three hours of tunicamycin treatment). Figure 
4.12 shows all three glycosylated forms of csA could be detected in WT cells. Combined with 
the normal localization of csA in hd- cells supplemented with calcium (Figure 4.8 B), these data 
suggest that improper glycosylation is unlikely to account for the decreased levels of csA in hd- 
cells. 
Figure 4.12. Western blot of WT and hd- cells at 6 hours of 
starvation following 0.4 µg/mL tunicamycin treatment from 
3-6 hours, probed with 1:1000 csa antibody (33-294-17). 
Representative blot of n=3 replicates.  
 
 
 
 
To investigate whether reduced csA protein levels resulted from enhanced protein 
degradation, cells were treated with the proteasome inhibitor lactacystin. After three hours of 
starvation in liquid shaking culture, cells were treated with 10 µM lactacystin for an additional 
three hours. Western blot analysis revealed an accumulation of csA protein by six hours of 
starvation (three hours of lactacystin treatment) in WT cells (Figure 4.13). However, hd- cells 
failed to accumulate csA, providing preliminary evidence that the primary defect resulting in low 
csA levels in the absence of huntingtin is likely not due to increased protein turnover, but rather 
aberrant translation. 
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Figure 4.13. Western blot of WT and hd- cells at 6 hours 
of starvation following treatment with 10 µM lactacystin 
from 3-6 hours of starvation, probed with 1:1000 csa 
antibody (33-294-17). Quantified by densiometry using 
ImageJ. Error bar = standard deviation of three 
replicates; n=3. 
 
 
 
 
 
 
 
 
 
 
Discussion 
Taken together, our results suggest that the lack of csA protein in hd- cells is not a result 
of rapid degradation or failure of transcription, but rather reflects a protein synthesis or 
translation defect in the absence of huntingtin that can be overcome by calcium or magnesium 
supplementation. The fact that calcium or magnesium alone can partially rescue the cell 
adhesion phenotype suggests that huntingtin deficient cells possess all of the machinery 
necessary for csA synthesis and cell adhesion. 
Importantly, csA is not capable of completely restoring EDTA-resistant adhesion in the 
absence of huntingtin, indicating an additional novel role for huntingtin in homotypic cell 
adhesion that is yet to be identified. In the absence of huntingtin or csA, calcium allows for 
transient initial cell-cell contact (within 3-5 minutes of starvation) that may activate 
compensatory intracellular signaling pathways that are capable of supporting homotypic 
adhesion. Recent sequencing and annotation of the D. discoideum genome has identified a 
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number of putative cell adhesion molecules of unknown function so novel molecular players are 
likely to be uncovered. Additionally, the known Ca2+-dependent/EDTA sensitive adhesion 
molecules cad1 and lagC may strengthen cell adhesion in the presence of calcium in a manner 
sufficient to produce partial rescue of adhesion since compensatory roles for these molecules 
have been previously identified and D. discoideum mutants of the three canonical early 
adhesion molecules are fully capable of development despite their respective adhesion defects 
(Figure 1.3) [59]. 
Exactly how calcium alleviates the csA protein translation defect remains to be 
determined. However, calcium has been previously shown to be integral to various aspects of 
protein synthesis [129-131]. Furthermore, colleagues in the lab have characterized a defect in 
osmoregulation and the contractile vacuole (CV) system in hd- cells (manuscript in preparation). 
The CV network in D. discoideum, is a double-membrane structure that helps to regulate water 
and ion homeostasis and is an important store of intracellular calcium in D. discoideum [132, 
133]. It will be interesting to investigate whether the defect in the CV system could be affecting 
calcium signaling or levels in a way that disrupts homotypic cell adhesion in the hd- cells. 
Our study adds to accumulating evidence that the huntingtin protein is involved in 
cytoskeletal biology and this conserved role is manifest functionally in cell adhesion in both D. 
discoideum and mammalian models [47, 60]. Future experiments will focus on gaining 
mechanistic insight into the conserved functional role of huntingtin in the regulation of cell 
adhesion. These investigations will set the stage for follow-up studies to determine the 
relationship between the identified huntingtin function(s) and HD pathogenesis.  
Methods 
Cell culture and development 
 Dictyostelium discoideum AX3 (WT) cells were grown at 21°C either on SM/2 agar 
plates (DictyBase) in the presence of Klebsiella aerogenes, axenically in tissue culture dishes, 
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or in HL5 medium (ForMedium; Norfolk, UK) in 50 mL flasks shaking on a platform shaker at 
150 rpm. All cells were cultured in the presence of streptomycin (300 µg/ml). The hd- cells were 
grown in blasticidin (25 µg/ml). WT and hd- cells were obtained from Dr. Michael Myre, cad- 
cells were from DictyBase, and csA- cells were obtained from Dr. Salvo Bozarro. 
Homotypic cell adhesion assay 
 Homotypic cell adhesion was assessed as described previously with the following 
modifications [134]. Briefly, cells from HL5 shaking cultures were inoculated in fresh HL5 media 
for overnight culture at a density of 2-3*106 cells/mL. Cells were counted by hemocytometer and 
an aliquot containing 5*106 cells/mL was transferred to a 50 mL Falcon tube and centrifuged at 
2500 rpm for 5 min. Cells were washed twice in a half volume of chilled Soerensen’s buffer (SB) 
(DictyBase), resuspended in 15 mL SB, transferred to a 50 mL beaker, and placed on a shaking 
platform at 150 rpm. Cells were collected at various time points in 300 µL aliquots and placed in 
300 µL SB either containing or lacking 10 mM EDTA for 30 minutes in 10 mL beakers. Cells 
were then fixed with glutaraldehyde (company) at a final concentration of 2% for 10 minutes. 
Single cells were counted using a hemocytometer. All experiments were performed in duplicate 
and the average of the single cell counts for the replicates was used to calculate the total 
percentage of single cells normalized to WT and the results were plotted over time. The effect of 
supplementation with CaCl2, MgCl2, MgSO4, and other divalent cations was tested by making 
stock solutions in SB media and resuspending cells in SB containing the ions at 0.1-1 mM 
concentrations from the outset of the adhesion assay after washing. 
Immunoblot analysis 
Whole cell protein extracts were prepared by lysis on ice for one hour in a buffer 
containing 1X RIPA buffer and a Complete mini EDTA-free protease inhibitor tablet (Roche) with 
mixing by tapping every 20 minutes. The total lysates were cleared by centrifugation at 14,000g 
for 10 minutes and the supernatants were collected. The protein concentration was determined 
by using the Pierce BCA protein assay (Thermo Scientific) protein assay. 40 µg of protein 
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extract was mixed with 4X SDS sample buffer, boiled for 5 minutes, and subjected to SDS-
PAGE with 4-12%Tris-Glycine gels (Invitrogen). After electrophoresis, the proteins were 
transferred to Immobilon-P transfer membranes (Millipore) and then incubated for one hour in 
blocking solution containing 5% nonfat powered milk in TBS-T (50 mM Tris-HCl, 150 mM NaCl, 
pH 7.4, 0.1% Tween 20). The blots were probed overnight at 4°C with primary antibodies. After 
four washes of 10 minutes each in TBS-T, the blots were incubated for one hour at room 
temperature with horseradish peroxidase-conjugated anti-mouse or anti-rabbit antisera. After 
three 10-minute washes TBS-T, the membranes were processed using a chemiluminiscence 
detection kit (GE Healthcare) and exposed to autoradiographic film (Hyperfilm ECL; Amersham 
Bioscience). Quantification of the immunoreactive bands was performed by scanning and 
analysis using the GS-800 Calibrated Densitometer and the ImageJ software. 
 For tunicamycin treatment, 0.4 µg/mL tunicamycin was added to the starvation culture at 
three hours of starvation and cells were assessed by immunoblotting at six hours. For 
lactacystin treatment, 10 µM lactacystin was added to the starvation culture at three hours of 
starvation and cells were assessed by immunoblotting at six hours.  
CsA antibody (33-294-17 [128, 135]; Developmental Studies Hybridoma Bank, IA) was 
used at a concentration of 1:1000 for Western blotting. DdCad-1 antiserum was provided by Dr. 
Chi-hung Siu [136] and used at a concentration of 1:10,000 for Western blotting. 
Overexpression of csA 
 The pDCEV csA expression vector was kindly obtained from DictyBase. This vector 
results in constitutive overexpression of csA driven by the actin15 promoter as described 
previously [124]. Transfected cells were kept under constant selection by adding 25 µg/mL 
G418 to the medium. 
Immunofluorescence microscopy 
 CsA localization was examined by gently mixing a 100 µL aliquot of cells, removed from 
shaking suspension culture after five hours of starvation, with 100 µL csA antibody (mAb 448; 
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generously provided by Dr. Salvo Bozarro). The cell-antibody mixture was placed on ice for 20 
minutes with vortexing during the incubation to disaggregate cells. Cells were washed twice with 
PBS, using brief centrifugation to collect cells. Following washes, cells were resuspended in 
secondary antibody (Alexa 488; Invitrogen) at 1:500 dilution and once again incubated on ice for 
20 minutes followed by two PBS washes as described previously and resuspension in PBS. A 
20 µL aliquot of cells was placed on a slide and covered with no. 1.5 coverglass. Cells were 
imaged on a Zeiss microscope at 40 X magnification. 
 The cad1 localization protocol was modified from [122, 136]. Briefly, 1*106 cells/mL were 
plated on a coverslip in a 24-well dish with 1 mL per well HL5 medium and allowed to settle 
overnight. The next day, media was gently aspirated and coverslips were washed two times with 
Sorenson’s starvation buffer. Cells were either fixed immediately (for the zero hour time point) or 
allowed to starve for six hours in 1 mL fresh Sorenson’s starvation buffer (for the six hour time 
point). Cells were washed once with PBS and the fixed with 3.7% formaldehyde in PBS for 15 
min at room temperature. Samples were permeabilized with cold (-20°C) methanol containing 
1% formaldehyde for five minutes. Cells were washed once with PBS and blocked with 1% w/v 
BSA in PBS for 10 minutes, followed by incubation with DdCAD-1 antibody (generously 
provided by Dr. Chi-hung Siu) at 1:200 dilution in PBS with 0.1% BSA for one hour at room 
temperature. Samples were washed three times with PBS containing 0.05% Tween 20 and then 
incubated with Alexa-488 (1:300 dilution) secondary antibody for one hour at room temperature. 
Samples were washed once in PBS and once in water and then mounted in Prolong Gold 
Antifade with DAPI reagent. Cells were imaged on a Zeiss microscope at 40 X magnification. 
RT-PCR analysis 
 RNA extraction was performed with the RNeasy mini kit (Qiagen). Levels of csA and acA 
mRNA expression were measured by RT-PCR using the following primers: for csA forward 
primer 5’- TAA CCA TGG GAA CCT CAA GC -3’ and reverse primer 5’- ACA ATC GAA ACA 
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TGG GCA TT -3’; for acA forward primer 5’- CAA ACA TTT TCC AAA AAT ATA CTC TCA -3’ 
and reverse primer 5’- AAA TCG CTT CTT TTG TAA ATC CA -3’. 
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Chapter 5: 
Discussion and future directions 
 Huntingtin has a function in cellular adhesion 
Using genetic models of huntingtin polyQ expansion in striatal neuronal progenitor cells, 
I provided the first evidence that cell-cell and cell-substrate adhesion is altered. This finding has 
been replicated by a variety of approaches including unbiased gene expression studies [39, 
137] and targeted approaches [47]. My preliminary cell biological investigations of adhesion in 
the mouse embryonic stem cell models of huntingtin deficiency or polyQ expansion suggested 
that ES cells also display altered cell-cell and cell-substrate and that the alteration was different 
in huntingtin deficient compared to polyQ huntingtin expansion cells. I contributed ES cell 
samples to a larger transcriptional profiling study in an effort to gain unbiased global insight into 
what cell adhesion and cytoskeletal changes may be occurring and to address the question of 
whether loss of huntingtin mirrors huntingtin polyQ expansion [39]. In fact, it appears that while 
similar cellular pathways are influenced by either huntingtin deficiency or polyQ expansion, the 
specific genes altered and the direction of gene expression change differs. These studies also 
led directly to the development of a quantitative, embryoid body adhesion assay in 96-well 
format that can be used for future genetic and small molecule screening (Singh-Atwal, et al., 
manuscript in preparation). 
New insights into conserved huntingtin function 
 The findings in D. discoideum greatly reinforce the notion from mammalian cell systems 
that huntingtin plays a role in cellular dynamics related to the cytoskeleton and cell adhesion, 
and further indicate that this function may be evolutionarily conserved. Mechanistic 
understanding of huntingtin function is still lacking, but my results from D. discoideum suggest 
that huntingtin is affecting both translational regulation and playing a role in a novel cell 
adhesion mechanism in early development that remains to be characterized. This research now 
enables dissection of molecular mechanisms through a combination of hypothesis-driven and 
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screening-based approaches by providing optimized genetic models in multiple organisms with 
well-characterized and complementary phenotypes ready for further investigation. 
D. discoideum deficiency rescue with native and human huntingtin 
Rescue of the hd- cell phenotypes with Dictyostelium and human huntingtin are essential 
for ongoing efforts to characterize the normal function of huntingtin and impact of CAG repeat 
length in this model system and validate the usefulness of the model to support parallel 
mammalian and human research. Another group claims to have created a full-length D. 
discoideum hd expression construct with an N-terminal GFP fusion product [46]. However, upon 
obtaining this construct from the DictyBase repository we found that it did not contain the D. 
discoideum hd sequence. 
Numerous attempts to create cloning vectors expressing full-length human or D. 
discoideum huntingtin by colleagues in the lab and by the company GeneArt have failed; the 
main obstacle being the size of the HD gene. Two primary strategies have been tried thus far. 
The first approach involved cloning either the D. discoideum hd cDNA or genomic DNA using 
standard RT-PCR followed by PCR. However, amplification of the full-length gene product failed 
likely due to the size and degree of AT richness of the sequence, which produced many 
homodimers. Altering primers, optimizing polymerases and assay reagents, and attempting to 
clone in three fragments that could be sequentially stitched together are all strategies that were 
tried unsuccessfully by my colleagues and GeneArt independently. The second approach was a 
knock-in homologous recombination strategy to regenerate the genomic hd locus by removal of 
the gene disruption cassette that confers blasticidin resistance and introduction of a GFP 
product for selection. Clones positive for recombination event – as assessed microscopically by 
GFP expression – were obtained but all clones remained resistant to blasticidin and displayed 
characteristics phenotypes of huntingtin deficiency, indicating a failure of the double crossover 
event. 
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Interestingly, rescue of knockout D. discoideum mutants by electroporating endogenous 
D. discoideum or human protein into cells has been previously demonstrated [138]. My 
colleague, Dr. Michael Myre has successfully used this approach to demonstrate that 
introduction of the human huntingtin protein is capable of restoring at least one of the 
osmolarity-related huntingtin deficiency phenotypes (manuscript in preparation). Although this 
approach suffers from low and variable transformation efficiency, it provides important 
preliminary evidence of at least partial conservation of huntingtin function from D. discoideum to 
human. Chimeric mixing experiments with either 1:1 or 2:1 ratios of WT:hd- cells that I 
performed failed to rescue the EDTA-resistant adhesion phenotype (data not shown), 
suggesting that the low transformation efficiency of electroporated protein is unlikely to achieve 
effective rescue. However, my colleagues’ success in rescue of a single cell hd- phenotype with 
purified full-length human huntingtin indicate that at least some functions of huntingtin are likely 
to be conserved and has motivated us to focus cloning efforts on human huntingtin expression 
using newly obtained D. discoideum vectors. Initial attempts to create a construct where human 
huntingtin is expressed from the endogenous D. discoideum promoter produced clones 
expressing the mRNA but that failed to produce the protein, likely as a result of codon bias. My 
colleagues are currently preparing a vector corrected for D. discoideum codon bias and 
anticipate obtaining and using this construct to validate the effect of the human protein on 
known D. discoideum huntingtin deficiency phenotypes in the next six months. Once this 
construct is obtained, modified versions of the construct will be developed with varying CAG 
repeat lengths. These tools are essential for addressing disease relevance of identified 
conserved functions. 
Translation back to mammalian systems and HD 
My research has contributed to mounting proof-of-principle evidence that the D. 
discoideum huntingtin deficiency model will prove useful for identifying evolutionarily conserved 
functions of the huntingtin protein and, by enabling huntingtin-structure function studies, will 
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prove useful for uncovering the effect of the CAG repeat that may ultimately be relevant to HD. 
Indeed, my colleague, Dr. Michael Myre is currently developing expression constructs that will 
lead to establishment of D. discoideum models of CAG repeat length modulation of huntingtin 
function and investigation of the relevance of specific portions of the protein to function. The true 
potential of D. discoideum is not just as a discovery tool of huntingtin conserved function, 
modifiers and interactors, but also as a more rapid guide to triaging the most important lines of 
investigation for parallel study in mammalian systems.  
Development of the D. discoideum model combined with recent advances in the Mus 
musculus genetic models and HD patient-derived cellular systems are currently converging to 
allow simultaneous, mutually informative experimentation. If genetic pathways affected by CAG 
repeat-related huntingtin biology in D. discoideum overlap to some extent with the pathways 
discovered in human patient cells, this would validate the huntingtin conserved function 
approach and facilitate a new round of investigation in D. discoideum, where biological 
discovery may be faster. I have started from the hypothesis that understanding conserved, 
potentially essential, huntingtin function(s) may be crucial to developing effective disease-
modifying therapeutic intervention. If this hypothesis is proven accurate, a synergistic approach 
– harnessing the strengths of each of the genetic model systems to their greatest utility – could 
hasten our understanding of the structural/functional features of the molecular mechanism that 
initiates the disease process that culminates in HD symptoms. This understanding would 
increase the likelihood of being able to treat patients by intervening at the initiation of the 
pathogenic process. 
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Striatal neurons expressing full-length mutant
huntingtin exhibit decreased N-cadherin and
altered neuritogenesis
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The expanded CAG repeat that causes striatal cell vulnerability in Huntington’s disease (HD) encodes a poly-
glutamine tract in full-length huntingtin that is correlated with cellular [ATP] and [ATP/ADP]. Since striatal neur-
ons are vulnerable to energy deficit, we have investigated, in Hdh CAG knock-in mice and striatal cells, the
hypothesis that decreased energetics may affect neuronal (N)-cadherin, a candidate energy-sensitive adhesion
protein that may contribute to HD striatal cell sensitivity. In vivo, N-cadherin was sensitive to ischemia and to the
effects of full-length mutant huntingtin, progressively decreasing in HdhQ111 striatum with age. In cultured
striatal cells, N-cadherin was decreased by ATP depletion and STHdhQ111 striatal cells exhibited dramatically
decreased N-cadherin, due to decreased Cdh2 mRNA and enhanced N-cadherin turnover, which was
partially normalized by adenine supplementation to increase [ATP] and [ATP/ADP]. Consistent with decreased
N-cadherin function, STHdhQ111 striatal cells displayed profound deficits in calcium-dependent N-cadherin-
mediated cell clustering and cell–substratum adhesion, and primary HdhQ111 striatal neuronal cells exhibited
decreased N-cadherin and an abundance of immature neurites, featuring diffuse, rather than clustered, staining
for N-cadherin and synaptic vesicle markers, which was partially rescued by adenine treatment. Thus, mutant
full-length huntingtin, via energetic deficit, contributes to decreased N-cadherin levels in striatal neurons, with
detrimental effects on neurite maturation, strongly suggesting that N-cadherin-mediated signaling merits
investigation early in the HD pathogenic disease process.
INTRODUCTION
The CAG expansion mutation that causes Huntington’s
disease (HD) elongates a polymorphic polyglutamine
segment in the huntingtin protein. Full-length huntingtin
with a polyglutamine region of more than 37 residues
initiates a disease process that culminates in the loss of
neurons, especially in the striatum, and the onset of
the motor, psychiatric and cognitive symptoms (1,2).
Understanding the rate-limiting events that contribute to the
early vulnerability of striatal neurons would guide efforts to
track the natural history of the disease and may provide new
avenues for therapeutic development.
Studies investigating the earliest consequences of full-
length mutant huntingtin, in HD patient cells and tissues and
in genetically accurate Hdh CAG knock-in mouse cells and
tissues, have revealed perturbations in membrane vesicle traf-
ficking, gene transcription, intracellular signaling pathways
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(3–6), as well as altered energetics, characterized by
decreased [ATP] and [ATP/ADP], which is correlated with
the size of the polyglutamine repeat (7–9). We have been
studying the effects of altered energetics because the corre-
lation of energetic measures with the polyglutamine repeat
in full-length huntingtin implies a dominant effect that
conforms to the genetic features of the HD trigger mechanism,
and energetic defects, thought to be important to striatal cells,
may be evident throughout the lifetime of the cell (7–9). Cer-
tainly, early weight loss in HD and a systemic metabolic
defect in branched chain amino acids are consistent with a sys-
temic attempt to compensate for an early energy deficit (10).
Neuronal (N)-cadherin, which is intimately involved in
neuronal cell adhesion, signaling, differentiation and synapse
function (11,12), is a prime candidate for being affected by
energy deficit. Members of the cadherin family exhibit selec-
tive degradation in response to renal ischemia and ATP
depletion (13–15), and in normal rat kidney cells via cleavage
by membrane-type 1 matrix metalloprotease (MT-MMP) (16).
However, N-cadherin has not been studied either in acute
neuronal ischemia and ATP depletion or in response to the
HD mutation, which elicits a chronic energy deficit in a
process that culminates in neurodegeneration.
N-cadherin is a transmembrane cell adhesion glycoprotein
composed of an extracellular domain, a single-pass transmem-
brane region and a cytoplasmic tail (17). N-cadherin mol-
ecules make calcium-dependent homophilic bonds between
their extracellular domains (18). The cytoplasmic domain con-
tains two main binding regions, the C-terminal domain (CTD)
and the juxtamembrane domain (JMD). The CTD binds b- and
g-catenin, which in turn associate with the actin cytoskeleton
to modulate cell adhesion and mobility via a-catenin (19,20).
The JMD interacts with p120-catenin and with presenilin 1,
which has emerged as a potential regulator of cell adhesion
and neuronal physiology (21,22).
Here, we have assessed the candidacy of N-cadherin as an
energy-sensitive contributor to the striatal cell vulnerability
that ensues from the HD mutation. Specifically, we have
investigated N-cadherin in HdhQ111 CAG knock-in mouse
striatum and cultured HdhQ111 striatal neuronal cells, which
express endogenous full-length 111-glutamine mutant hun-
tingtin. We first tested whether N-cadherin was sensitive to
acute ATP depletion/ischemia and to the chronic effects of
full-length mutant huntingtin protein and then we evaluated
immortalized STHdhQ111 and primary HdhQ111 striatal
neurons to explore N-cadherin ATP sensitivity and the pheno-
typic consequences of decreased N-cadherin function. Our
findings reveal that N-cadherin is an ATP-sensitive protein
that is associated with altered HD CAG striatal cell adhesion
and neuritogenesis.
RESULTS
Striatal N-cadherin was sensitive to acute ischemia and to
the HD CAG mutation
To assess whether N-cadherin might be affected in a mild
ischemic brain injury paradigm where the striatum displays
early vulnerability, we performed transient middle cerebral
artery (MCA) occlusion with 12-month-old wild-type HdhQ7/Q7
and mutant HdhQ111/Q111 knock-in mice. For both genotypes,
immunoblot of protein extracts at 24 h after reperfusion
(Fig. 1A and B) revealed robustly decreased N-cadherin in
the ischemic, compared with the contralateral, striatal hemi-
spheres. Both the reduction in N-cadherin and the infarct
size (at 30 and 60 min) were similar in wild-type and mutant
brain, consistent with a previous report demonstrating that
CAG expansion did not sensitize to acute ischemic injury
(23). In contrast, full-length wild-type 7-glutamine huntingtin
and 111-glutamine mutant huntingtin cleaved by calpains in
response to severe ischemia (24), a-catenin and b-catenin
were not decreased, though p120 was slightly reduced by
ischemia, attesting to the mildness of the lesion and demon-
strating the exquisite sensitivity of N-cadherin in the striatum
to ischemia.
The immunoblot results also revealed reduced N-cadherin
in contralateral HdhQ111/Q111 striata compared with wild-type
striata, suggesting an effect of the CAG mutation. This was
confirmed by immunoblot analysis of wild-type and
HdhQ111/Q111 striatal tissues at different ages, which revealed
a progressive decrease in N-cadherin (normalized to
a-tubulin) from 3 to 5 months of age that reached statistical
significance by 12 months of age (Supplementary Material,
Fig. S1).
Notably, N-cadherin (Cdh2) mRNA levels were not reduced
in total striatal tissue, following ischemic reperfusion or in
response to the CAG mutation (data not shown), implying
that cell-specific and/or multiple mechanisms may contribute
to the energy-dependent N-cadherin decrease in vivo.
Striatal cell N-cadherin was sensitive to ATP depletion and
the HD CAG mutation
We then assessed whether N-cadherin might be sensitive
to ATP depletion and to the CAG mutation in
cultured STHdhQ7/Q7 and STHdhQ111/Q111 striatal neuronal
cells expressing wild-type (7-glutamine) and mutant
(111-glutamine) full-length huntingtin, respectively. Cells
were treated with 2-deoxyglucose and antimycin A, to
inhibit both glycolysis and mitochondrial respiration, and
nucleotides in cellular extracts were measured by HPLC
analysis. As reported previously (7,8), the baseline [ATP/
ADP] was significantly lower in mutant, compared with wild-
type, striatal cells, and, for both genotypes, [ATP/ADP] was
dramatically decreased within 2 h of energy depletion (Sup-
plementary Material, Fig. S2A), although cell viability was
not significantly changed (Supplementary Material, Fig.
S2B). Immunoblot analysis revealed that N-cadherin was
decreased at baseline in mutant, compared with wild-type,
striatal cell extracts, with a progressive reduction over the
time course of ATP depletion for both genotypes (Fig. 1C).
In contrast, a-catenin, b-catenin and p120 levels were
similar for cells of either genotype and were not changed by
ATP depletion (Fig. 1C). Thus, the N-cadherin level was
reduced concomitant with decreased [ATP/ADP], both due
to purposeful energy depletion and in response to ATP
deficit due to full-length mutant huntingtin.
Further analyses demonstrated that decreased N-cadherin in
mutant, compared with wild-type, striatal cells reflected
decreased Cdh2 mRNA, as demonstrated by the results of
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RT–PCR analysis (Supplementary Material, Fig. S3A), as
well as the increased turnover rate of the protein, which had
a half-life of 2 h in STHdhQ111/Q111 cells compared with a
half-life of .4 h in wild-type cells (Supplementary Material,
Fig. S3B). To explore the energy sensitivity of these measures,
mutant striatal cell culture medium was supplemented with
adenine, a precursor of high-energy nucleotides. By 2 days,
[ATP/ADP] was mildly but significantly elevated (Supplemen-
tary Material, Fig. S2C), and by 4 days of treatment, N-
cadherin was modestly but consistently increased (Fig. 1D),
though Cdh2 mRNA levels were not altered over the entire
6 day time course (data not shown). These results suggested
that enhanced N-cadherin protein turnover in the mutant stria-
tal cells may involve an energy-sensitive process, while
altered Cdh2 mRNA may reflect a different underlying
process. However, assays to explore the involvement of
metalloproteases, activated in ischemia, failed to disclose
elevated MT-MMP, and MT-MMP inhibition with GM-6001
did not alter the half-life of N-cadherin in mutant striatal
cells (data not shown).
STHdhQ111/Q111 cells exhibited deficits in
N-cadherin-mediated cell–cell adhesion
The potential functional consequences of decreased
N-cadherin in mutant striatal cells were then evaluated, begin-
ning with confocal microscopy to investigate N-cadherin sub-
cellular localization. Wild-type STHdhQ7/Q7 cells exhibited
prominent N-cadherin immunostain at cell–cell contacts,
whereas mutant striatal cells displayed a decreased N-cadherin
signal that was not prominent at cell–cell contacts (Fig. 2A),
strongly implying a defect in calcium-dependent
Figure 1. ATP-sensitive N-cadherin stability. (A) A representative coronal section of wild-type HdhQ7/Q7 mouse brain, following MCA occlusion/reperfusion,
stained with 2,3,5-triphenyltetrazolium chloride (TTC), to demonstrate the infarct region (white area) in the left hemisphere (L), as well as the contralateral right
hemisphere (R). The infarct sizes (mm3 and mean+ standard errors) were measured from mice brains of both genotypes at 30 and 60 min MCA occlusion as
33.9+3.64 and 35.2+3.55 for wild-type brain at 30 and 60 min and 41.5+5.97 and 43.1+6.81 for mutant brain and showed no significant differences by
genotypes and times (n ¼ 3), consistent with the previous report (23). (B) Immunoblot showing bands of N-cadherin, b-catenin, a-catenin and p120 detected in
protein extracts of striata from the MCA-occluded hemisphere (L) and contralateral hemisphere (R) for wild-type HdhQ7/Q7 (Hdh7/7) and mutant HdhQ111/Q111
(Hdh111/111) mice, with 30 min MCA occlusion (30′) or 60 min MCA occlusion (60′), demonstrating decreased N-cadherin on the lesion side, relative to the
a-tubulin loading control band. However, the reduction in N-cadherin was not statistically different between two genotypes or two occlusion times (n ¼ 3). (C)
Immunoblot showing bands of N-cadherin, b-catenin, a-catenin and p120 detected in protein extracts of wild-type STHdhQ7/Q7 (ST7/7) and mutant STHdhQ111/
Q111 (ST111/111) cells, at time 0 (cont), and 0.5, 1 and 2 h in ATP-depletion medium. The adjacent graph plots the relative band intensity of N-cadherin normal-
ized to a-tubulin in the same lane (y-axis), with the time in ATP-depleting medium (x-axis), illustrating decreased N-cadherin in mutant cells at baseline and
ATP-sensitive degradation of N-cadherin in cells of both genotypes. Bars denote the standard deviation from three independent experiments. (D) Immunoblot
showing N-cadherin in extracts of STHdhQ111/Q111 cells, after incubation in medium supplemented with 10 mM adenine for 0, 2, 4 and 6 days (D), relative to the
a-tubulin band. The adjacent bar graph plots the relative N-cadherin intensities normalized to the a-tubulin band intensities (y-axis) for the time points analyzed
(x-axis). Relative to the untreated control, N-cadherin levels were significantly elevated by day 4 (∗P , 0.05, n ¼ 3).
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N-cadherin-mediated cell–cell adhesion (25,26). To
assess this possibility, wild-type STHdhQ7/Q7 and mutant
STHdhQ111/Q111 cells were evaluated in a cell-clustering
assay, which measured the time taken for detached single
cells to form clusters (Fig. 2B). Within 30 min of dispersal
to single cells, 70% of the wild-type cells, but only 30%
of the mutant striatal cells, formed clusters in Ca2+-containing
media, though cells of both genotypes exhibited similar Ca2+-
independent (in EGTA) cell clustering. This phenotype was
N-cadherin dependent, as exogenous expression of
N-cadherin, after transfection, raised N-cadherin levels
to 50% of wild-type levels (Supplementary Material,
Fig. S3C) and partially rescued the mutant cell deficit in Ca2+-
dependent cluster formation. At 30 min after being dispersed,
20% more N-cadherin-transfected mutant striatal cells
formed clusters in Ca2+ media, compared with mutant cells
transfected with the control vector (Fig. 2C). In the absence
of Ca2+ (in EGTA), the transfection of N-cadherin had no
effect on cell–cell adhesion.
STHdhQ111/Q111 cells exhibited deficits in cell–substratum
adhesion
N-cadherin is known to regulate cell–substratum adhesion
(27) and actin cytoskeleton dynamics (28,29). Consequently,
co-stained striatal cells were monitored by epifluorescence
microscopy to detect DAPI-stained nuclei and filamentous
actin (F-actin) cytoskeletal-binding proteins (Fig. 2D). Com-
pared with wild-type STHdhQ7Q/7 cells, the mutant
STHdhQ111/Q111 striatal cells appeared smaller with elongated
shapes, and decreased stress fiber-like rhodamine–phalloidin
signal, though in the inset the pattern of the phalloidin
Figure 2. STHdhQ111/Q111 striatal cells exhibited decreased N-cadherin function. (A) Confocal images of the N-cadherin immunostain signal (red) in wild-type
STHdhQ7/Q7 (ST7/7) and STHdhQ111/Q111 (ST111/111) striatal cells, indicating decreased N-cadherin signal at STHdhQ111/Q111cell–cell contacts. (B) Plot sum-
marizing the results of three independent cell-clustering assays, showing the proportion of single cells compared with time zero (Nt/N0) (y-axis) relative to time of
clustering (x-axis) for STHdhQ7/Q7 (square) and STHdhQ111/Q111 (circle) striatal cells, in the absence (open symbols) and presence (closed symbols) of Ca2+,
illustrating that mutant striatal cells exhibit impaired calcium-dependent clustering. Error bars denote the standard deviation. (C) Plot summarizing the
results of three independent STHdhQ111/Q111 cell-clustering assays for cells transfected with the phN-cad human N-cadherin expression vector (squares) or
with the control vector (circles), performed in the absence (open symbols) and presence (closed symbols) of Ca2+. Error bars denote the standard deviation.
(D) Fluorescence images of STHdhQ7/Q7 (ST7/7) and STHdhQ111/Q111 (ST111/111) striatal cells, showing the pattern of DAPI (blue) nuclei, TRITC–phalloidin
(red) F-actin signal and anti-cofilin (green) immunostain, illustrating decreased nuclear size, paucity of actin stress fibers and bright perinuclear cofilin stain of
the mutant cells, consistent with an elongated rounded-up (less flat) morphology. The adjacent bar graph shows the average phalloidin signal and the total or
nuclear area cofilin intensities. The average intensity of the phalloidin signal was significantly reduced in mutant striatal cells (∗P, 0.001) and the inset was
taken at different exposure conditions to examine the pattern of the phalloidin signal in mutant cells. The average intensity of the total cofilin signal was not
altered but its localization was shifted to the nuclear and perinuclear region (∗∗P , 0.001). Error bars represent standard errors.
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signal resembled that of wild-type cells (Fig. 2D). Consistent
with the elongated (less flat) morphology, mutant striatal
cells exhibited smaller DAPI-stained nuclei and the significant
intense cofilin stain of the mutant cells was localized to the
nuclear and perinuclear region, although quantification
demonstrated that the total cofilin signal in mutant and wild-
type cells was similar (Fig. 2D). The mutant striatal cells
also exhibited a similar nuclear/perinuclear immunostaining
pattern for profilin, another F-actin-binding protein, which,
like cofilin, is involved in actin filament structure and
dynamics (30) (data not shown). Notably, immunoblot
revealed similar levels of F-actin, and actin monomer
(G-actin), in extracts of mutant and wild-type striatal cells
(data not shown). Thus, rather than lacking an actin cytoskele-
ton, the altered subcellular patterns of actin-associated pro-
teins, along with decreased N-cadherin, were consistent with
the elongated, less flat morphology of the striatal cells expres-
sing full-length mutant huntingtin and strongly implied deficits
in cell–substrate adhesion, as well as cell–cell adhesion.
HdhQ111/Q111 primary striatal neuronal cells exhibited
decreased N-cadherin and immature neuritis
N-cadherin-mediated cell–substrate adhesion promotes
neurite outgrowth (27) and N-cadherin is required for proper
vesicle clustering essential for neurite formation and matu-
ration (31–34). To evaluate the potential impact of full-length
mutant huntingtin on N-cadherin function in developing stria-
tal neurons, we examined primary neuronal cell cultures from
the striatum of E14 control and HdhQ111/Q111 knock-in mouse
embryos. At day 10 of differentiation (days in vitro, div10),
F-actin rhodamine–phalloidin binding was assessed by confo-
cal microscopy, as a surrogate for proper actin cytoskeleton/
cell–substratum adhesion, and cultures were immunostained
to detect MAP2, a neuronal cell microtubule-associated
protein, to evaluate the developing neuronal cell projections.
Compared with wild-type primary striatal neuronal cells, the
primary HdhQ111/Q111 cells exhibited decreased rhodamine–
phalloidin stain and an abnormally robust network of fine
MAP2-stained projections, which confirmed neuronal cell
differentiation, while implying altered adhesion and develop-
ment (Fig. 3).
Consistent with decreased N-cadherin function, co-staining
revealed dramatically decreased N-cadherin signal, detected
in b-III-tubulin-positive HdhQ111/Q111 striatal neuronal cells,
compared with the intense signal of wild-type striatal cells
(Fig. 4A), with only weak diffuse stain along the projections
instead of the bright punctate pattern of wild-type cells
(Fig. 4A inset, quantified in Supplementary Material, Fig.
S4A and B). This observation implied that the synaptic vesicles
that transport N-cadherin were not clustered, as expected of
mature neurites, but instead were distributed along the processes
in the diffuse pattern characteristic of immature neurons (35).
To explore the potential developmental deficits, b-III-
tubulin-positive neuronal cell processes (here called neurites)
of div10 primary neuronal cells were quantified. Automated
image analysis revealed that mutant cells exhibited a 3-fold
increase in total length of b-III-tubulin-positive neurites,
compared with wild-type striatal neuronal cells (Fig. 4B, quanti-
fication in Supplementary Material, Fig. S4C), implying
delayed maturation of the neurite network. Moreover,
co-staining to detect N-cadherin and markers of synaptic
vesicles, synapsin and synaptophysin, confirmed this interpret-
ation. The decreased N-cadherin signal, as well as the synapsin
and synaptophysin vesicle signals, was distributed diffusely
within the processes of the mutant HdhQ111/Q111 striatal neur-
onal cells, rather than assuming the bright punctuate matured
appearance of these markers in wild-type HdhQ7/Q7 striatal
cells (Fig. 4C). This immature pattern, which prominently
featured decreased N-cadherin (35), was consistent with
decreased N-cadherin function and delayed maturation of the
network of developing neurites and synapses elaborated by
the mutant primary neuronal cells.
HdhQ111/Q111 primary striatal developmental deficit was
partially rescued with adenine
As adenine treatment of mutant STHdhQ111/Q111-immortalized
striatal cells partially elevated [ATP/ADP] (Supplementary
Material, Fig. S2C) and partially normalized the N-cadherin
level (Fig. 1D), we determined whether adenine treatment
Figure 3. Primary HdhQ111/Q111 striatal neurons exhibit altered cytoskeletal
elements. Confocal images of primary HdhQ7/Q7 (Hdh7/7) and HdhQ111/Q111
(Hdh111/111) striatal cell cultures at 10 days (div10), showing the pattern
of rhodamine–phalloidin F-actin signal (left) and anti-MAP2 microtubule
immunostain (right), illustrating decreased phalloidin signal and an abundance
of fine MAP2-positive projections of the mutant neuronal cells, consistent with
impaired adhesion and altered neuronal cell development. The bar graph
below plots the fold intensity of the signal in mutant cells relative to wild-type
cells (∗P , 0.001). Error bars represent standard errors.
2348 Human Molecular Genetics, 2011, Vol. 20, No. 12
 at Ernst M
ayr Library of the M
useum
 Com
p Zoology, H
arvard U
niversity on O
ctober 8, 2012
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
90
might modulate the propensity of primarydiv10 E14HdhQ111/Q111
striatal neurons to form abnormally extensive neurite net-
works. As shown in Figure 5, after treatment with adenine
for 10 days, the div10 HdhQ111/Q111 striatal cultures exhibited
MAP2-positive neuronal cells with fewer neurites per cell
body compared with DMSO vehicle-treated cultures, though
the number of cell bodies was not appreciably altered, as
shown by DAPI nuclear staining. Consistent with the ameli-
orative effect of adenine on energy measures and N-cadherin
levels demonstrated in STHdhQ111/Q111 cells, these findings
suggest that the delayed development of mutant primary
neuronal cells may, at least in part, reflect decreased function
of the ATP-sensitive N-cadherin adhesion molecule.
DISCUSSION
HD is a progressive neurodegenerative disorder, with marked
loss of the major population of neurons in the striatum
(medium-sized spiny neurons), which are vulnerable to acute
energetic challenge. The neuronal specificity of HD stems
from the effects of the HD CAG repeat, encoding a
Figure 4. Primary HdhQ111/Q111 striatal neurons displayed decreased N-cadherin signal and abnormally extensive neurite networks. (A) Confocal images of
primary HdhQ7/Q7 (Hdh7/7) and HdhQ111/Q111 (Hdh111/111) striatal cell cultures, at 10 days (div10), showing the pattern of N-cadherin immunostain
(green), b-III-tubulin microtuble immunostain (red) and DAPI-signal marking nuclei (blue), with an overlay of all layers (merge), showing in mutant cells
decreased N-cadherin signal intensity and paucity of bright puncta (inset), concomitant with an extensive network of b-III-tubulin-positive extensions (neurites).
(B) Bar graph plotting the total b-III-tubulin-positive neurite length per cell, which was significantly increased in the div10 primary HdhQ111/Q111 (Hdh111/111)
striatal neuronal cells compared with the wild-type HdhQ7/Q7 (Hdh7/7) cells (∗P , 0.005). Error bars represent standard errors. (C) As a consequence of HD
mutation, several markers of synaptic development showed decreased signal intensity, such as N-cadherin (green) and presynaptic markers, synapsin 1 (red
in the left column) and synaptophysin (red in the right column). Along with a decrease in the markers for synaptic development in the HdhQ111/Q111
neurons, there was also a diffuse staining pattern in contrast to a punctuated pattern in the wild-type processes.
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polyglutamine repeat in the full-length huntingtin protein of
more than 37 residues. We and others have discovered
that the polyglutamine repeat modulates the, as yet
unknown, role of full-length huntingtin in negatively regulat-
ing measures of energy metabolism in human cells and in
genetically accurate CAG knock-in mice and striatal cells
(7,8,36). In the current study, in order to guide in vivo inves-
tigations of striatal cell vulnerability, we have explored the
hypothesis that chronically decreased energetics, due to
endogenous full-length mutant huntingtin, may affect critical
aspects of the biology of cultured striatal neuronal cells.
In a candidate approach, we have evaluated N-cadherin, an
integrator of adhesion and cytoskeletal signaling required for
proper neuronal cell development and synaptic function. N-
cadherin was sensitive to acute ATP depletion, in striatal
tissue and cultured striatal neuronal cells, and was strikingly
sensitive to the effects of full-length mutant huntingtin. N-
cadherin was progressively reduced with age in HdhQ111
knock-in mouse striatum and, consistent with a defect from
birth, was dramatically decreased both in cultured
STHdhQ111 immortalized neuronal cells, generated from
embryonic HdhQ111 striatal primordia (37), and in primary cul-
tures of embryonic HdhQ111 striatal neurons.
The molecular basis of decreased N-cadherin in response to
full-length mutant huntingtin is not yet clear, but in
STHdhQ111 striatal cells appears to involve regulation of Cdh2
mRNA, as well as N-cadherin protein stability. Chronic
energy deficit appears to contribute to the latter, but not the
former, as adenine nucleotide was able to elevate both [ATP/
ADP] and N-cadherin levels, and the rate of N-cadherin turn-
over was increased under ATP-depletion conditions, while
these manipulations did not affect Cdh2 mRNA levels, which
instead may reflect a role for full-length huntingtin in mediating
some aspect of Cdh2 gene expression or mRNA stability.
Enhanced N-cadherin turnover in STHdhQ111 striatal cells
did not appear to involve MMP-1, which mediates
ischemia-induced turnover of cadherin (15,16). MMP-1 levels
were not increased in mutant STHdhQ111 striatal cells and
N-cadherin turnover was unaffected by GM-6001, a specific
MMP inhibitor (data not shown). Rather, elevated
Figure 5. Adenine ameliorated altered HdhQ111/Q111 primary striatal neuron neuritogenesis. Confocal images of primary HdhQ111/Q111 striatal cell cultures at 10
days (div10), after culture in media supplemented with vehicle (DMSO) or with adenine (Adenine), showing MAP2-immunostained microtubules (red) and
DAPI-stained nuclei (blue) and overlapped images (merge), illustrating that adenine-treated neuronal cells displayed a less branched neurite network than
vehicle-treated cells. The bar graph below shows that adenine supplementation significantly decreased the total length of neurites/cell by 25% (∗P ¼ 0.001),
while a similar number of DAPI-stained nuclei confirmed that adenine did not result in toxicity or loss of cells. Error bars represent standard errors.
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N-cadherin instability may entail altered GTPase-regulated N-
cadherin phosphorylation (38,39), consistent with decreased
STHdhQ111 striatal cell GTP and [GTP/GDP], as well as ATP
and [ATP/ADP] (8). However, other possibilities include:
altered calcium-dependent ligand or catenin binding and intern-
alization, consistent with full-length huntingtin/syntaxin 1A
regulation of N-type calcium channels (40), impaired N-
cadherin membrane association due to altered cholesterol
metabolism (41,42) or abnormal N-cadherin precursor proces-
sing, trafficking and/or glycosylation, as implied by the findings
that STHdhQ111 and primary HdhQ111 neuronal cells demon-
strated a paucity of clustered N-cadherin and synaptic marker-
positive vesicles. Certainly, STHdhQ111 striatal cells display
diverse membrane trafficking defects, involving endocytic ves-
icles (43,44), autophagic vacuole cargo engulfment (45) and the
ER/Golgi network (37), attesting to the impact of the polygluta-
mine repeat on full-length huntingtin function in regulating
membrane trafficking (37,43,46).
N-cadherin-mediated calcium-dependent adhesion/cyto-
skeletal organization and signaling are especially needed for
normal neuronal cell development and functionality, for
example to achieve proper neurite outgrowth, synaptic vesicle
clustering in maturing neurons, and synapse formation, matu-
ration and dynamics (27,29,47–49). Mutant striatal cells exhib-
ited impaired cell–cell, as well as cell–substrate adhesion,
deficits in N-cadherin, synaptophysin and synapsin vesicle clus-
tering and immature neurite networks, strongly suggesting
delayed developmental maturation, though this interpretation
remains to be tested. In part, the chronic energetic deficit con-
tributed to impaired N-cadherin function, perhaps via decreased
N-cadherin half-life. Adenine, which partially normalized
STHdhQ111 striatal cell ATP and N-cadherin levels, signifi-
cantly rescued primary HdhQ111 striatal cell neurite develop-
ment, consistent with the hypothesis that the energetic state
may be a prominent factor in determining N-cadherin levels
and function in cells expressing full-length mutant huntingtin.
HD is typically assumed to be due to a disease process that
begins later in life. However, our observation of decreased N-
cadherin and delayed development of embryonic HdhQ111
striatal neurons in vitro offers a possible explanation for
impaired development of the striatum in E13.5–15.5
HdhQ111 embryos (50), and for decreased measures of brain
neurodevelopment in humans with expanded CAG repeats
(51), which demonstrate effects of the HD CAG repeat that
become manifest even before birth. Later in life, N-cadherin
progressively decreased with age in HdhQ111 striatum, imply-
ing chronic synaptic dysfunction, as N-cadherin orchestrates
activity-modulated CNS synapses (35). Indeed, decreased N-
cadherin may contribute to impaired actin polymerization
and long-term potentiation detected in HdhQ92 mice (52,53).
Accumulated evidence now supports CAG-dependent ener-
getic deficits in human cells and tissues, before onset of overt
clinical symptoms, as well as in the brains of symptomatic
individuals (7,10,54–56). Therefore, it will be important to
determine whether decreased levels of N-cadherin may con-
tribute to the HD pathogenic process, in a manner that is
specific to striatal neurons, thereby contributing to the early
vulnerability of the striatum, compared with other brain
regions. Furthermore, it will be of interest to determine
whether subtly altered development may sensitize striatal
cells, and perhaps other neuronal cells, to the disease
process or may represent a rate-limiting step in the disease
process that is initiated by the impact of the polyglutamine
repeat on full-length huntingtin.
MATERIALS AND METHODS
Mice and striatal neuronal cell cultures
HdhQ111/Q111 knock-in mice have been described previously
(57). Striata were dissected from genotyped homozygous
mutant HdhQ111/Q111 and wild-type HdhQ7/Q7 littermates from
heterozygous HdhQ111/Q7 matings, at various ages. Con-
ditionally immortalized wild-type STHdhQ7/Q7 striatal cells
and homozygous mutant STHdhQ111/Q111 striatal cells, gener-
ated from HdhQ111/Q111 and HdhQ7/Q7 littermate embryos,
were described previously (37). The striatal cells were grown
at 338C in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum, 1% non-essential
amino acids, 2 mM L-glutamine and 400 mg/ml G418 (Geneti-
cin; Invitrogen). Primary neuronal cell cultures were set up
from striata dissected from E14 wild-type HdhQ7/Q7 and
mutant HdhQ111/Q111 embryos, from heterozygous HdhQ111/Q7
matings. The striata were dissociated with trypsin (0.5%),
trypsin inhibitor (0.1%) and DNase (228 U/ml) treatments for
1 min each in a 378C warm water bath. Dissociated cells were
plated onto poly-L-lysine (0.1 mg/ml) and laminin (50 mg/ml)
(Sigma) double-coated coverslips in neurobasal medium
(GIBCO) supplemented with 2% B27 and 1% penicillin/strepto-
mycin/gentamycin. Cells were cultured for 10 days (div10) at
378C and 5% CO2.
Focal ischemia
All focal ischemia experiments were conducted in accordance
with the National Institutes of Health and Massachusetts
General Hospital institutional guidelines on animal exper-
imentation. Three wild-type HdhQ7/Q7 and three HdhQ111/
Q111 mice (12 months of age) were anesthetized with 2%
halothane in 70% N2O and 30% O2, and then maintained on
1% halothane in a similar gaseous mixture. Transient focal
cerebral ischemia was performed using an 8-0 nylon monofila-
ment coated with silicone, which was introduced into the
internal carotid artery via the external carotid artery and
then advanced 10 mm distal to the carotid bifurcation to
occlude the MCA as described (58). Laser Doppler flowmetry
(PF2B; Perimed Stockholm) of relative cerebral blood fluid
(CBF) was used to verify successful occlusion (,20% base-
line value). The MCA was occluded for 0.5 and 1 h followed
by withdrawal of filament and reperfusion for 24 h. Relative
CBF returned to .95% of baseline values, indicating almost
complete reperfusion without residual occlusion. After reper-
fusion, right (control hemisphere) and left (infarct hemisphere)
striata from each mouse brain were dissected for tissue extrac-
tion and immunoblot analysis.
Immunoblot analysis
Whole-cell protein extracts were prepared from harvested
striata and striatal cells by lysis on ice for 30 min in a buffer
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containing 20 mM HEPES (pH 7.6), 1 mM EDTA, 0.5% Triton
X-100, protease inhibitor mixture (Roche, Indianapolis, IN,
USA) and 1 mM phenylmethyl sulfonyl fluoride (PMSF),
mixed by tapping every 10 min. The total lysates were cleared
by centrifugation at 14 000g for 30 min and the supernatants
were collected. Protein concentration was determined by the
Bio-Rad (detergent compatible) protein assay. An amount of
25 mg of protein extract was mixed with 4× SDS sample
buffer, boiled for 2 min and subjected to 6 or 10% SDS–
PAGE. After electrophoresis, the proteins were transferred to
nitrocellulose membranes (Schleicher & Schuell) and incubated
for 30 min in blocking solution containing 5% non-fat pow-
dered milk in TBS-T (50 mM Tris–HCl, 150 mM NaCl, pH
7.4, 0.1% Tween 20). The blots were probed overnight at 48C
with primary antibodies: MAB2166 for huntingtin (Chemicon),
N-cadherin (BD-bioscience), a-catenin (Chemicon), b-catenin
(Sigma), p120 (Sigma) and a-tubulin (Sigma). After four
washes of 10 min each in TBS-T, the blots were incubated for
1 h at room temperature with horseradish peroxidase-
conjugated anti-mouse or anti-rabbit antisera. After a 30 min
wash, the membranes were processed using an ECL chemilumi-
nescence substrate kit (New England Biolabs, Beverly, MA,
USA) and exposed to autoradiographic film (Hyperfilm ECL;
Amersham Bioscience). Quantification of the immunoreactive
bands was performed by scanning and analysis using the
GS-800 Calibrated Densitometer and the Quantity One software
(BioRad, Hercules, CA, USA).
Immunocytochemistry
Wild-type STHdhQ7/Q7 and homozygous mutant STHdhQ111/Q111
cells were grown on 4-chamber glass slides at a density of 2 ×
105 cells/well. The cells were fixed in 4% paraformaldehyde for
20 min, permeabilized for 5 min in 0.1% Triton X-100 in
phosphate-buffered saline (PBS), treated for 30 min in blocking
buffer [2% bovine serum albumin (BSA) in PBS] and incubated
for 2 h in blocking solution containing anti-N-cadherin. After
several washes in PBS (3 × 5 min), cells were incubated for
1 h in blocking solution containing the anti-mouse fluorescent
secondary antibody. Cells were imaged with a laser confocal
microscope (Leica) using a 60× oil objective. Primary cells
were fixed with 4% formaldehyde for 10 min, followed by
20 min of 100% MeOH for permeabilization. Single or double
incubation of neurons with various primary antibodies was per-
formed overnight at 48C. The primary antibodies in this study
were N-cadherin antibody (Abcam; 1:200), b-III-tubulin (Che-
micon; 1:500), Cofilin (Sigma: 1:1000), Synapsin-1 (Synaptic
Systems: 1:1000), Synaptophysin-1 (Synaptic Systems 1:200)
and MAP2 (EnCor Biotechnology Inc: 1:10 000). For visualiza-
tion, 1 h treatment with Alexa-488 and Alexa-568 secondary
antibodies (both Molecular Probes, 1:500) was performed.
The Phalloidin–TRITC (Sigma: 1:1000) signal was visualized
without the secondary antibody. Coverslips were fixed onto
object glasses using ProLong Gold antifade reagent containing
DAPI (Invitrogen) for subsequent laser confocal microscopy
(Leica) or epifluorescence microscopy (Zeiss).
Cell-clustering assay
Sub confluent striatal cell cultures were incubated for 10 min
in cold PBS and the cells were then collected with a scraper.
After washing twice with PBS containing 10 mM HEPES–
NaOH (pH 7.4), cells were resuspended in PBS containing
10 mM HEPES–NaOH (pH 7.4), 1 mg/ml BSA, 1 mM EGTA
and maintained at 48C. Before the start of clustering assays,
cells were carefully resuspended to ensure single-cell suspen-
sions, and viability of cells (.90%) was confirmed by trypan
blue exclusion. Clustering assays, which were performed at
338C with rotation in non-tissue culture 24-well Falcon
dishes to prevent cell–dish attachment, were started by
addition of 50 ml of cell suspension (5 × 106 cells/ml) to
500 ml of pre-warmed (338C) PBS containing 1 mg/ml BSA,
10 mM HEPES–NaOH (pH 7.4) and either 2 mM CaCl2 or
2 mM EGTA. Incubations were terminated by addition of
500 ml of 5% glutaraldehyde in PBS and particle numbers
were determined on a Coulter Counter Model Z2 (Beckman
Coulter, Fullerton, CA, USA). Clustering is expressed as the
fractional loss of particle number, Nt/N0, where N0 is the
particle number at time 0 and Nt is the particle number after
any given time point.
RNA extraction and quantitative RT–PCR
Harvested striatal cells or dissected striata were extracted with
TRIzol reagent (Invitrogen) to isolate total RNA according to
the manufacturer’s instructions. cDNA was synthesized using
Oligo(dT)15 primer and Reverse Transcription System
(Promega) according to the manufacturer’s instructions. Ampli-
fication by PCR was performed with 10 ml aliquots of cDNA in
a total volume of 50 ml using iQTM SYBR Green Supermix
(Bio Rad) with a Bio-Rad iCycler (Hercules, CA, USA).
Expression of Cdh2 was specifically detected by using two
primers: Cdh2 forward, 5′-AGAGGCCTATCCATGCT
GAG-3′ and Cdh2 reverse, 5′-AGCAGCTTTAAGGC
CCTCAT-3′. The thermocycling program used began with
incubation at 958C for 1 min, followed by 30 cycles of 958C
for 15 s, 568C for 20 s and 728C for 15 s. A primer set of
b-actin, forward, 5′-GACGGCCAGGTCATCACTAT-3′,
reverse, 5′-ATGCCACAGGATTCCATACC-3′, was used as a
positive control to ensure the integrity and quantity of RNA.
PCR amplification was performed for b-actin under the follow-
ing conditions: 958C for 1 min; 30 cycles of 958C for 15 s, 548C
for 20 s and 728C for 20 s. The DDCT method was used to cal-
culate gene expression levels from quantitative RT–PCR (59).
N-cadherin half-life
STHdhQ7/Q7 and STHdhQ111/Q111 cells plated on 6-well dishes
were incubated in growth medium containing cycloheximide
at a final concentration of 30 mg/ml for 0, 1, 2 and 4 h. At
each time point, the cells were washed once with ice-cold
PBS and lysed by incubation for 30 min in a buffer containing
20 mM HEPES (pH 7.6), 1 mM EDTA, 0.5% Triton X-100,
protease inhibitor mixture (Roche, Indianapolis, IN, USA)
and 1 mM PMSF, followed by tapping every 10 min. The
total lysates were then cleared by centrifugation at 14 000g
for 30 min and the supernatants were collected. The protein
concentration was determined by the Bio-Rad (detergent com-
patible) protein assay and equal amounts of protein from each
lysate were resolved by 10% SDS–PAGE. The proteins were
transferred to nitrocellulose membranes, blocked in 5%
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non-fat milk TBS-T and incubated overnight at 48C with a
monoclonal anti N-cadherin antibody. The immunoblot was
then probed with horseradish peroxidase-conjugated second-
ary antibody and visualized by ECL reagents.
ATP depletion
STHdhQ7/Q7 and STHdhQ111/Q111 cells plated on 6-well dishes
were washed twice with PBS and then were incubated at 338C
in either normal growth medium (control cells) or glucose-free
DMEM containing 10 mM 2-deoxyglucose and 10 mM antimy-
cin A to yield ATP-depleted cells. After incubation for 0.5, 1
and 2 h, cells were collected with a scraper and extracts were
generated for immunoblot analysis.
After ATP depletion, viability was assessed by the MTS assay
kit (Promega, Madison, WI, USA). Prior to the assay, cells were
washed three times with PBS. MTS [3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetr-
azolium, inner salt] solution was added to each well, followed
by incubation at 338C for 2 h. Absorbance was measured at
490 nm on a multi-well spectrophotometer (Molecular
Devices). For measuring altered ATP nucleotide in cells after
ATP depletion, HPLC analysis was performed as described pre-
viously (7).
Image analysis of primary cultures
Quantification of immunostain was performed using ImageJ,
image analysis software available through the NIH website
(http://rsb.info.nih.gov/ij/). To determine the area for cells
(cell bodies and neurites separately), the number of
b-III-positive pixels were counted within a field of view. For
cell bodies, b-III-tubulin staining defined the edges of the cell
body, so that the total area of the cell body could be determined.
Four different fields per genotype were analyzed. For quantifi-
cation of N-cadherin, intensity histograms of N-cadherin in
b-III-tubulin-defined neurites and cell bodies were measured.
To obtain the amounts of the N-cadherin signal for a specific
genotype and the respective cell part, the products of each
intensity over a threshold value multiplied by the percentage
of the area covered by that intensity were added up∑i=maximum intensity
i=minimum intensity intensityi × pixeli/total pixel number
( )
.
To compare the four different amounts with one another (wild-
type cell body, wild-type neurites, mutant cell body and mutant
cell neurites), the signal amount in mutant neurites was defined
as one, and the other three signal amounts were expressed as a
ratio. The number of N-cadherin signal particles was deter-
mined by using the Analyze Particle plug-in of ImageJ. Thirty
images of neurites per genotype were analyzed. Images were
thresholded six times for different signal intensity intervals
(intensity 30–90; 40–90, 50–90, etc., until 80–90). For each
thresholded image, the number of particles was calculated
(i.e. I30 – 90, I40 – 90, I50 – 90,. . ., I80 – 90). To obtain the number of
particles with a specific highest intensity (40, 50, . . ., 90), the
number of particles within one intensity interval was subtracted
from the one of the next lower interval (i.e. N30 – 40 ¼ I30 – 90 –
I40 – 90). The number of particles was also normalized to the
length of neurites. In order to determine the total neurite
length, in four fields of view per genotype of b-III-tubulin
images, the cell bodies were removed. The resulting images
were skeletonized and the length of the skeleton was measured.
Subsequently, this number was divided by the number of DAPI-
positive nuclei in the appropriate field.
Statistical analysis
All cell images were quantified in 10 randomly chosen groups
comprising at least 100 cells and other experiments, such as
immunoblot and [ATP/ADP] measurement, in three indepen-
dent experiments. The mean, standard deviation (SD) and
standard error (SE) were calculated and statistical significance
analyzed using an unpaired two-sample t-test.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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Appendix B 
Reprint of:  
Jacobsen, J. C., Gregory, G. C., Woda, J. M., Thompson, M. N., Coser, K. R., Murthy, V., 
Kohane, I. S., Gusella, J. F., Seong, I. S., MacDonald, M. E., Shioda, T., Lee, J. M. HD CAG-
correlated gene expression changes support a simple dominant gain of function. Hum Mol 
Genet, 2011. 20(14): p. 2846-60. 
Attributions 
My questions: 
 Pertaining to this manuscript, the question I personally sought to address was: Do the 
cell adhesion & cytoskeletal phenotypes represent a normal function of huntingtin revealed by 
huntingtin deficiency and, if so, might huntingtin with longer polyQ tracts alter adhesion in the 
same way or in a different way?  
My research contributions: 
I reestablished and optimized growth conditions for multiple clones of mouse ES cell 
lines, including wild-type (HdhQ7/7), knock-out (Hdhex4/5/ex4/5), and knock-in (HdhQ20/7, HdhQ50/7, 
HdhQ91/7, HdhQ111/7) alleles. Subsequently, I demonstrated the stem cell character of the allelic 
cell series by morphology (Supplemental Figure 1 A), RT-PCR marker panel (Supplemental 
Figure 1 B and D, Supplemental Figure 2 A and D), and developmental potential by embryoid 
body formation (Supplemental Figure 1 C). I used these reagents for cell biological 
investigations that uncovered evidence of distinct adhesion phenotypes for null and knock-in ES 
cell colonies as judged by colony morphology that has been further characterized by my 
colleague Dr. Randy Singh Atwal (manuscript in preparation). 
Significance: 
 My research led directly to transcriptional profiling, which demonstrated that cellular 
adhesion processes are differentially altered in null and CAG knock-in ES cells as detailed in 
the manuscript included as Appendix B. Furthermore, identification of cell adhesion changes in 
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the ES allelic series led directly to development of quantitative embryoid body adhesion assays 
by my colleague Dr. Randy Singh Atwal; a manuscript detailing this work is currently in 
preparation. 
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Huntington’s disease is initiated by the expression of a CAG repeat-encoded polyglutamine region in
full-length huntingtin, with dominant effects that vary continuously with CAG size. The mechanism could
involve a simple gain of function or a more complex gain of function coupled to a loss of function (e.g. domi-
nant negative-graded loss of function). To distinguish these alternatives, we compared genome-wide gene
expression changes correlated with CAG size across an allelic series of heterozygous CAG knock-in
mouse embryonic stem (ES) cell lines (HdhQ20/7, HdhQ50/7, HdhQ91/7, HdhQ111/7), to genes differentially
expressed between Hdhex4/5/ex4/5 huntingtin null and wild-type (HdhQ7/7) parental ES cells. The set of
73 genes whose expression varied continuously with CAG length had minimal overlap with the
754-member huntingtin-null gene set but the two were not completely unconnected. Rather, the 172 CAG
length-correlated pathways and 238 huntingtin-null significant pathways clustered into 13 shared categories
at the network level. A closer examination of the energy metabolism and the lipid/sterol/lipoprotein metab-
olism categories revealed that CAG length-correlated genes and huntingtin-null-altered genes either were
different members of the same pathways or were in unique, but interconnected pathways. Thus, varying
the polyglutamine size in full-length huntingtin produced gene expression changes that were distinct
from, but related to, the effects of lack of huntingtin. These findings support a simple gain-of-function mech-
anism acting through a property of the full-length huntingtin protein and point to CAG-correlative approaches
to discover its effects. Moreover, for therapeutic strategies based on huntingtin suppression, our data high-
light processes that may be more sensitive to the disease trigger than to decreased huntingtin levels.
INTRODUCTION
Huntington’s disease (HD) features degeneration, especially of
the striatum, along with motor, cognitive and psychiatric
symptoms (1). All cases of HD are caused by an expanded
CAG trinucleotide repeat in one copy of the 4p16.3 HD
gene (2). In humans, the CAG alleles span a continuum
from fully penetrant HD alleles (≥40 CAGs), which lead to
HD pathology and clinical symptoms, through alleles with
progressively reduced penetrance that can often (36–39
CAGs) (2–4), or only very rarely (27–35 CAGs), result in
overt HD (5), to the shorter, more frequent, ‘normal’ alleles
at the lower end of the distribution (6–26 CAGs), for which
no HD case has been reported (6).
The dominant effects of endogenous CAG repeats are
graded with the allele size. In the fully penetrant range,
CAG length is inversely correlated with the age at onset of
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overt HD symptoms in humans (2,7,8) and with the onset of
striatal phenotypes in heterozygote Huntington’s disease
homolog (Hdh) CAG repeat knock-in mice (made to replicate
the human CAG spectrum) (9–16). Graded effects of the poly-
morphic CAG stretch are also evident through the reduced
penetrance HD range, for example, in sensitizing major
depressive disorder (17), as well as in the normal range, as
part of a continuous relationship of CAG size with ATP/
ADP levels in human lymphoblastoid cells (18). Thus, the
CAG repeat is a functional polymorphism, specifying a poly-
glutamine region in the full-length 3144 amino acid huntingtin
protein (2), such that most humans express full-length hunting-
tins with polyglutamine repeats of different sizes. This large
alpha-helical HEAT domain protein (19–22) is thought to act
as a mechanical facilitator of multi-subunit complexes (21),
as suggested for other predominantly HEAT proteins (23).
The preponderance of evidence argues that the polygluta-
mine segment modulates the full-length huntingtin in a
manner most consistent with a simple gain of a novel func-
tion, rather than either a simple or a dominant-negative loss
of function. Chiefly, huntingtin deficiency fails to mimic
CAG expansion. Individuals with a balanced chromosomal
translocation inactivating one HD allele express 50% of
normal levels of huntingtin without exhibiting HD symptoms
(24). In mice, more severe decreases in full-length huntingtin
levels, below 50%, produce developmental defects and
embryonic lethality (9,25–28). Yet HD homozygote
humans (29,30) and knock-in mice (9,13,15,16,31) do
exist, despite expressing no normal-range full-length
huntingtin. There is mounting evidence that the polygluta-
mine repeat, though not required for basal activity (32),
enhances, rather than impairs, the full-length huntingtin
function in repressing energy metabolism (18,32) and in
stimulating the multi-subunit enzyme, polycomb repressive
complex 2 (21).
However, some findings from studies on CAG knock-in and
full-length HD transgenic mouse systems seem more consist-
ent with a dominant-negative effect or a combination of gain
of function and loss of function. These include the failure of
the full-length mutant huntingtin to exhibit functional activi-
ties attributed to the normal protein, such as in NRSE/REST
target gene transcription (33), as well as SREBP (34–36)
and LXR (37) regulated transcription of genes involved in
cholesterol and lipid metabolism that lead to decreased
biosynthetic intermediates. The alternate to the simple
gain-of-function hypothesis is that the polyglutamine repeat
confers a novel property on the full-length huntingtin that
produces, or combines with, a loss of huntingtin function
(37–40).
To more fully understand the molecular response to the
impact of the polyglutamine region on the full-length hunting-
tin, and to reconcile seemingly conflicting evidence, we have
created an isogenic allelic panel of heterozygous CAG
knock-in mouse embryonic stem (ES) cells, augmenting an
existing wild-type and huntingtin-null knock-out ES cell
panel. With this new resource, we have conducted an unbiased
genome-wide search for dominant CAG length-dependent
gene expression changes and tested the validity of predictions
that distinguish the alternate hypotheses: CAG-length-
dependent gene changes would either be novel (simple gain
of function) or overlap with the molecular effects of absent
huntingtin (dominant-negative loss of function or combined
gain and loss of function). The results of our analyses dis-
tinguish these alternatives and offer insights into the biology
of the full-length huntingtin, as revealed by structure–function
and deficiency analyses.
RESULTS
An isogenic panel of heterozygous CAG knock-in
ES cell lines
To enable a discovery strategy based on the continuous
relationship between CAG size and phenotype, we generated
an allelic series of heterozygous Hdh CAG knock-in mouse
ES cell lines, which would appropriately express full-length
huntingtins from endogenous alleles. This series was produced
from a matching series of targeted ‘PGKneo-in’ CAG exon 1
knock-in (CAG 18, CAG 48, CAG 89 and CAG 109) ES cell
lines (14,27). As the ‘neo-in’ alleles express decreased levels
of full-length huntingtin, due to the floxed PGKneo cassette
in the promotor region (9,27), the selection cassette (confer-
ring G418 resistance) was removed by Cre-recombinase-
mediated excision (Fig. 1A) and multiple G418-sensitive ES
subclones were identified for each line (Fig. 1B) (Materials
and Methods). The results of polymerase chain reaction
(PCR) amplification assays with genomic DNAs confirmed
proper PGKneo excision (Fig. 1C), and DNA sequence analy-
sis confirmed the size of the CAG repeat (data not shown).
Immunoblot analysis revealed the 350 kDa band of the wild-
type full-length huntingtin with seven glutamines and, with
progressively decreased mobility, a band of full-length hun-
tingtin with a polyglutamine region from the normal human
range (Q20), the adult-onset (Q50) and the juvenile-onset
(Q91 and Q111) HD range (Fig. 1D). As expected, the wild-
type parental ES cells expressed only the 7-glutamine full-
length huntingtin and no huntingtin band was detected in the
extract of double knock-out (null) Hdhex4/5/ex4/5 ES cells
(25) (Fig. 1D).
The entire allelic panel comprises three to four heterozy-
gous CAG knock-in ES cell subclones for each repeat
length, and subclones of wild-type ES cells and double knock-
out Hdhex4/5/ex4/5 ES cells, that were chosen based upon mor-
phological, developmental and molecular criteria. The chosen
subclones displayed an appropriate stem cell morphology
(Supplementary Material, Fig. S1A), the expression of stem
cell marker mRNAs (Supplementary Material, Fig. S1B), the
ability to develop into embryoid bodies (Supplementary
Material, Fig. S1C) and the expression of germ-layer marker
mRNAs (Supplementary Material, Fig. S1D).
The members of this heterozygous Hdh CAG knock-in ES
cell panel, which share an 129Sv genetic background with
the wild-type HdhQ7/7 and huntingtin-null Hdhex4/5/ex4/5 ES
cell lines, are named HdhQ20/7, HdhQ50/7, HdhQ91/7 and
HdhQ111/7 to denote the polyglutamine region, encoded by
the pure CAG tract and adjacent CAA, CAG codons, in the
endogenous full-length huntingtin proteins expressed from
the wild-type and targeted CAG alleles.
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ATP/ADP ratio decreased with increased CAG length
The ATP/ADP ratio, a dominant quantitative phenotype
known to vary with CAG size in human lymphoblastoid
cells (18), was measured in all members of the ES cell
panel, to assess the utility of this new resource for evaluating
dominant CAG-correlated effects. Results of the HPLC analy-
sis demonstrated that huntingtin-null Hdhex4/5/ex4/5 cells
showed a trend toward higher ATP/ADP ratios than the wild-
type HdhQ7/7 ES cells (Fig. 2A), consistent with the proposal
that the full-length huntingtin negatively regulates this energy
measure (18,32). In contrast, across the HdhQ20/7, HdhQ50/7,
HdhQ91/7 and HdhQ111/7 ES cell panel, ATP/ADP
ratios decreased concomitantly (Pearson’s correlation test,
P ¼ 0.018) with the increased size of the longer CAG allele
(Fig. 2B), confirming that lengthening the polyglutamine
region in full-length huntingtin expressed from one allele
enhanced the negative regulation of this energy measure, as
reported previously (18,32).
In demonstrating the utility of the allelic ES cell panel for
assessing a candidate CAG length-dependent phenotype,
these results also implied that comprehensive phenotyping
across the members of the panel would permit the discovery
of new dominant CAG length-dependent responses.
Continuous analysis effectively identified changes
correlated with CAG size
As an unbiased discovery approach, we utilized Affymetrix
Mouse 430 2.0 gene chips to generate genome-wide gene
expression datasets from RNA isolated from three independent
subclones for each of the HdhQ20/7, HdhQ50/7, HdhQ91/7 and
HdhQ111/7 ES cell genotypes (12 samples), as well as six wild-
type HdhQ7/7 and six null Hdhex4/5/ex4/5 ES cell replicates
(12 samples). The raw data sets were subject to standard
quality control filtering steps (Materials and Methods).
The 12 CAG knock-in ES cell data sets were then analyzed
to identify probes/genes with expression altered progressively
with the CAG repeat size. As the CAG length is a single
source of variation expected to produce subtle incremental
changes, we reasoned that a continuous analytic strategy
Figure 1. Generation of an allelic panel of heterozygous CAG knock-in ES cell lines. (A) The upper schematic depicts the targeted Hdh CAG knock-in allele in
heterozygous Hdhneo20/7, Hdhneo50/7, Hdhneo91/7 and Hdhneo111/7 ES cell lines, with the location of the loxP-flanked PGKneo selection cassette in the promotor
region upstream of the chimeric mouse (gray)/human (red) exon 1 with different CAG repeat sizes (CAG 18, CAG 48, CAG 89 and CAG 109), encoding
adjacent CAA, CAG codons, the polyglutamine repeat in the full-length endogenous huntingtin. The corresponding PGKneo-out-targeted allele in the
cognate Hdh20/7, Hdh50/7, Hdh91/7 and Hdh111/7 ES cell subclones created by Cre-recombinase-mediated excision is depicted below. Arrows denote the locations
of primer sets for ‘neo-in’ (2 and 3) and ‘neo-out’ (1 and 3) PCR amplification assays. The schematic is not drawn to scale. The wild-type allele is not shown. (B)
Trypan blue staining reveals the growth of G418-resistant (G418R) Hdhneo111/7 (Q111 neo-in) ES cells and the lack of growth of a subclone of G418-sensitive
(G418S) Hdh111/7 (Q111 neo-out) ES cells, derived by Cre-recombinase excision of the pGKneo selection cassette. (C) Agarose gel analysis of PCR amplification
products generated by specific PGKneo-in (left gel) and PGKneo-out (right gel) assays. The expected bands confirmed the presence of the PGKneo cassette in the
parental Hdhneo20/7, Hdhneo50/7, Hdhneo91/7and Hdhneo111/7 ES cell genomic DNAs (lanes left gel) and the proper removal of the PGKneo cassette from the tar-
geted allele in the cognate neo-out Hdh20/7, Hdh50/7, Hdh91/7 and Hdh111/7 ES cell DNAs (lanes on the left gel). The latter assay also amplifies the expected
product from the wild-type allele present in all of the ES cell lines, including the Hdhex4/5/ex4/5 ES cell genomic DNA (dKO), which harbor alleles with a targeted
inactivating mutation replacing/deleting exons 4 and 5 (data not shown). PCR products were not detected in genomic DNA minus lanes (2ve) for each assay. (D)
The immunoblot, detected with mAb2166, confirms proper expression of both full-length wild-type huntingtin (7 glutamines) and, migrating more slowly, hun-
tingtins from the targeted allele with distinct polyglutamine tracts (Q20, Q50, Q91 and Q111) in protein extracts of Hdh20/7, Hdh50/7, Hdh91/7 and Hdh111/7 ES
cells, respectively. Wild-type ES cells (Q7/7) express full-length 7-glutamine huntingtin from both alleles and Hdhex4/5/Hdhex4/5-null ES cells (dKO) express no
full-length huntingtin. mAb2166 and other anti-huntingtin antibodies differentially detect the huntingtin with the shorter polyglutamine tract, compared with
those with the longer tracts, for reasons that are not yet understood. Bands are 350 kDa (the position of the 250 kDa marker is not depicted on this immuno-
blot). An asterisk indicates a cross-reacting band, previously noted (25).
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should effectively identify such alterations from among the
gene expression changes due to all other factors (technical,
biological and chance), whereas the standard dichotomous
comparison (normal range versus HD range) would be
expected to highlight any probes with altered expression,
regardless of the cause.
Continuous analysis to uncover graded differences in signal
intensity, with increased CAG size, was conducted by com-
paring the probe intensities from the HdhQ20/7, HdhQ50/7,
HdhQ91/7 and HdhQ111/7 data sets with the CAG length of
the corresponding cell lines using Pearson’s correlation analy-
sis. A total of 73 probes (Supplementary Material, Table S1)
passed a rigorous statistical cut-off (absolute correlation
coefficient . 0.8; P , 0.001). Of these, 48 probes were nega-
tively correlated and 25 probes were positively correlated with
the length of the CAG allele. Validation of a subset of these
genes, by RT Q-PCR assay, verified that the RNA levels of
the majority were significantly altered in the predicted direc-
tion (Supplementary Material, Fig. S2), strongly implying
that the RNA levels of most of the genes in the set identified
by this continuous analysis approach were likely to truly vary
in a continuous fashion with CAG length.
The dichotomous normal-range versus HD-range allele
analysis was conducted by comparing the normalized
average signal intensity for each probe from the combined
expanded CAG data sets (HdhQ50/7, HdhQ91/7 and HdhQ111/7)
with the average signal intensity in the normal human CAG
allele datasets (HdhQ20/7). Thirteen probes met stringent stat-
istical criteria (Student’s t-test, P , 0.001; absolute
fold-change . 1.5) and 37 probes passed a less stringent
cut-off (P , 0.005; absolute fold-change. 1.5), providing a
set of probes whose expression differed significantly
between ES cells with short and long CAGs (Supplementary
Material, Table S2). However, as shown in the volcano plots
presented in Figure 3, none of the 13 high-stringency probes
(Fig. 3A) and only one of the 37 relaxed-stringency probes
(Fig. 3B, filled red circle) exhibited a signal intensity that
correlated with the CAG size. These results indicated that
the traditional dichotomous analytical approach, most
often used in the HD field, disclosed variation due to
non-CAG repeat factors and did not efficiently uncover gene
expression changes continuously correlated with the CAG
length.
Genes altered with CAG size are distinct from genes
altered with lack of huntingtin
Identification of a set of probes/genes whose expression con-
formed to the HD trigger mechanism (dominant, continuous
with CAG length) allowed an empirical test to distinguish
the main alternative hypotheses for the effects of the impact
of the polyglutamine region on the full-length huntingtin: a
simple gain of a novel function versus a more complex
gain-of-function/loss-of-function scenario, including a
dominant-negative loss of function. We determined whether
the probes altered in a dominant CAG-continuous fashion,
as outcomes of the full-length huntingtin gain of function
might also be prominent in the ES cell response to the
absence of huntingtin. Any model in which the expanded
CAG contributes to a loss of huntingtin function would
predict an extensive overlap in the molecular responses
observed. However, the simple gain of a novel function
hypothesis does not require any overlap.
First, the set of probes/genes with expression that differed
between the Hdhex4/5/ex4/5 and wild-type ES cell data sets
was identified by Student’s t-test (Material and Methods).
This comparison disclosed 754 probes with significantly
different signal intensities (absolute fold-change . 1.5;
P, 0.001): 398 increased and 356 decreased in the huntingtin-
null ES data sets (Supplementary Material, Table S3). RT
Q-PCR analysis of a subset of these genes generally confirmed
the microarray data (Supplementary Material, Fig. S2A), though
one gene (Mest), altered 20-fold in the RT Q-PCR analysis, was
an outlier on the microarray platform (200-fold change).
Comparison of the ‘huntingtin-null’ probe set with the set of
probes whose expression was continuously altered with CAG
length revealed virtually no overlap; 99.6% (751 of 754) of the
probes altered in cells lacking full-length huntingtin did not
vary with CAG size (Fig. 3C) and 96% (70 of 73) of the CAG-
correlated probes did not distinguish wild-type and full-length
huntingtin-null ES cells (Fig. 3D). Probes for only three genes
(Mapt, Erdr1 and Mll5) were altered in both genetic para-
digms. A second more global analytical approach, gene set
enrichment analysis, also failed to disclose a significant
overlap. The rank order of the probes significant in one para-
digm, when assessed in the entire 45 000 probe data set from
the other paradigm, did not differ from what might be
Figure 2. ATP/ADP ratio across the members of the ES cell panel. (A) The bar plot summarizes the results of HPLC determination of ATP/ADP ratio for repli-
cates of Hdhex4/5/Hdhex4/5-null ES cells (dKO), expressed as a percentage of the parental wild-type ES cell ATP/ADP ratio, showing a trend (P ¼ 0.057) toward
increased ATP/ADP ratio in the absence of full-length huntingtin. All data points are included. (B) The bar plot summarizes the results of HPLC determination of
ATP/ADP ratio for two biological replicates performed in duplicate for each member of the Hdh20/7, Hdh50/7, Hdh91/7 and Hdh111/7 knock-in ES series, expressed
as a percentage of the Hdh20/7 ATP/ADP ratio, demonstrating a decrease with increasing CAG repeat length (Pearson’s correlation coefficient P ¼ 0.018).
All data points are included.
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observed by chance, with low enrichment scores and high
nominal P-values (Fig. 4).
The dominant molecular effects of extending the polygluta-
mine region in the full-length huntingtin, therefore, did not
mimic the responses to lack of huntingtin function, contradict-
ing dominant-negative loss of function or mixed
gain-of-function/loss-of-function mechanisms, but consistent
with a simple gain of a novel function hypothesis.
Related huntingtin pathways
If extending the polyglutamine region in the full-length hun-
tingtin confers a simple gain of function, how then to
explain reports of phenotypes implying loss of function? We
reasoned that the response to the polyglutamine region in
the full-length huntingtin (a structural alteration with a domi-
nant impact, potentially acting through an intrinsic activity of
huntingtin) and the response to lack of huntingtin (classic
deficiency) might be expected to engage related pathways,
predicting that the probe sets from the two genetic paradigms,
though almost completely distinct, might actually be con-
nected via common pathways.
sigPathway analysis identified 238 pathways significantly
(gene set permutation q , 0.01 and phenotype permutation
q, 0.01) altered between wild-type and huntingtin-null ES
cell data sets (Supplementary Material, Table S4) and 172
Figure 3. Comparisons of CAG-correlated and huntingtin-null gene sets. (A) Volcano plot showing 2log10(P) (Y-axis) for the 13 probes discovered by the
dichotomous analysis of the CAG knock-in ES cell data sets at high statistical stringency (P, 0.001) relative to fold-change (X-axis) (green symbols) and
the 2log10(P) (Y-axis) for each of these probes in the continuous analysis across the CAG knock-in ES cell data sets relative to Pearson’s correlation coefficient
(X-axis) (red symbols), demonstrating that none of the significant probes in the dichotomous analysis of the CAG knock-in ES cells was significantly correlated
with the CAG repeat size. (B) Volcano plot showing 2log10(P) (Y-axis) for the 37 probes discovered by the dichotomous analysis of the CAG knock-in ES cell
data sets at more relaxed statistical stringency (P , 0.005) relative to fold-change (X-axis) (green symbols) and the 2log10(P) (Y-axis) for each of these probes in
the continuous analysis across the CAG knock-in ES cell data sets relative to Pearson’s correlation coefficient (X-axis) (red symbols), demonstrating that only
one probe from the less-stringent dichotomous analysis of the CAG knock-in ES cells was significantly correlated with the CAG repeat size (filled red circle).
(C) Volcano plot showing 2log10(P) (Y-axis) for the 754 probes significantly (P , 0.001) different in huntingtin-null ES cell data sets, compared with wild-type
parental ES cell data sets (P , 0.001) relative to fold-change (X-axis) (blue symbols) and the 2log10(P) (Y-axis) for each of these probes in the continuous
analysis across the CAG knock-in ES cell data sets relative to Pearson’s correlation coefficient (X-axis) (red symbols), revealing that few of the significant
probes in the huntingtin-null ES cells were significantly correlated with the CAG repeat size. Mest, an outlier, was excluded from this analysis. (D) Volcano
plot showing 2log10(P) (Y-axis) for the 73 probes with expression significantly (P , 0.001) correlated with CAG repeat length across the CAG knock-in
ES cell data sets relative to Pearson’s correlation coefficient. 0.8 (X-axis) (red symbols) and the 2log10(P) (Y-axis) for each of these probes in the huntingtin-
null versus wild-type ES cell data set comparison relative to fold-change (X-axis) (blue symbols), demonstrating that most of the CAG-correlated probes were not
significantly changed in the absence of huntingtin. The X-axis corresponds to fold-change for the dichotomous analysis and Pearson’s correlation coefficient for
continuous analysis. Open and filled circles represent non-significant and significant probes, respectively.
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pathways that correlated with CAG size across the knock-in
ES cell panel data sets (Supplementary Material, Table S5).
In support of overlap at the pathway, if not the probe level,
74 pathways were significant in both genetic paradigms (Sup-
plementary Material, Table S6), and the gene set enrichment
analysis (GSEA) with the top 20 ranked pathways from each
paradigm disclosed significant enrichment in the entire 1947
pathways for the other paradigm (Fig. 5A and B). These
results were unlikely to have been produced by chance
because the true enrichment score (i.e. average rank of top
20 pathways in the other paradigm) significantly deviated
from the majority of the enrichment scores obtained from
Figure 4. Tests of gene set enrichment by phenotype permutation analysis. The results of GSEA, using phenotype permutation (1000 iterations), are presented.
Top: enrichment score (ES) representing the degree to which the test gene set is overrepresented at the top or bottom of the ranked genes from the other data set;
middle: position of the test set probes in the other dataset; bottom: ranked metric (Pearson’s correlation coefficient for the CAG-correlated data set or t-statistic
for the huntingtin-null data set). The enrichment score (ES) and nominal P-value are shown at the bottom. (A) The probes with significantly increased (left panel)
or decreased (right panel) expression in the huntingtin-null ES cell comparison were not significantly enriched in the CAG-correlated knock-in ES cell data set.
(B) The probes with expression significantly positively correlated (left) or negatively correlated (right) with the CAG length in the knock-in ES cell data sets
were not significantly enriched in the huntingtin-null ES cell data set.
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simulations for each paradigm, with 10 000 iterations of per-
muted data sets. In addition, the majority of these pathways
could be assigned to 13 categories at the network level,
though, as shown in Figure 6A, six clusters were more promi-
nently altered in the huntingtin-null ES cells (reproduction/
development/growth, amino acid/peptide/protein metabolism,
chromatin regulation, immune process, transcription/trans-
lation and signal transduction) and seven clusters were more
prominently altered by extending the polyglutamine region
in the full-length huntingtin (nucleotide metabolism, energy
metabolism, regulation of cell cycle/death, RNA metab-
olism/ribosomal process, cell structure/adhesion, cellular com-
ponent and lipid/sterol/lipoprotein metabolism).
Despite these general features of commonality and intercon-
nection of the pathways altered in the two genetic paradigms,
statistical analysis continued to highlight the lack of
one-to-one correspondence between the specific alterations
detected in these pathway data sets. The alterations of the
238 significant pathways in huntingtin-null were mildly
predictive of a significant effect on the same pathways in
the continuous CAG comparison (Spearman’s rho 0.291;
P ¼ 5.08E26) (Fig. 6B). However, alterations of the 172 full-
length huntingtin polyglutamine region-correlated pathways
were not at all predictive of a significant effect in the wild-
type/huntingtin-null data set comparison (Spearman’s rho
0.142; P ¼ 0.06282) (Fig. 6C). Nor did the alterations
observed in the 74 common pathways predict statistical
significance from one genetic comparison to the other
(Spearman’s rho 0.147; P ¼ 0.2117) (Fig. 6D). Therefore,
while the huntingtin-null pathways captured a portion of the
dominant response to increase the full-length huntingtin poly-
glutamine region, the conversing was not true.
Taken together, these findings implied that the probes/genes
contributing to the CAG-correlation genetic paradigm and
those contributing to the huntingtin-null genetic paradigm rep-
resent either different members of the same pathways or
members of distinct but interconnected pathways within the
same category networks.
Figure 5. Tests of enrichment of significant pathways by permutation analysis. The results of permutation-based enrichment analysis to test whether a sort of the
top 20 significant pathways in one paradigm was also significantly enriched in the other paradigm. Left: original sigPathway results (black bars) representing rank
(X-axis) and NTk value from gene set permutations (Y-axis), with the rank of test pathways highlighted (red bars). Right: average ranks of test pathways (enrich-
ment score) compared with the distribution obtained from a random sampling of 20 pathways from the compared data set (10 000 permutations). (A) Top 20
huntingtin-null significant pathways in CAG-correlated knock-in ES cell pathways indicated significant enrichment, with an enrichment score of 4.51, compared
with a distribution of enrichment scores obtained from a random selection of 20 pathways in knock-in pathway results. (B) Top 20 CAG-correlated pathways in
huntingtin-null pathways indicated significant enrichment, with an enrichment score of 4.55, compared with a distribution of enrichment scores obtained from a
random selection of 20 pathways in knock-out pathway results. Red triangles in the right panels represent true enrichment scores.
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Interconnectedness of CAG-correlated and huntingtin-null
pathways
To explore this possibility, we examined the hierarchical
relationships of the pathways in the energy and lipid/choles-
terol/sterol categories. The energy network (24 pathways)
(Fig. 7 and Supplementary Material, Fig. S3) comprised path-
ways altered with the size of the full-length huntingtin poly-
glutamine region (carbohydrate metabolism, glycolysis) and
other pathways prominent in huntingtin deficiency (mitochon-
drial, TCA cycle, oxidative respiration) with only a few path-
ways common to both. In contrast, the lipid/sterol/lipoprotein
network (17 pathways) (Fig. 8 and Supplementary Material,
Fig. S4) comprised nearly equal proportions of processes pro-
minent in the response to extending the full-length huntingtin
polyglutamine region (phospholipid metabolism), pathways
prominent in the wild-type/huntingtin-null comparison
(acetyl-CoA, glycerophospholipid metabolism) and shared
pathways common to both genetic paradigms (cholesterol,
sterol).
These hierarchies demonstrated that some of the genes that
were uniquely changed with increasing CAG repeat length
were different members of the same pathways as genes
that were altered by the complete absence of huntingtin,
while other CAG-repeat-altered genes were members of dis-
tinct pathways that were not significantly affected by the
lack of huntingtin. However, even the latter CAG-correlated
pathways, though distinct, were often closely connected in
the network to the pathways changed in the absence of
Figure 6. CAG-correlated and huntingtin-null pathway categories. A summary of sigPathway analysis results, with significant pathways for each paradigm
grouped by category is presented (A), with results of correlation analysis testing the relationship between huntingtin-null significant pathways (KO) and the
CAG-correlated pathways (KI) (B–D). (A) Bar plot of the proportion (X-axis) of the 238 pathways significantly enriched in the huntingtin-null ES cell com-
parison (blue) and the 172 significantly CAG-correlated pathways across the knock-in ES cell data sets (red) within 13 shared categories (Y-axis). (B) Left scatter
plot displays the relationship of the enrichment scores of 238 huntingtin-null significant pathways (X-axis; NTk values) with the enrichment score for these path-
ways in the continuous CAG ES cell knock-in pathways analysis (Y-axis; NTk values). The Spearman’s rank correlation statistic (rho) and the significant P-value
indicate that the huntingtin-null pathways capture to some extent the CAG-correlated pathway set. Middle scatter plot displays the relationship of the enrichment
scores of the 172 continuous CAG-correlated pathways (X-axis) with the enrichment score for these pathways from the huntingtin-null analysis (Y-axis). The
Spearman’s rank correlation statistic (rho) and the non-significant P-value indicate that the pathways significantly altered with the CAG size are not altered
by the absence of huntingtin. The right scatter plot shows the relationship between the enrichment scores of 74 pathways significant in both the huntingtin-null
ES cell analysis (X-axis) and the CAG continuous ES cell data analysis (Y-axis). The Spearman’s rank correlation statistic (rho) and the non-significant P-value
indicate that the enrichment score in one analysis does not predict the enrichment score in the other paradigm, indicating that these pathways are not consistently
altered in the different paradigms.
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huntingtin. The highly interconnected character of these net-
works, which are impacted by altering both the full-length
huntingtin polyglutamine repeat and the dose of the full-length
huntingtin, predicts that, integrating across the network, both
genetic paradigms might in some cases be expected to
produce similar phenotypic outcomes despite emanating
from different initial insults, whereas in other cases the pheno-
typic outcomes may be distinct.
DISCUSSION
The accumulated evidence indicates that the HD CAG repeat
acts as a functional DNA polymorphism, encoding a polyglu-
tamine region in the full-length huntingtin that exerts domi-
nant effects that are graduated with CAG length across an
allelic continuum. Yet HD homozygotes exist, despite expres-
sing no normal-range full-length huntingtin, and conversely,
huntingtin deficiency does not mimic HD. A parsimonious
explanation is that the polyglutamine repeat confers a simple
gain of a novel function, such that the full-length huntingtin
is modulated, though not impaired, in a graded manner that
yields dominant effects that are continuous with polygluta-
mine length.
Investigations of this hypothesis and alternative proposals,
such as a gain of a dominant-negative loss of full-length hun-
tingtin function, have been hampered by the lack of an appro-
priate series of CAG alleles in a cell culture system, for which
there are also HD knock-out alleles. The isogenic allelic ES
cell panel that we have generated now provides a suitable
cell culture system. It comprises a series of heterozygous
Figure 7. Energy category pathways network. A schematic demonstrating the hierarchy of relationships between the processes/pathways significantly correlated
with the CAG repeat length (red), significantly altered in the absence of huntingtin (blue) or significantly altered in both full-length huntingtin genetic paradigms
(yellow). The cellular component ‘Mitochondrial matrix’, significantly altered only in the huntingtin-null ES cell analysis, is not shown. Only directly related
pathways are illustrated. The KEGG/GO annotations for the pathways are provided in Supplementary Material, Figure S3.
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CAG knock-in ES cell lines, appropriately expressing full-
length huntingtins with 20, 50, 91 or 111 polyglutamine
repeats (from endogenous alleles), augmenting the wild-type
and huntingtin-null ES cell lines, previously reported. The
members of this ES cell panel can undergo development,
allowing studies in differentiated cell types, such as neuronal
cells.
The allelic ES cell panel allows investigations to determine
whether candidate phenotypes may (or may not) be dominant
and progressive with CAG size. ATP/ADP ratios, continu-
ously decreased with CAG size in human lymphoblastoid
cell lines (18), were decreased with CAG length across the
knock-in ES cell members, and ATP/ADP ratio was increased
in the absence of full-length huntingtin, in knock-out ES cells,
consistent with the proposal that the polyglutamine repeat
enhances an as-yet uncharacterized role of full-length hunting-
tin in negatively regulating this energetic measure (18,32).
The allelic CAG ES cell series, therefore, offers a resource
with which to further assess purported HD-associated differ-
ences from studies in human and non-human systems to deter-
mine whether they conform to the dominant continuous effects
of the HD CAG repeat, rather than emanating from other
sources of variation that may distinguish HD and non-HD
samples.
The discovery of new dominant CAG length-dependent
effects can also be efficiently accomplished by phenotyping
across the members of a CAG allelic panel. Continuous analy-
sis, though not dichotomous analysis, efficiently uncovered
genes with CAG-correlated expression from genome-wide
data sets. The success of the continuous analytical approach,
with four different CAG allele lengths on an isogenic
genetic background, predicts that this strategy can be effective
in identifying the dominant effects of the CAG repeat in
human samples, though the increased genetic heterogeneity,
Figure 8. Lipid, sterol and lipoprotein metabolism category pathways network. A schematic demonstrating the hierarchy of relationships between the processes/
pathways significantly correlated with the CAG repeat length (red), significantly altered in the absence of huntingtin (blue) or significantly altered in both full-
length huntingtin genetic paradigms (yellow). The catalytic activity ‘phospholipase A2’, which is significantly changed only in the absence of huntingtin, is not
depicted on the pathway annotation diagram. Only directly related pathways are illustrated. The KEGG/GO annotations for the pathways are provided in
Supplementary Material, Figure S4.
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and higher proportion of expanded CAG alleles in the adult
onset rather than the juvenile onset range, will likely require
a larger panel representing a denser series of CAG alleles
across the continuum. Knowledge of the dominant molecular,
biochemical and cellular responses that emanate from the
quantitative impact of the polyglutamine repeat on full-length
huntingtin, especially in cells of neuronal lineages, should
provide a better understanding of the molecular mechanism
that initiates the pathogenic process to which these cells are
vulnerable.
In our study, the CAG knock-in and huntingtin-null panel
members allowed an evaluation of alternate hypotheses for
the impact of the polyglutamine repeat on full-length hun-
tingtin: a simple gain of a novel function versus a dominant-
negative or a mixed gain/loss of function. The CAG-
correlated gene set was strikingly distinct from the
huntingtin-null gene set, failing to support a model involving
a loss of function. However, this outcome was completely
consistent with a simple novel gain-of-function hypothesis,
which posits different mechanisms for the two genetic para-
digms and does not require any overlap in the two gene sets
to be valid. This finding joins the previous genetic evidence
supporting a mechanism of a simple gain of a novel function,
wherein the structural alteration of the full-length huntingtin
by the polyglutamine repeat produces a graded effect on
some action of huntingtin, though it does not impair the pro-
tein’s inherent function. Whether the gain of function
involves the graded modulation of a property/task intrinsic
to the full-length huntingtin or, alternatively, adds a novel
non-intrinsic property/task into full-length huntingtin’s bio-
logical repertoire remains to be determined. Simple enhance-
ment of an intrinsic action of huntingtin by the polyglutamine
repeat is supported by the interrelated nature of the pathways
that emerged from the two genetic huntingtin paradigms.
However, the polyglutamine repeat might also confer a
new property, because, while the huntingtin-null changes
do to a certain extent capture the CAG repeat-correlated
changes, the converse is not the case. Thus, our results
support the view that the polyglutamine repeat may confer
enhanced intrinsic huntingtin activity and/or confer
some additional non-intrinsic property on the full-length
huntingtin.
Indeed, rather than revealing a common mechanism, our
analyses indicate that the distinct CAG-correlated and
huntingtin-null genes, defined by the structure–function and
deficiency strategies, respectively, identify instead an inter-
related hierarchy of biological pathways. The pathways that
were specifically correlated with CAG size were not predictive
of the pathways altered by huntingtin knock-out. However,
together, the pathways clustered into about a dozen biological
categories or networks in realms consistent with previous
reports of huntingtin function (41), some influenced more
prominently by the full-length huntingtin polyglutamine
repeat (energy, cholesterol/sterol/lipid, nucleotide metabolism,
regulation of cell cycle/death, RNA metabolism/ribosomal
process and cell structure/adhesion) (18,32,42–45) and
some by huntingtin deficiency (reproduction/development,
protein metabolism, chromatin regulation, transcription and
translation, immune process and signal transduction)
(28,37,46–50).
The energy metabolism network revealed the effects of the
polyglutamine-size in full-length huntingtin on glycolysis and
of huntingtin deficiency on the tricarboxylic acid (Krebs)
cycle, respectively. However, few processes were shared,
implying that the elevated or decreased ATP/ADP ratios,
respectively, that result from these insults may result from dis-
tinct rate-limiting steps in each case. The lipid/sterol/lipopro-
tein metabolism network, with unique impacts of
polyglutamine size in full-length huntingtin on phospholipid/
lipid biosynthesis and huntingtin deficiency on lipid catabo-
lism (b-oxidation) and acetyl-CoA catabolism, respectively,
featured a high proportion of shared processes, notably lipid,
steroid and cholesterol biosynthesis. Thus, the two distinct
full-length huntingtin mechanisms, polyglutamine expansion
versus protein deficiency, which altered the expression of
completely different gene sets, both converged at the
pathway level on cholesterol biosynthesis, strongly implying
that decreased levels of cholesterol biosynthetic intermediates
in cells expressing either normal or mutant huntingtin likely
result via different mechanisms due to the effects on distinct
rate-limiting steps within the same network (34,51).
The CAG-correlated genes and pathways, which conform to
genetically defined properties expected of the consequences of
the HD disease-initiating mechanism, demonstrate the wide
physiological impact of varying the polyglutamine repeat in
full-length huntingtin. Though a common regulator is formally
possible, it seems unlikely that targeting any single candidate
regulator will effectively mitigate most of the many hundreds
of interconnected consequences of the CAG repeat. Instead,
our results strongly support a system-wide approach to the dis-
covery and validation of factors that may moderate the domi-
nant effects of extending the polyglutamine region in
full-length huntingtin. Moreover, for therapeutic strategies
aimed at lowering the expression of the expanded CAG
allele, our results in this proof-of-concept experiment in
murine ES cells strongly suggest that understanding the bio-
logical processes perturbed by the lack of full-length hunting-
tin may be important, as such treatments might instead
exacerbate the physiologic effects of the expanded CAG
repeat.
MATERIALS AND METHODS
ES cell culture
Wild-type parental, huntingtin null Hdhex4/5/ex4/5 and
HdhneoQ20/7, HdhneoQ50/7 HdhneoQ91/7 HdhneoQ111/7 mouse ES
cell lines have been reported previously (9,14,25,27). ES
cells were maintained on feeder layers of irradiated mouse
embryonic fibroblasts (Global Stem Sciences) at 378C in 5%
CO2 or on gelatin-coated plates (1% gelatin solution;
Millipore). ES cell media (ESCM) typically contained Knock-
Out D-MEM (Invitrogen), 15% FBS (Hyclone), 50 I.U/ml of
penicillin, 50 mg/ml of streptomycin (Cellgro), 0.2 mM
GlutaMax (Invitrogen), 0.1 mM MEM non-essential amino
acids (Invitrogen), 0.1 mM 2-mercaptoethanol (Sigma) and
1000 U/ml of leukemia inhibitory factor (LIF) (Millipore).
For ES cell lines with targeted alleles, the media also contained
G418 (150–450 mg/ml). Cells were passaged by trypsinization
(0.05% trypsin, 0.53 mM EDTA) (Cellgro) every 3 days. For
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molecular analysis (protein, RNA, DNA), cells were grown on
gelatin-coated plates in ESCM. Molecular analyses and ana-
lyses of nucleotide (ATP and ADP) levels were performed on
independent cell cultures, grown under standard conditions.
To induce embryoid body (EB) formation, 5 × 106 ES cells
were grown in the absence of feeder cells on 10 cm bacterial
plates in ESCM without LIF. The day 4 EBs were character-
ized with germ-layer-specific markers using RT–PCR ampli-
fication assays as described below.
Adeno-Cre recombinase and identification of ES cells
with neo-out CAG knock-in alleles
The Hdhneo20/7, Hdhneo50/7, Hdhneo91/7 and Hdhneo111/7 ES cells,
in each case, were plated in 12-well plates at 2.5 × 105 cells/
well, in G418 selection, and infected with 200 infectious units/
cell Adeno-Cre (Ad5CMVCre). The following day, the selec-
tion was removed by changing to a medium lacking G418.
Established colonies were subsequently plated into wells of
duplicate 96-well plates, into media with G418 or media
without G418. For each line, those G418-sensitive subclones
that grew in the absence of G418, but not in the presence of
G418, were propagated to establish PGKneo-minus lines for
three to four subclones for each member of the allelic ES cell
series. PCR amplification analysis confirmed the proper
Cre-recombinase removal of the PGKneo cassette. DNA was
purified using the Gentra Puregene Cell kit (Qiagen) and
treated with RNase A, following the manufacturer’s instruc-
tions. Primers to assess the presence of the PGKneo cassette
were: Mouse mod-2 Neo-in F: 5′-GATCTCCTGTCATCTC
ACCTTG-3′ and 5′-UTR R: 5′-CAGGCAGGCAGC
AGTAGTTA-3′. Cycling conditions were as follows: 948C
for 5 min, followed by 30 cycles of 948C for 30 s, 608C for
30 s, 728C for 90 s and a final extension at 728C for 7 min.
Primers to assess the absence of the PGKneo cassette were:
Neo-out F: 5′-TCACTGCTTGGCTTTTTCCT-3′ and 5′-UTR
R: 5′-CAGGCAGGCAGCAGTAGTTA-3′. Cycling conditions
were as follows: 948C for 5 min, followed by 30 cycles of
948C for 30 s, 608C for 30 s, 728C for 1 min and a final exten-
sion at 728C for 7 min.
Quantitative RT–PCR amplification assays
For RNA extraction, washed ES cell pellets were homogen-
ized in TRIzol (Invitrogen) and total RNA isolated using
phenol/chloroform. Following digestion with DNaseI recom-
binant RNase-free (Roche), RNA was reverse-transcribed to
produce cDNA using Superscript III according to the manu-
facturer’s guidelines (Invitrogen). An oligo-dT primer was
used to prime cDNA synthesis. Each quantitative real-time
PCR amplification reaction was performed in a total volume
of 40 ml using 2× iQ SYBR Green Supermix (Bio-Rad) and
0.2 pmol primer. Primers were designed to the 3′ end of
each transcript analyzed and all products were 70–100 bp in
length. Cycling parameters were: 958C for 2 min to denature
followed by 40 cycles of 958C for 15 s and 608C for 1 min.
Melting temperature analysis was performed at the end of
each run to validate the specificity of the PCR amplicon.
Assays were conducted in a 96-well plate format with ‘no
template’ and ‘no reverse transcriptase’ controls and run on
the iQ cycler (Bio-Rad). Three technical replicates were per-
formed for each sample and all genes were compared with
the reference gene, mouse b-actin. Primers were designed
using Primer3 software (http://frodo.wi.mit.edu/).
Primers to assess EB primary germ layers were: Afp F:
5′-AGCAAAGCTGCGCTCTCTAC-3′ and Afp R: 5′-CCGA
GAAATCTGCAGTGACA-3′, Pdx1 F: 5′-GAAATCCA
CCAAAGCTCACG-3′ and Pdx1 R: 5′-TCTCCGGCTATA
CCCAACTG-3′, Bry F: 5′-CCGGTGCTGAAGGTAAATGT
-3′ and Bry R: 5′-TGACCGGTGGTTCCTTAGAG 3′,
Actc F: 5′ GCTTTGGTGTGTGACAATGG-3′ and Actc
R: 5′-AGAGACAGCACTGCCTGGAT-3′, Pax6 F: 5′-
AGGGGGAGAGAACACCAACT-3′ and Pax6 R: 5′ GG
TTGCATAGGCAGGTTGTT-3′, Ncam1 F: 5′-AGCTG
AAAACCAGCAAGGAA-3′ and Ncam1 R: 5′-TTTTGTTTG
TGTGGCATCGT-3′. Cycling conditions for Afp, Actc, Pdx
and Pax6 were 948C for 5 min, followed by 30 cycles of
948C for 30 s, 558C for 30 s, 728C for 45 s and a final exten-
sion at 728C for 7 min. Cycling conditions for Bry are: 948C
for 5 min, followed by 30 cycles of 948C for 30 s, 508C for
30 s, 728C for 45 s and a final extension at 728C for 7 min.
Cycling conditions for Ncam1 are: 948C for 5 min, followed
by 30 cycles of 948C for 30 s, 608C for 30 s, 728C for 45 s
and a final extension at 728C for 7 min.
Primers to validate microarray results were: Mapt F:
5′-GCTCGTTAGGGAACATCCAT-3′ and Mapt R: 5′- TC
GACTGGACTCTGTCCTTG-3′, Mll5 F: 5′-GAACAGTTT
GAAGCAAATGGAT-3′ and Mll5 R: 5′-CCTCATTCCCA
AAAGTCCTC-3′, Erdr1 F: 5′-AGTGATGTCACCCACG
AAAG-3′ and Erdr1 R: 5′-GTGGGGATGGCAGAGAC
AT-3′, Bhlhb2 F: 5′-CACCCCAAGATCCTTTCTGT-3′ and
Bhlhb2 R: 5′-GGAGATGGAACCCTTTTTAGC-3′, Ccdc18
F: 5′-TGGTTTAAGTCAGGGAGGAAA-3′ and Ccdc18 R:
5′-AGCACAGTACCAACAATTCCA-3′, Abca1 F: 5′-TGT
TGCATCCCTTTTTGTAGA-3′ and Abca1 R: 5′-AAAGCA
CAAAACCAGCTTCA-3′, Mest F: 5′-AGTGAGGGAGG
AGCTTGCTA-3′ and Mest R: 5′-GCAGCCGATGAAA
CTAAATG-3′, Xlr F: 5′-GGAAGCCAGAAAGCTAATGG-3′
and Xlr R: 5′-GATTGAACACCATCCTTTGC-3′, Tgm2 F:
5′-AGAGCCTGGGAAGAATCAAA-3′ and Tgm2 R: 5′-AA
AAGAAACAGAACCGTGTGG-3′, Lrp2 F: 5′-CTGAGC
AAAAGGAAGCTGTG-3′ and Lrp2 R: 5′-CAGTGTA
GCCTGGAGTCGAA-3′, Snapc1 F: 5′-TCCAACAGAA
GAAAGGTGTCA-3′ and Snapc1 R: 5′-GCATGCTCTTCC
ATCTCACA-3′, Utp14a F: 5′-AAGGCTGTGGATCTGA
CCTT-3′ and Utp14a R: 5′-CCCTCAGGGGCTTTAAT
AAG-3′, NfuI F: 5′-TCCATCATCACCCTGAAGAG-3′ and
NfuI R: 5′-TTCGTCATCATCCATCACCT-3′, Hsd17b11 F:
5′-GAAAGGATCGTCCCTGAGAG-3′ and Hsd17b11 R: 5′-
GCTGCGTCACTTGTCTTTGT-3′, Rpap2 F: 5′ GTTG
CTGGAGGTGTCCACTA-3′ and Rpap2 R: 5′-AGGGGA
GAGAGTGGGAAAGT-3′, Nicn1 F: 5′-AGTTAAGCCCCAC
TGACAGG-3′ and Nicn R: 5′-GATCCTCTTTGCCCAAG
TGT-3′, Ngdn F: 5′-CAGAGTCAGGAGGATCAGCA-3′ and
Ngdn R: 5′-CCTTCGCAGTCCTTTCTCTC-3′, b-actin F:
5′-GACGGCCAGGTCATCACTAT-3′ and b-actin R:
5′-ATGCCACAGGATTCCATACC-3′. Cycling conditions
are described previously.
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Immunoblot analysis
Protein extracts were prepared from washed cell pellets by
lysis on ice for 30 min in a buffer containing 20 mM HEPES
(pH 7.6), 1 mM EDTA, 0.5% Triton X-100, protease inhibitor
mixture (Roche) and 1 mM phenylmethyl sulfonyl fluoride.
Lysates were mixed every 10 min during the incubation. The
lysates were then cleared by centrifugation at 14 000g for
30 min and the supernatants collected. The protein concen-
tration was determined using the Bio-Rad (detergent compati-
ble) protein assay. Twenty-five micrograms of protein extract
was mixed with 4× SDS sample buffer, boiled for 2 min and
subjected to 6 or 10% SDS–PAGE. After electrophoresis,
the proteins were transferred to nitrocellulose membranes
(Schleicher & Schuell) and incubated for 30 min in a blocking
solution containing 5% non-fat powdered milk in TBS-T
(50 mM Tris–HCl, 150 mM NaCl, pH 7.4, 0.1% Tween-20).
The membranes were probed overnight at 48C with the
primary antibody mAb2166 (Chemicon). After four 10 min
TBS-T washes, the blots were incubated for 1 h at room temp-
erature with horseradish peroxidase-conjugated anti-mouse
antibodies. After an extensive 30 min wash, the membranes
were processed using an ECL chemiluminiscence substrate
kit (New England Biolabs) and exposed to autoradiographic
film (Hyperfilm ECL; Amersham Bioscience). Notably, on
SDS–PAGE immunoblots, anti-huntingtin antibodies are
known to detect full-length huntingtin proteins differentially,
based upon the length of the polyglutamine tract, though the
reasons for this phenomenon are not yet known.
HPLC ATP/ADP measurement
Nucleotide extraction was as previously described (18,52). To
normalize the amount of nucleotide, each pellet was solubil-
ized with 1 N NaOH and the protein content was analyzed
by Bio-Rad DC protein assay (Bio-Rad). HPLC-grade nucleo-
tide standards (Fluka) were used to calibrate the signals.
Internal standards were occasionally added to the samples to
test recovery, which exceeded 90% for all nucleotides. Data
were quantified by Breez software.
Microarray analysis
RNA extracted from ES cells using TRIzol reagent (Invitro-
gen) was further purified through RNeasy mini columns
(Qiagen). All RNA samples passed quality control steps,
including RNA purity check (OD 260/280 ratio) and Bioana-
lyzer analysis (Agilent). Total RNA (5 mg) was converted,
using SuperScript II reverse transcriptase (Invitrogen), to
cRNA, and labeled cRNA was prepared by in vitro transcrip-
tion (Affymetrix). Twenty-five micrograms of labeled probe
was hybridized to Affymetrix MG 430 2.0 arrays. Expression
data were normalized using gcrma (R, 2.6.2; gcrma, 2.6.0),
and significant probes were identified by nominal P-value
(P , 0.001) and fold-change (absolute fold-change. 1.5)
or Pearson’s correlation coefficient (absolute correlation
coefficient . 0.8). All microarray data have been deposited
in NCBI’s Gene Expression Omnibus (accession number
GSE26001).
Gene set enrichment analysis
To test whether a set of significantly altered probes in knock-
out ES cells was enriched in knock-in ES cells, GSEA (53)
was performed using phenotype permutation procedures
(1000 permutations). Similarly, we tested whether signifi-
cantly correlated probes in knock-in ES cells were signifi-
cantly enriched in knock-out ES cells using GSEA. For
identification of significantly enriched pathways in knock-out
and knock-in ES cells, pre-compiled gene sets from pathway
databases (Biocarta and KEGG) and Gene Ontology were ana-
lyzed using the sigPathway program (54). Gene sets with sizes
between 25 and 500 were selected, and gene sets showing
undirectional enrichment were identified by gene set permu-
tation (10 000) and phenotype permutation (1000) (false dis-
covery rate, q , 0.01). To assess commonality between
significant pathways in knock-out and CAG knock-in cells,
the average of ranks of the top 20 knock-out significant path-
ways in the CAG knock-in data (i.e. enrichment score; 4.51)
was compared with a distribution of averages of ranks
obtained by randomly choosing the same number of pathways
in knock-in data (10 000 permutations). Similarly, the average
of ranks of the top 20 knock-in significant pathways in the
knock-out data (i.e. enrichment score; 4.55) was compared
with a distribution of averages of ranks of 20 randomly
chosen pathways in knock-out data. Networks of significant
pathways were hand-annotated, identifying shared pathway
categories using the graphical view feature on the gene ontol-
ogy website. Significant pathways from the KEGG database
were annotated using the corresponding GO pathway. Net-
works were drawn using Cytoscape (version 2.7.0).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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Attributions 
My question: 
Pertaining to this manuscript, the question I personally sought to address was: Is the 
functional requirement for huntingtin in cell adhesion & the cytoskeleton conserved in 
Dictyostelium? 
My research contributions: 
I discovered a defect in the developmental acquisition of cell-cell adhesion in huntingtin 
deficient Dictyostelium (Figure 7) that was included in the manuscript reprinted here in Appendix 
C. Since that time, I have performed all of the experiments to characterize this defect in cell-cell 
adhesion, detailed in Chapter 4, and a manuscript of this work is in preparation. 
Significance: 
 My research provides preliminary evidence that the function of huntingtin in cell 
adhesion may be conserved. I uncovered the existence of novel adhesion biology in early 
Dictyostelium development, developing two assay systems that can be used in future 
mechanistic studies. 
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Deficiency of Huntingtin Has Pleiotropic Effects in the
Social Amoeba Dictyostelium discoideum
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Abstract
Huntingtin is a large HEAT repeat protein first identified in humans, where a polyglutamine tract expansion near the amino
terminus causes a gain-of-function mechanism that leads to selective neuronal loss in Huntington’s disease (HD). Genetic
evidence in humans and knock-in mouse models suggests that this gain-of-function involves an increase or deregulation of
some aspect of huntingtin’s normal function(s), which remains poorly understood. As huntingtin shows evolutionary
conservation, a powerful approach to discovering its normal biochemical role(s) is to study the effects caused by its
deficiency in a model organism with a short life-cycle that comprises both cellular and multicellular developmental stages.
To facilitate studies aimed at detailed knowledge of huntingtin’s normal function(s), we generated a null mutant of hd, the
HD ortholog in Dictyostelium discoideum. Dictyostelium cells lacking endogenous huntingtin were viable but during
development did not exhibit the typical polarized morphology of Dictyostelium cells, streamed poorly to form aggregates
by accretion rather than chemotaxis, showed disorganized F-actin staining, exhibited extreme sensitivity to hypoosmotic
stress, and failed to form EDTA-resistant cell–cell contacts. Surprisingly, chemotactic streaming could be rescued in the
presence of the bivalent cations Ca2+ or Mg2+ but not pulses of cAMP. Although hd2 cells completed development, it was
delayed and proceeded asynchronously, producing small fruiting bodies with round, defective spores that germinated
spontaneously within a glassy sorus. When developed as chimeras with wild-type cells, hd2 cells failed to populate the pre-
spore region of the slug. In Dictyostelium, huntingtin deficiency is compatible with survival of the organism but renders cells
sensitive to low osmolarity, which produces pleiotropic cell autonomous defects that affect cAMP signaling and as a
consequence development. Thus, Dictyostelium provides a novel haploid organism model for genetic, cell biological, and
biochemical studies to delineate the functions of the HD protein.
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Introduction
Huntington’s disease (HD) is an autosomal dominant neurode-
generative disorder whose clinical manifestations include psychi-
atric disturbances, cognitive decline and characteristic involuntary
movements, typically diagnosed in mid-life [1,2]. HD is caused by
a CAG trinucleotide repeat expansion mutation (.35 units) that
produces an elongated version of a normally polymorphic
polyglutamine segment in huntingtin [3–5], a large 350 kDa
ubiquitously expressed HEAT (huntingtin, elongation factor 3, the
A subunit of protein phosphatase 2A, and TOR1) repeat protein.
Several lines of evidence indicate that the HD mutation confers
a CAG length-dependent ‘gain-of-function’ that likely produces its
distinctive neuropathology through a modulatory effect on some
structural or functional feature of huntingtin [6–9]. HD homozy-
gote individuals with two mutant HD genes, and therefore no wild-
type huntingtin, develop the characteristic movement disorder
with timing comparable to that seen in typical HD mutation
heterozygote individuals, indicating the absence of a strong dosage
effect. Moreover, complete deficiency of huntingtin causes
developmental abnormalities and embryonic lethality in the
mouse that can be fully rescued by mutant huntingtin, indicating
that these fundamental normal functions of huntingtin are not
abrogated by the HD mutation. Thus, defining the disease-
producing ‘gain-of-function’ - either a polyglutamine-length
dependent increase or deregulation of a normal huntingtin activity
or the introduction of a novel polyglutamine-length dependent
activity, will require an understanding of the protein’s normal
function(s).
Huntingtin is present throughout eukaryotic evolution except in
fungi and plants and shows no close primary sequence homology
to any other protein [6]. Therefore, one approach to huntingtin
function is to investigate its orthologs in tractable experimental
models. Manipulation of the HD gene homologs in model
organisms has revealed that huntingtin is essential for normal
embryonic development both in the mouse and in the zebrafish
[10–13], is dispensable for Drosophila development [14] and is
implicated in a variety of functions ranging from vesicle trafficking
to chromatin silencing and gene expression [15–18]. However,
though murine embryonic stem cells lacking huntingtin are viable
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in tissue culture, permitting multi-cellular developmental studies in
vitro [10], investigation of huntingtin function in single cells versus
multicellular stages of development would be expedited by an
experimental organism with a short life-cycle, comprising cellular
and multicellular developmental stages.
The soil amoeba Dictyostelium discoideum is a bona fide multicellular
eukaryotic organism with a haploid genome and a relatively simple
developmental program that serves as a model for basic biological
research [19] and is emerging as a valuable tool for understanding
gene function and pathogenic mechanisms in a variety of human
disorders [20–24]. During development, Dictyostelium undergoes a
series of coordinated morphological and physiological changes
that are initiated by starvation and progress in defined stages over
a 24 hour period. Within the first 6 hours of development, cells
secrete, and undergo chemotaxis toward cyclic adenosine
monophosphate (cAMP) to form aggregation centers. The
secretion of cAMP promotes a G protein-coupled receptor
signal/response cascade resulting in the formation of loose mounds
comprising up to 100,000 cells [25,26]. As development continues,
cells within the mound are directed to differentiate into either
prestalk or prespore cells, leading to morphological changes that
yield a multicellular stalk, supporting a ball of encapsulated
dormant spores [27].
To explore huntingtin function in both single cells and
multicellular structures of the same organism, we have character-
ized a Dictyostelium ortholog (hd) of the human HD gene, have
generated a viable hd-null mutant and have delineated a number
of consequent phenotypes. We present evidence to suggest that
huntingtin is a multifunctional protein that plays a protective role
during hypoosmotic stress, regulates cell shape and homophilic
cell-cell adhesion through a cytoskeletal–based mechanism,
modulates pre-spore/spore cell fate determination and affects
spore dormancy in Dictyostelium. Interestingly, hd2 cells were found
to have a requirement for bivalent cations in the medium for
optimal chemotaxis and cell aggregation. Our findings establish
Dictyostelium as a valuable experimental eukaryotic organism for
exploring in biochemical detail huntingtin’s normal function(s), as
defined by the pleiotropic effects of huntingtin deficiency
throughout the developmental life cycle.
Results
The Dictyostelium huntingtin ortholog
The Dictyostelium discoideum genome, examined via dictyBase
(www.dictybase.org) [28], contains a single gene
(DDB_G0272344) with evident sequence homology to human
huntingtin. The hd locus is comprised of four exons, located on
chromosome 2. Analysis of GenBank with psi-BLAST [29,30]
placed the product of hd firmly within the huntingtin family
(Figure 1A), with a length of 3,095 amino acids comparable to the
3,144 amino acids of human huntingtin. Structural analysis of
huntingtin proteins has identified the presence of numerous
HEAT and HEAT-like repeats thought to produce a large a-
helical solenoid rather than a typical globular protein [6,15,31,32].
Dictyostelium huntingtin is also predicted to be a-helical across most
of its length (Figure 1B) and, as in other organisms, BLASTP
searches of GenBank revealed no significant sequence alignments
with other Dictyostelium proteins. Interestingly, Dictyostelium hun-
tingtin contains a polyglutamine tract of 19 residues (Figure 1B)
that is comparable in size to that found in normal-range human
huntingtin but is encoded by the trinucleotide repeat CAA
interrupted by a single CAG codon, is not followed by a
polyproline domain, is located further downstream of the initiator
methionine (at residue 533 rather than residue 18 as in the human
protein), and may reflect the unusually high number of predicted
proteins (,34%) that contain homopolymer tracts of 15 residues
or more in Dictyostelium [33].
Dictyostelium huntingtin was expressed throughout
growth and development
To determine the spatial and temporal pattern of huntingtin
mRNA expression throughout the life cycle (Figure 2A); we cloned
the intergenic region up to the closest upstream gene (608 bp) and
used it to replace the actin15 promoter in pTX-GFP and to direct
expression of the green fluorescent protein (GFP), which was
detected in all cell types of transformed AX3 wild-type Dictyostelium
cells during growth and development (Figure 2B, 2C, 2D), a
pattern that fits well with the developmental and cell-type specific
mRNA expression data acquired through extensive microarray
and RNA-seq analysis which is freely available in dictyBase
(DDB_G0272344) [34]. To further characterize the function of
huntingtin in Dictyostelium, we examined the existence of alternate
transcripts using exon specific primers and reverse transcriptase
polymerase chain reaction (RT-PCR). No alternatively spliced
forms of mRNA could be detected using various primer sets
specific for exons (exon 1–exon 4) during vegetative growth and
development of AX3 cells (Figure 2E).
Huntingtin-null cells display pleiotropic phenotypes
To explore huntingtin function, we utilized homologous
recombination to create multiple independent Dictyostelium strains
carrying a disruption of the hd gene in the haploid genome
(Figure 3A). The disruption cassette targeted hd such that a double-
recombination event would remove 278 bp of exon 2 and insert a
blasticidin resistance (Bsr) selection cassette (Figure 3B, 3C).
Following transformation of parental AX3 cells and blasticidin
selection, 150 independent resistant clones were isolated and those
(16) with the properly targeted hd gene disruption were identified
by PCR amplification of the expected genomic DNA products
Author Summary
Genetic evidence in humans and mouse models of
Huntington’s disease suggests that the disease mutation
confers a deleterious gain-of-function on huntingtin that
acts through the deregulation of some aspect of the
protein’s normal function(s). While huntingtin’s function is
poorly understood, its evolutionary conservation makes
investigation of its physiological role in lower organisms
an attractive route that has yet to be fully exploited.
Therefore, we have used Dictyostelium discoideum to study
the consequences of huntingtin (hd) deficiency. Develop-
ing Dictyostelium cells chemotax to form a multicellular
slug that forms a fruiting body, comprising dormant
spores encased above dead stalk cells. We found that hd2
cells were hypersensitive to hypoosmotic stress. When
starved, hd2 cells aggregate by accretion, showed
disorganized F-actin, and failed to form EDTA-resistant
cell–cell contacts. Surprisingly, chemotactic signaling was
rescued with Ca2+ or Mg2+ but not pulses of cAMP.
Development of hd2 mutants produced small fruiting
bodies with round, defective spores, and when mixed with
wild-type cells they didn’t differentiate into spores. Our
results are consistent with mammalian studies that show
huntingtin is a multifunctional protein involved in many
biochemical processes; and, importantly, they establish
Dictyostelium as a valuable experimental organism for
exploring in biochemical detail huntingtin’s normal
function(s).
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(Figure 3D). Proper targeting was also confirmed by Southern blot
using DIG-labeled Bsr specific probes as well as by RT-PCR
amplification of cellular mRNA which demonstrated that hd
mRNA was absent (Figure 3E, 3F). Clonal isolates from multiple
independent mutants possessing the same disruption and devel-
opmental phenotype (glassy sori and round spores) were obtained.
One of these clones (httE13) was used in all subsequent
experiments and is referred to as hd2 for clarity.
Actin cytoskeleton and contractile vacuole defects in hd2
cells
We did not observe differences in the growth properties of hd2
and wild-type cells when grown as adherent cultures in tissue
culture dishes (data not shown). However, in contrast to wild-type
cells, axenically grown shaking cultures of hd2 cells consistently
grew faster with a doubling time of ,10 hours compared to the
,12 hour doubling time of wild-type cells (Figure S1), suggesting a
physiological impact of the absence of huntingtin at the level of
single cells. Plating of hd2 cells under non-nutrient, low ionic
strength phosphate buffer (KK2; ,40 mOsmol/L), elicited a cell
rounding phenotype that suggested an actin-cytoskeleton defect,
which we examined by staining for F-actin. The morphology of
hd2 cells grown as an adherent culture in HL-5 medium was
similar to that of wild-type cells (Figure 4A) and phalloidin staining
showed a similar distribution of F-actin in extended pseudopods in
both genotypes (Figure 4C). However, removal of nutrients and
the addition of KK2 buffer resulted in a rapid reduction in
pseudopod formation (,20 minutes) and ultimately a failure to
polarize only in the hd2 cells (Figure 4B). The rounded cell
phenotype of hd2 cells was accompanied by a redistribution of F-
actin from the cell cortex to the cytosol (Figure 4D).
As the extreme cell rounding observed in low osmotic buffer
hinted at a potential defect in contractile vacuole osmoregulation,
we assessed the ability of hd2 cells to respond to osmotic stress.
When wild-type cells were placed in water, several small
contractile vacuoles formed within 30 minutes and, over time,
the cells compensated for the sudden change in their osmotic
environment and gradually regained their original size, shape and
cell-substratum adhesion (Figure 4E; Video S1). In contrast, hd2
Figure 1. Phylogenetic and structural analysis of Dictyostelium huntingtin. A. A phylogenetic tree showing the relationship of Dictyostelium
huntingtin to huntingtin proteins from 51 other organisms was prepared as the average distance tree using BLOSUM62 of a CLUSTALW alignment in
JALVIEW (reference: Waterhouse, A.M., Procter, J.B., Martin, D.M.A, Clamp, M. and Barton, G. J. (2009) ‘‘Jalview Version 2 - a multiple sequence
alignment editor and analysis workbench’’ Bioinformatics 25 (9) 1189–1191). B. Dictyostelium huntingtin (open line) is depicted with amino acid
coordinates (above) above secondary structure predictions from PROF (www.predictprotein.org; B Rost, G Yachdav and J Liu (2004) The
PredictProtein Server. Nucleic Acids Research 32(Web Server issue):W321–W326) where pHsec, pEsec and pLsec represent the probability (1 high, 0
low) for helix (red), strand (blue) and neither helix nor strand (green). Locations in the huntingtin schematic of natively unstructured regions
predicted by NORSnet (Avner Schlessinger and Jinfeng Liu and Burkhard Rost (2007)) and of a 19 residue polyglutamine repeat are shown by cyan
and black, respectively.
doi:10.1371/journal.pgen.1002052.g001
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cells failed to form any visible vacuoles, but instead became round,
swollen, lost their adhesion to the substratum and underwent
complete lysis within 5–6 hours (Figure 4F; Video S2), indicating
that contractile vacuole activity was dramatically compromised in
hd2 cells under conditions of hypotonic stress. No difference was
observed between wild-type and hd2 cells under hyperosmotic
(400 mM sorbitol) conditions (data not shown).
Loss of huntingtin caused developmental delay and
abnormal morphogenesis
To determine whether the mutant cells were capable of carrying
out the full program of multicellular development, we assayed
wild-type and hd2 cells by plating on filters. Wild-type cells formed
numerous streaming aggregation centers by 6 hours that went on
to form tight mounds by 12 hours, early culminants by 18 hours
and fruiting bodies by 24 hours as expected (Figure 5). By contrast,
hd2 mutant cells formed delayed aggregates, and by 12 hours had
constructed comparatively loose mounds with supernumerary
prestalk tips, which subsequently went on to form multiple slugs
and small fruiting bodies (Figure 5). Thus, whereas wild-type cells
had completed the developmental program by ,24 hours, the
development of hd2 cells was delayed and asynchronous, resulting
in the appearance of aborted intermediates and the formation of
small fruiting bodies that develop glassy sori.
Huntingtin-deficient cells exhibited abnormal shape and
motility during early development
A closer examination of the effects that loss of huntingtin has
on the earliest stages of development revealed deficits in both the
aggregation properties and cell-cell cohesiveness of wild-type and
hd2 cells. When assayed on non-nutrient KK2 agar or buffer-
soaked nitrocellulose filters, wild-type cells migrated as streams to
form aggregates by 6–8 hours (Figure 6A). The hd2 cells did not
form streams that led to distinct aggregation territories, but rather
form delayed aggregation territories by accretion (Figure 6B). We
next examined the behavior of cells deposited at different cell
densities under starvation buffer (non-nutrient phosphate buffer
KK2, pH 6.2) in order to get a better view of the streaming
defect. When plated at 16105 cells/cm2, wild-type cells formed
long streams of polarized, elongated cells that congregated into
aggregation signaling centers (Figure 6C; Video S3). In contrast,
hd2 cells adopted the rounded shape noted previously and
ultimately failed to polarize, form aggregation centers or initiate
streams (Figure 6D; Video S4). Yet, when assessed at high cell
densities (56106 cells/cm2), hd2 cells managed to form aggrega-
tion centers, largely by accretion; however the mounds appear
polarized (regular shape on one side, irregular with dark
clumping cells on the other side) and many cell were excluded
(Figure 6E, 6F).
The observed defects suggest two possibilities; 1) hd2 cells are
defective in cAMP signaling, or 2) the extreme sensitivity of hd2
cells to conditions of low osmolarity negatively affects develop-
ment. The secretion of periodic cAMP pulses is required to
initiate Dictyostelium development [35] and so the addition of
timed pulses of exogenous cAMP should facilitate early
development in hd2 cells if they are defective in cAMP signaling.
Pulsing wild type cells in KK2 buffer with 75 nM cAMP every
6 minutes for a period of 4–5 hours accelerated the onset of
chemotactic streaming, but equivalent cAMP pulses did not
rescue the rounding or chemotactic streaming of hd2 cells (data
not shown). We next assessed what effect the addition of bivalent
Figure 2. The predicted endogenous hd promoter drives expression of GFP during growth and development. (A) Developmental life
cycle of Dictyostelium discoideum*. Dictyostelium spends most of its life as vegetative cells that prey upon bacteria and divide mitotically. When
starved, the cells enter the developmental cycle that completes in a 24 hour period. During development, amoebae chemotactically aggregate
towards secreted cAMP to form a hemispherical mound. Within the mound cells differentiate and sort out to form a motile slug. The slug ultimately
forms a fruiting body comprised of a multicellular stalk supporting a ball of encapsulated dormant spores. (B) A cloned region of DNA sequence
595 bp upstream of the hd gene was used to replace the actin 15 promoter in the expression vector pTX-GFP. Wild-type AX3 cells were transformed
with this construct and expression of GFP was assessed in vegetative cells; (C) mound structure showing GFP expression from hd promoter; (D) slug
showing expression of GFP in both prestalk (anterior) and prespore (posterior) regions. Scale bar (mm) is shown at the bottom right. (E) Dictyostelium
huntingtin is a single copy gene comprised of four exons. Total RNA was extracted from wild-type Dictyostelium strain AX3 during vegetative growth
and 6-hour increments during synchronous development on nitrocellulose filters supported by filter pads soaked in DB buffer and developed at 21uC.
The presence of alternate transcripts was analyzed with a combination of hd exon-specific primer sets, RT-PCR and resolved using ethidium bromide
stained agarose gels. rnlA was used as a mRNA amplification control. Collection time points are shown in hours (top). hd exon boundaries are shown
on the left. PCR product sizes (bp) are shown on the right. *Figure representing the developmental life cycle of Dictyostelium was adapted from CC
Creative Commons Attribution – Share Alike 3.0, David Brown & Joan E. Strassmann and is freely available online for download at the dictyBase.
doi:10.1371/journal.pgen.1002052.g002
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cations (higher osmolarity) would have on cAMP signaling and
chemotactic aggregation of hd2 cells under KK2 buffer.
Interestingly, the addition of 1 mM CaCl2 (Figure 6G, 6H),
1 mM MgCl2 or 1 mM MgSO4
2 (data not shown) rescued
endogenous cAMP signaling and chemotactic aggregation of hd2
cells (Video S5). However, the streams formed by hd2 cells in the
presence of bivalent cations were shorter and had a tendency to
break and re-form when compared to wild type streams (Figure
S2A, S2B). In addition, rescue of cAMP signaling and
chemotactic aggregation of hd2 cells in the presence of bivalent
cations was inhibited by the addition of 1 mM ethylene glycol
tetraacetic acid (EGTA) (Video S6).
To further assess cAMP signaling in hd2 cells, we explored their
aggregation properties on KK2 agar containing caffeine (1, 2.5
and 5 mM), a compound shown to inhibit cAMP signaling in
Dictyostelium [36]. Hd2 mutant cells were equally sensitive and
exhibited similar developmental phenotypes to wild type cells
when treated with caffeine. Aggregation and development of wild
type and hd2 cells was severely inhibited at 5 mM caffeine and at
1 mM caffeine both wild type and hd2 cells were capable of
forming fruiting bodies (data not shown). We next assessed
aggregation and development of wild type and hd2 cells on KK2
agar containing EGTA (1 mM or 2 mM). In contrast to caffeine
treatment, development of wild type cells in the presence of 1 mM
EGTA was unaffected (Figure 6I) whereas hd2 cells failed to form
chemotactic streams and arrested development as loose aggregates
(Figure 6J). Taken together, our data suggest that hd2 cells are not
primarily defective in cAMP signaling but rather have a
hypersensitivity to conditions of low osmolarity which affects
cAMP signaling and thus development.
Figure 3. Targeted disruption of the hd gene by homologous recombination. (A) Physical map of the hd gene is shown. The four exons (I, II,
III and IV) that comprise the hd gene are shown (grey) interrupted by three introns (white bars). PCR primers are shown as arrows at the positions in
which they prime including amplicon sizes. The exon-intron boundaries are not to drawn to scale. (B) The targeting vector and sites of recombination
are shown. The vector contains the Blasticidin S resistance gene (Bsr) that is flanked by loxP sites and allows for selection of transformed cells. (C)
Physical map of the targeted deletion is shown. PCR primers are shown as arrows at the positions that they prime including amplicon sizes. (D)
Genomic PCR of wild-type (wt) and hd2 (ko) clones. Control PCR amplification of the sequence immediately upstream of the hd gene (panel 1); No
amplification in clones carrying a targeted deletion of the hd gene which removes 278 bp of sequence from exon 2 (panel 2); PCR amplification of
genomic DNA using primers that prime outside the vector (P5 or P8) and inside the Bsr cassette (P6 or P7), respectively (panels 3 and 4). No DNA is
amplified from wild-type cells; PCR of genomic sequences that flank the insertion site (panel 5). The endogenous wild-type allele yields a fragment of
,400 bp whereas the knockout mutant yields a much larger fragment representing insertion of the Bsr cassette. Molecular weight markers are
shown on the left. (E) Confirmation of gene disruption by Southern blot analysis. Genomic DNA from wild-type or two independent hd2 clones
(clones 13 and 33) were probed by Southern blot hybridization for the presence of Bsr sequences. (F) RT-PCR of total RNA isolated from wild-type and
two independent hd2 clones (clones 13 and 33). In each panel, lane 1 represents the amplicon derived from priming the exon 2 deletion; lane 2
represents priming inside the Bsr cassette; and lane 3 represents control RT-PCR reactions. Molecular weight markers are shown on the left.
doi:10.1371/journal.pgen.1002052.g003
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Figure 4. Removal of nutrients caused rounding of hd2 cells and affects F-actin localization. (A) The morphology of hd2 cells (right panel)
grown and photographed as an adherent culture in HL-5 was similar to wild-type cells (left panel). Scale bars (20 mm) are shown on the bottom right.
(B) Removal of nutrients (HL-5) and replacement with starvation buffer (KK2) caused rounding of hd
2 cells. Cells were photographed 20 minutes after
the addition of starvation buffer. Wild-type cells (left panel) displayed morphology similar to that observed for cells in HL-5 whereas all hd2 cells
immediately adopted a rounded morphology (right panel). Scale bars (20 mm) are shown on the bottom right. (C) Aberrant localization of F-actin in
starved hd2 cells. Vegetative wild-type cells (left panel) and hd2 cells (right panel) collected from axenic medium (HL-5) were deposited into Lab-tek
chambered cover glass (8 well) at 16105 cells/cm2 and allowed to grow overnight in HL-5 at 21uC. For F-actin staining, the cells were fixed with 4%
formaldehyde in PDF buffer and then stained with Texas red-phalloidin. Arrows indicate membrane extensions enriched with F-actin. (D) Localization
of F-actin in cells submerged in starvation buffer (KK2). One hour after starvation in KK2, wild-type cells retained their normal amoeboid morphology
(left panel); hd2 cells remained rounded and exhibited a redistribution of F-actin away from the cell cortex as it concentrated in the cytosol (right
Huntingtin Function in Dictyostelium
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The cell-cell adhesion properties of hd2 cells in the absence or
presence of 10 mM ethylenediaminetetraacetic acid (EDTA)
mirrored those observed for wild-type cells during the first 3 hours
of development (Figure 7). However, after ,4 hrs of development,
wild-type cells began to attain EDTA-resistant cell-cell contacts
whereas hd2 cells not only failed to acquire EDTA-resistant cell-
cell contacts but also began to display an overall loss in cell-cell
cohesion as judged by an increase in the number of single cells
assayed in the absence of EDTA (Figure 7). Even by 24 hours,
neither EDTA-resistant adhesion in hd2 cells nor recovery of their
cohesion properties in suspension developed (data not shown).
Thus, stringent conditions exacerbated hd2 cell developmental
deficits, revealing aberrant cell polarization, aggregation and
motility consistent with abnormal cell shape, cytoskeletal function
and cell-cell adhesion properties.
hd2 mutants exhibited abnormal prespore/spore cell
differentiation
Though streaming and aggregation of hd2 cells were abnormal
and overall development was delayed, multiple prestalk tips
formed atop most of the developing hd2 mounds. Each of these
tips elongated into a finger structure, suggesting the possibility of
aberrant prestalk/prespore cell differentiation (Figure 8A, 8B), and
eventually produced a fruiting body with a glassy sorus containing
a reduced spore complement when developed on KK2 agar or
with a lawn of Klebsiella on SM agar (Figure 8C, 8D). In contrast to
wild-type fruiting bodies, the numbers of spores in hd2 sori
decreased as the fruiting bodies aged, resulting in a glassy sorus;
this suggested a potential defect in spore formation or alternative-
ly, spore dormancy. We used electron microscopy to examine the
fine structure of the elliptical wild-type spores and round mutant
hd2 spores from 72 hr fruiting bodies (Figure 8E, 8F). The EM
images revealed the premature germination of spores in the sori of
hd2 fruiting bodies. In stark contrast to the dormant wild-type
spores, the hd2 sori contained a mixture of apparently dormant
spores with three wall layers, swollen spores, swollen spores with
thin spore walls about to release amoebae, and nascent amoebae
(Figure 8F). Our data suggest that shortly after fruiting body
formation hd2 spores are unable to maintain dormancy, or
alternatively, fail to achieve dormancy possibly through poor
differentiation properties and germinate within the sorus.
Consequently, we assessed the ability of hd2 cells to differentiate
into stalk and spore cells in low cell density monolayer culture
[37]. In response to 10–100 nM of the stalk cell inducer,
differentiation inducing factor 1 (DIF-1), hd2 mutants were able
to produce stalk cells as efficiently as wild-type cells (data not
shown). However, in response to the sporulation inducer 8-Br-
cAMP (5–15 mM), a cell permeable analogue of cAMP,
sporulation in the mutants was delayed ,24 hours compared to
wild-type cells (Figure 8G). hd2 cells collectively formed spore cells
at ,40% efficiency relative to wild-type controls after 48 hours
differentiation (Figure 8G).
hd2 mutants produced spores with abnormal
morphology and reduced viability
At least some spores produced by development of hd2 organisms
were capable of germination and formation of viable amoebae.
The spore coats of both wild-type and hd2 cells also stained
brightly with Calcofluor, demonstrating the normal presence of
cellulose in the mutant spores (data not shown). To test the relative
viability of the hd2 mutant spores, we compared their germination
rates with wild-type spores. Spores harvested from sori of each cell
line were mixed with Klebsiella, deposited on SM agar plates and
the number of plaques that formed was scored. Spores harvested
from wild-type sori displayed an average survival rate of
8263.4%, whereas hd2 spores demonstrated a dramatically
reduced mean survival rate of 2062.2% (Figure 9). This did not
appear to be due to reduced resilience of hd2 mutant spore coats,
Figure 5. hd2mutants exhibited asynchronous delayed development. Exponentially growing wild-type and hd2 cells (26106 cells/mL) were
washed three times with DB buffer, resuspended at a density of 56107 cells/mL, deposited on black nitrocellulose filters supported by filter pads
soaked in DB buffer and developed for 28 hours at 21uC. All photographs are top view. Wild-type cells developed distinct aggregation territories after
6 hours whereas hd2 null cells displayed a much smoother appearance and the noticeable absence of streams. By 12 hours hd2 cells formed mounds
that tended to produce multiple tips. Further development of hd2 cells proceeded in a delayed asynchronous manner resulting in the presence of
various intermediate structures and small aborted mounds. The developmental time points in hours are shown at the top.
doi:10.1371/journal.pgen.1002052.g005
panel). Nuclei were stained with Hoechst 33342. Scale bars (5 mm) are shown on the bottom right. (E) hd2 mutants were impaired in osmoregulation.
Wild-type (wt) and (F) huntingtin-null (hd2) cells were grown in cell culture dishes with HL-5 media. The media was exchanged with dH2O and the
cells were examined after 1 hour. Wild-type cells initially rounded and showed partial swelling under the hypoosmotic conditions, but quickly
recovered the ability to crawl and change shape. In contrast, hd2 cells were completely round and swollen in dH2O, and barely remained attached to
the culture dish. The hd2 cells began to rapidly lyse after ,3 hours of this treatment and underwent complete lysis by 6 hours suggesting that the
mutants may retain some very low level of osmoregulation. Scale bar 10 mm.
doi:10.1371/journal.pgen.1002052.g004
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Figure 6. hd2 cells displayed aggregation defects and failed to stream under submerged culture. Wild-type and hd2 cells (16106 cells/
mL) were deposited on non-nutrient KK2 agar plates and visualized by brightfield microscopy. Images are top view. (A) Wild-type cells migrated in
Huntingtin Function in Dictyostelium
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as spore viability of both wild-type and hd2 mutant spores was not
differently altered by treatment with the non-ionic detergent NP-
40 (0.5%) and brief heat treatment (45uC) (Figure 9).
Developmental defects in huntingtin-deficient organisms
are cell-autonomous
To distinguish whether the developmental defects observed in
hd2 cells were cell autonomous or non-cell autonomous, we
followed the cell fate of hd2 cells during chimera development in
mixed cell cultures. Mutant hd2 cells and wild-type cells carrying
an act15/GFP construct, which marks all cells, were prepared and
mixed in ratios of 1:1, 1:3 or 1:9 with unmarked cells of the
opposite genotype (or of the same genotype as controls). As
expected, the deficits revealed by hd2 cells in assays at the single
cell stage (e.g., cell rounding, actin cytoskeleton rearrangement,
sensitivity to osmotic shock) or early in development (cell-cell
adhesion) were not rescued by the presence of wild-type cells in co-
culture (data not shown). Similarly, in developing co-aggregates of
cells developed under starvation buffer, hd2 cells failed to populate
the central region of the developing aggregate, consistent with the
inability of wild-type cells to correct the observed failure in the
initiation of intracellular cAMP signaling pathways required to
trigger aggregation (Figure 10A) or, possibly, the onset of cell-cell
adhesion properties in hd2 cells.
We then studied cell pattern organization of live cells during the
slug stage, where prestalk cells primarily populate the anterior region
and prespore cells occupy the slug posterior [38]. In the context of an
excess of unmarked wild-type cells (3:1 ratio), GFP-marked hd2 cells
Figure 7. Loss of EDTA-resistant adhesion in hd2 cells. Wild-type and hd2 cells (56106 cells/mL) were developed in Soerensen’s buffer at
150 rpm and 21uC. Samples were collected at the start of the assay and at one hour time points over a period of 6 hours. For each collection point,
cells were dissociated by vortexing and then incubated in the presence or absence of 10 mM EDTA for 30 minutes, fixed with 2% glutaraldehyde
(10 min.) and single cells were counted in triplicate using a hemocytometer. All experiments were performed in duplicate at least three times and the
mean value for single cells in duplicate samples, expressed as percentage of total cells was plotted over time.
doi:10.1371/journal.pgen.1002052.g007
streams (arrows) to form aggregation territories (m) by ,6 hours. (B) hd2 cells did not form well-defined streams, but rather clusters of cells that
formed aggregation centers largely by accretion. Scale bar 100 mm. (C) Wild-type and (D) hd2 cells (16105 cells/cm2) were submerged under KK2 and
allowed to develop for 6 hours. Streams (arrows) of wild-type cells moving into an aggregation center (m) were readily apparent (left panel) whereas
hd2 cells failed to stream (right panel). (E) Wild-type and (F) hd2 cells were submerged under buffer at high density (56106 cells/cm2) and imaged
after 20 hours. Under these conditions, wild-type cells readily formed distinct organized mounds; high density partially restored the ability of hd2
cells to form aggregation territories but with an irregular polarized shape. (G) Wild-type and (H) hd2 cells (16105 cells/cm2) were submerged under
KK2 in the presence of 1 mM CaCl2 and imaged after 20 hours. Under these conditions exogenous calcium rescues early development of hd
2 cells.
Scale bar 100 mm. (I) Development on KK2 agar in the presence of EGTA. After 24 hours, wild type cells form fruiting bodies whereas development of
hd2 cells (J) is blocked in the presence of 1 mM EGTA.
doi:10.1371/journal.pgen.1002052.g006
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Figure 8. hd2 cells formed mounds with multiple prestalk-tips and fruiting bodies with a glassy sorus. (A) Wild-type mounds formed
mounds that develop a single tip which proceeded to form an elongated finger structure. (B) Multiple prestalk-tips formed atop most hd2 mounds
that went on to form comparably small individual finger structures. Cells were developed on SM agar with a lawn of Klebsiella. Images are top view.
(C) Terminal structures of wild-type (left panel) and (D) hd2 null cells (right panel). After 36–48 hours, the sori of hd2 cells became progressively glassy
in appearance and contained very few spores. (E) hd2 spores spontaneously germinated within the sorus. Wild-type and hd2 spores were collected
and fixed (see Materials and Methods) for imaging using electron microscopy. Wild-type sori contained intact elliptical dormant spores with well-
defined spore coats and without the presence of amoebae. (F) Spores collected from hd2 fruiting bodies showed a heterogeneous mixture of round
spores that represented the various stages of germination. Swollen spores, swollen spores with thin spore walls about to release amoebae, and
nascent amoebae (arrows) are shown. (G) hd2 mutants displayed defects in prespore/spore cell differentiation. Wild-type and hd2 cells were starved
at low density in monolayer culture in the presence of 15 mM 8-Br-cAMP to induce sporulation, viewed by brightfield microscopy and the number of
Huntingtin Function in Dictyostelium
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within chimeric slugs were distributed within the prestalk zone (pstO),
rearguard and anterior-like cells (ALC), which suggests that they have
a greatly reduced ability to form prespore cells in the presence of wild-
type cells (Figure 10B). In the complementary experiment, GFP-
marked wild-type cells co-developed with hd2 cells populated
primarily the prespore region at cell ratios of 1:1 or lower
(Figure 10C). In both comparable control experiments, GFP
fluorescence was observed throughout the entire slug. Furthermore,
this trend was also seen in terminally differentiated chimeric fruiting
bodies with wild-type cells predominantly found in the spore mass
whereas hd2 cells occupied the tip and lower cup region, stalk and
basal disc (Figure 10D, 10E). Thus, although hd2 cells were capable of
forming spores when developed as a pure population (albeit poorly,
with reduced viability), the presence of wild-type cells in a chimeric
organism did not rescue but rather reduced the contribution of hd2
cells to spore formation.
Discussion
Huntingtin is notable for its role in HD, where an expanded
polyglutamine tract near the amino terminus of human huntingtin
produces late-onset progressive neurodegeneration, likely through
a modulatory effect of the polyglutamine region on the structure
and/or function of the protein. In this study, we have investigated
the fundamental function(s) of huntingtin in the haploid eukaryote
Dictyostelium discoideum, by characterizing deficiency phenotypes in
the single and multicellular phases of development of this social
amoeba. The deletion of the hd gene, using targeted homologous
recombination, was compatible with cell growth but produced
pleiotropic cell autonomous phenotypes that demonstrated that
mutant cells could not efficiently complete the processes necessary
for coordinated synchronous development of a multicellular
organism. The pleiotropic effects of huntingtin deficiency could
be the result of loss of a single activity or could be separate effects
due to the protein having multiple functions. Further experimen-
tation will be required to resolve these options, but the multiple
phenotypes, at both single cell and multicellular stages, offer
several routes to further explore the issue.
Our findings suggest that huntingtin participates, directly or
indirectly, in actin cytoskeleton-membrane dynamics that affect
cell shape. The mechanical properties of the cytoplasm are
important determinants of cell shape and permit cells to change
Figure 9. hd2 cells produced spores with reduced viability. The viability of wild-type (grey bars) and hd2 (black bars) spores was assessed.
Spores were untreated, heated to 45uC for 10 minutes or incubated with 0.5% NP40 detergent for 5 minutes and aliquots of 100 spores were plated
in triplicate onto SM-5 agar plates in a suspension of bacteria and grown for 7 days at 21uC. The relative viability of hd2 spores was assessed by
counting the number of clear plaques formed on the bacterial lawns. Results are representative of three independent experiments.
doi:10.1371/journal.pgen.1002052.g009
spores formed was counted. The percentage of differentiated wild-type (grey bars) and hd2 (black bars) spore cells was calculated from the total cells
after 24 and 48 hour incubation periods. On average, hd2 cells collectively formed spore cells at ,30% efficiency relative to wild-type controls after
48 hours. Bars indicate standard errors that are derived from three independent experiments, each with three replicates.
doi:10.1371/journal.pgen.1002052.g008
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the cytoplasm from a rigid to a dynamic actin network that can
greatly influence cell motility [39]. Huntingtin under certain
conditions appears to act as an essential facilitator of this process.
Whereas hd2 cells displayed apparently normal cell shape,
pseudopod formation, F-actin localization and random motility
in nutrient-rich media, when assayed in the absence of nutrients
(under developmental buffer), they failed to produce membrane
extensions, were abnormally round and lacked cortical F-actin,
although at high cell density, rounded hd2 cells managed to form
delayed aggregation territories by accretion. These observations
could also reflect the loss of an excitatory signaling pathway during
development of hd2 cells, as the phenotypes resemble those
exhibited by Dictyostelium null mutants for adenylyl cyclase that
overexpress the catalytic subunit of protein kinase A (PKA) [40] or
cells expressing the constitutively active inhibitory heterotrimeric
G-protein Ga9 [41]. Addition of exogenous pulses of 75 nM
cAMP at 6 minute intervals over a period of 4–5 hours did not
rescue the aggregation defect in our hd2 cells (data not shown),
though it is plausible that high cell density partially rescues mound
formation by increasing cell-cell contacts. However, cAMP
signaling and subsequent chemotactic aggregation could be
rescued through the addition of bivalent cations (Ca2+ or Mg2+)
to the medium, which suggests the possibility that hd2 cells exhibit
depleted cationic stores. Our findings support the notion that
huntingtin may facilitate proper Ca2+- Mg2+-dependent actin
cytoskeleton remodeling that determines cell shape, but that the
detection of this role critically depends upon the conditions in
which the cells are evaluated.
A second function for huntingtin is maintenance of cellular
integrity under conditions of osmotic stress. Contractile vacuoles
are intracellular membrane organelles involved in osmoregulation,
function as a highly efficient acidic Ca2+-store that is required for
cAMP-induced Ca2+-influx and are found in free-living amoebae
and protozoa [42–44]. Normally, wild-type cells growing in
culture media contain a few moderately active contractile vacuoles
that maintain the osmotic balance of the cell. The contractile
Figure 10. Huntingtin regulates prespore/spore differentiation
cell-autonomously. GFP was expressed in wild-type cells and their
position in chimeric aggregation territories with unlabelled hd2 cells
was monitored. (A) Mixed (1:1) cell suspensions were submerged
(16105 cells/cm2) under KK2 buffer (left panel). After 12 hours,
aggregation centers were imaged under brightfield and fluorescence
using an inverted microscope. hd2 cells failed to populate the central
region of aggregation territories but were instead localized to the
periphery of the mound. Images are representative of three indepen-
dent experiments. (B) Wild-type and hd2 cells that express GFP were
mixed 1:3 or less with unmarked wild-type cells as indicated and cellular
organization in live cells during the slug stage was assessed. GFP-
labeled wild-type cells were mixed with the same genotype as a control
(top panel); GFP-labeled hd2 cells populated the prestalk regions of the
slug (lower panel). (C) GFP-labeled hd2 cells were mixed with the same
genotype as a control (top panel); GFP-labeled wild-type cells populated
the prespore regions of the slug (lower panel). Slugs are positioned with
their indicated posterior prespore (psp) zones to the left and anterior
prestalk (pst) zones to the right. (D) hd2 cells marked with an actin/GFP
reporter plasmid were mixed with unmarked wild-type cells in a 1:3
ratio and allowed to develop into fruiting bodies. Developing structures
(late culminant) were imaged by DIC and fluorescent microscopy. Wild-
type cells marked with GFP (left panel) predominantly occupied the
prespore/spore region; hd2 cells marked with GFP failed to populate
the prespore region and were overrepresented in the upper cup, lower
cup and basal disc (right panel). Psp – prespore; Pst – prestalk. (E)
Terminal fruiting structures were viewed by DIC and fluorescent
microscopy. Wild-type cells expressing GFP (top panel); hd2 cells
expressing GFP (lower panel). Results are representative of three
independent experiments for all panels shown. Scale bar 100 mm.
doi:10.1371/journal.pgen.1002052.g010
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vacuole system functions as a ‘‘bladder’’ during conditions of
hypoosmotic stress, where it collects fluid (water and neutral amino
acids) in a network of tubular channels that associate with the
cortical actin network to allow for transient fusion with the plasma
membrane and expulsion of its contents to the extracellular
environment [45,46]. The behavior and survival rate of hd2 cells
in response to hyperosmotic conditions is similar to wild-type cells
(data not shown). However, contractile vacuole activity in response
to hypoosmotic stress is completely abolished in hd2 cells, and
renders the cells sensitive to conditions of low ionic strength. These
effects were consistently associated with a retraction of F-actin
from the cell cortex to the cytosol, suggesting that in the absence of
huntingtin, inefficient actin cytoskeleton remodeling may underlie
the failure of the tubular network to convert into the contractile
vacuole. This could involve abnormal formation of the vacuole
and failure to discharge, or altered regulation of F-actin binding
proteins, as there are examples of both. Cells deficient for
MEGAP1 and MEGAP2, members of the Pombe/Cdc15
homology (PCH) family of proteins involved in actin cytoskeletal
reorganization, are sensitive to hypoosmotic conditions because
they are defective in the tubulation and the associated emptying of
contractile vacuoles [47]. Whereas MEGAP-null cells fail to form
tubules from vacuoles and therefore accumulate the latter, we
suggest that hd2 cells cannot effectively osmoregulate due to the
inability of the tubule system to convert to vacuoles. Indeed,
Dictyostelium double mutants lacking two F-actin crosslinking
proteins, a-actinin and gelation factor, display a general
weakening of the cortical cytoskeleton and, like hd2 cells, do not
exhibit the normal polarized morphology of wild-type cells during
aggregation and are sensitive to hypoosmotic shock [48]. Our data
further suggest that the defective CV system in hd2 cells renders
cells not only sensitive to extreme hypoosmotic shock, but
secondarily affects intracellular ion homeostasis as the CV has
been shown to function as a major Ca2+-store [42,44] as well as
being tightly linked to Ca2+/Mg2+-containing mass dense granules
[43]. As a consequence, unless these cations are provided
exogenously hd2 cells appear unable to initiate cAMP-induced
Ca2+-transients that may act in a feedback loop to positively
reinforce cAMP relay [44] leading to chemotaxis. Moreover, in
contrast to wild type cells, development of hd2 cells on non-
nutrient agar was blocked by EGTA and, interestingly, was not
differentially sensitive to low concentrations of caffeine (data not
shown) suggesting that a defect in cAMP signaling, if present, is
relatively minor in comparison to their sensitivity to low osmolarity
and/or cation chelation. We posit that huntingtin likely acts very
early in establishing CV activity or integrity under hypoosmotic
conditions. It may act indirectly, or it may function directly as a
regulatory scaffold in this setting to drive assembly of the cortical
cytoskeleton with CV-associated proteins during the conversion of
tubule to vacuoles. Importantly, several proteins associated with
the contractile vacuole network and involved in membrane protein
trafficking are related to human proteins, suggesting that some
functions of the contractile vacuole network have been preserved
during the evolution of higher eukaryotes [45,49].
The cell-cell adhesion properties of hd2 cells are similar to wild-
type cells during the first 3 hours of development, but as
development proceeds hd2 cells fail to acquire EDTA-resistant
contacts. This suggests that hd2 cells retain the ability to form early
functional adhesion sites but not the EDTA-resistant sites
characteristic of aggregating chemotactic cells. Cell-cell contact
plays an important role in differentiation and gene expression in
Dictyostelium [50–52]. EDTA-resistant cell-cell binding is mediated
by the expression of glycoprotein gp80 at the onset of aggregation
[53,54]. Interestingly, the expression of gp80 is greatly augmented
by pulsatile cAMP signaling and the formation of EDTA-sensitive
cell-cell contacts [51,55]. Taken together, the apparently normal
EDTA-sensitive adhesion properties of hd2 cells, their inability to
initiate signaling centers at densities where wild-type cells can, and
the rescue of cAMP relay and streaming by the addition of
exogenous cations suggest that hd2 cells potentially lack the Ca2+-
Mg2+-dependent excitatory intracellular signal transduction path-
ways that upregulate gp80 EDTA-resistant adhesion complexes, or
that they are deficient in transporting gp80 to the cell surface.
We also provide compelling evidence to suggest huntingtin
modulates prespore cell fate choice. In the context of either an
equal ratio or excess ratio (3:1 and 9:1) of unmarked wild-type
cells, GFP-marked hd2 cells within chimeric slugs are distributed
within the prestalk zone (pstO), and as rearguard and anterior-like
cells (ALC) which suggests they have a significantly reduced ability
to form prespore cells when challenged in the presence of wild-
type cells. This could be due to a defect in the mutant cells in cell-
cell interaction, either through extracellular signaling or direct
contact relative to the efficient homotypic interactions of wild-type
cells. Indeed, this difference in differentiation might be explained
by the adhesion defect in hd2 cells as, in chimeras with wild-type,
gp80-null cells are also directed preferentially toward the prestalk
pathway [56]. Differential differentiation of huntingtin deficient
cells during development has also been observed in vertebrates. In
zebrafish, reduced expression of huntingtin differentially targets
development of telencephalic neurons compared to mid- and hind-
brain [57]. In mouse chimeras, Hdh2/2 cells also preferentially
colonize the hypothalamus, midbrain, and hindbrain during
relative to the telencephalon and the thalamus during early
development [58]. Thus, like these latter neuronal populations,
Dictyostelium cells require huntingtin for the proper development of
viable spores in the presence of wild-type cells.
The culmination of Dictyostelium multicellular development
permits survival of the organism through the production of
environmentally resistant spores and the complex organization of
actin filaments in Dictyostelium spores contributes to their ellipsoid
shape and dormancy [59]. hd2 mutants produced abnormally
round spores, which exhibited decreased viability, suggesting that
they were poorly differentiated or had a defect in the actin-
cytoskeleton. Moreover, electron microscopic examination of the
fine structure of spores from wild-type and hd2 fruiting bodies
suggested that the formation of the glassy sorus was likely a result
of the premature germination of spores and the resulting death of
newly emerged amoebae. Spore dormancy is maintained via active
biological processes including high osmolarity, actin dynamics,
production of the germination inhibitor discadenine and active
PKA which in concert function to insure a viable supply of spores
[60–62]. Since hd2 amoebae are sensitive to changes in osmolality,
display aberrant F-actin staining and show compromised sporu-
lation when subjected to constitutive PKA activation via 8-Br-
cAMP in vitro, it is plausible that in the absence of huntingtin,
imprecise cytoskeletal architecture and signaling from PKA
required to maintain or enter dormancy might also be defective
at this late stage of development.
Our data do not provide a simple definition for a single normal
function for huntingtin, but, as huntingtin deficiency in Dictyoste-
lium produces pleiotropic effects throughout the life cycle, our
findings are consistent with the consensus from mammalian studies
that huntingtin is a multifunctional protein that can impact upon
many biochemical processes. In Dictyostelium, defects in CV activity
or integrity leading to a disruption in ion homeostasis affecting the
cytoskeleton, cell shape and cell-cell adhesion would all predictably
interfere with many aspects of chemotactic aggregation and
development. Defining the degree to which the phenotypes
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reported here are connected by common underlying biochemical
deficits or, alternately, reflect different functions of huntingtin will
require detailed molecular investigation. However, the existence of
a Dictyostelium ortholog of human huntingtin, the viability of the
null hd2 mutant, and its discrete, readily assayed deficiency
phenotypes indicate that this haploid organism provides an
effective genetic model system to identify molecular and cellular
processes affected by the loss of huntingtin function. While the
latter is of fundamental biological interest considering the unique
nature of this ancient large a-solenoid HEAT protein, delineating
which of these functions are conserved in mammals and
determining whether they are altered by expansion of the
polyglutamine tract in human huntingtin will also provide much
needed insights into the mechanism by which mutant huntingtin
triggers HD pathogenesis.
Materials and Methods
Cell culture and development
Wild-type Dictyostelium discoideum AX3 cells were grown in
association with Klebsiella aerogenes on SM plates, axenically in tissue
culture plates or as shaking cultures in HL-5 medium (Formedia)
at 21uC. To assess growth rates, shaking cultures (150 rpm) of
AX3 or hd2 null mutant cells were suspended in HL-5 at a density
of 16104 cells/mL and grown at 21uC. Cells were counted in
triplicate using a hemocytometer. For synchronous development
exponentially growing cells (,26106 cells/mL) were washed three
times from the nutrient source with DB buffer (5 mM Na2HPO4,
5 mM KH2PO4, 1 mM CaCl2, 2 mM MgCl2, pH 6.5) by
centrifugation at 1500 rpm for 5 min, resuspended at a density
of 56107 cells/mL, deposited on black nitrocellulose filters
supported by filter pads soaked in DB buffer and developed at
21uC. Growth curves were determined for the hd2 strain, and
parental (wild-type) strain AX3. Shaking (150 rpm) cultures were
grown axenically in HL-5 at 21uC. Exponentially growing cultures
were used to inoculate four 50 mL cultures for each strain, starting
at 16105 cells per mL and counted daily using a hemocytometer.
For development under buffer (KK2), cells were grown in 6-well
tissue culture dishes in HL-5 to a density of ,56105 cells/cm2.
Cells were washed twice with KK2 and then allowed to develop
under KK2 or KK2 supplemented with 1 mM CaCl2, 1 mM
MgCl2, 1 mM MgSO4 or were provided with 75 nM pulses of
cAMP every 6 minutes for a period of 4 hours [41]. For
development and assessment of streaming behavior cells were
washed twice with KK2 and then deposited on agar at a density of
,56105 cells/cm2 on non-nutrient 1.5% agar plates (KK2 buffer
pH 6.4) or KK2 supplemented with caffeine (1, 2.5 and 5 mM) or
1 mM EGTA.
Disruption of the hd gene by homologous
recombination
The targeting construct for disruption of the hd gene was made
by standard cloning procedures in the floxed-Bsr gene disruption
vector pLPBLP [63]. PCR was used to amplify genomic sequences
flanking and within the coding region of the hd gene. The 59
targeting region of hd was amplified using primers 59CCC-
GGTACCATGGATCTTATTCG39 and 59-CCCAAGCTTC-
CAATGATAATATA39 which incorporate restriction sites (un-
derlined) for KpnI and HindIII, respectively to facilitate cloning into
the vector pLPBLP. The 39 targeting region of the hd gene was
amplified using primers 59CCCCTGCAGTTCTCCACCAA-
TCT39 and 59CCCGGATCCGTTATATGATCGG39 which
incorporate restriction sites (underlined) for PstI and BamHI,
respectively to facilitate directional cloning into pLPBLP. For
electroporation, 56106 cells in 100 mL of ice cold buffer H-50
(20 mM HEPES, 50 mM KCl, 10 mM NaCl, 1 mM MgSO4,
5 mM NaHCO3, 1 mM NaH2PO4) was mixed with 10 mg of
linearized gene-targeting DNA and electroporated twice, waiting
for about 5 sec between pulses, using a Bio-Rad Gene Pulser
(0.85 kv, 25 mF) (Bio-Rad, Hercules, CA) [64]. The next day, the
media was replaced with fresh HL-5 supplemented with 10 mg/ml
blasticidin. Single colonies were collected and replica-plated into
multiple 96-well plates. Genomic DNA was extracted exactly as
described [65], and targeted gene disruptions were identified
initially by several PCR reactions using a combination of primers
(Table S1). Clonal isolates from multiple independent mutants
possessing the same disruption and sporulation phenotype were
obtained. One of these clones (httE13) was used in all subsequent
experiments. Southern blot hybridizations using Bsr DIG-labeled
probes were used for definitive confirmation of gene disruption.
The Bsr fragment from pLPBLP was agarose gel purified and used
to make a DIG-labeled probe using the DIG-High Prime starter
kit from Roche. Hybridization was carried essentially as described
in the DIG-DNA Detection manual (Roche). Blots were washed at
room temperature and then at 68uC, equilibrated in detection
buffer, incubated in disodium 3-(4-methoxyspiro {l,2-dioxetane-
3,29-(59-chloro)tricyclo[3.3.1.1]decan}-4-yl) phenyl phosphate
(CSPD) for 15 minutes at 37uC and developed using enhanced
chemiluminescence XOMAT Kodak film.
RT-PCR analysis of hd splice variants
The analysis of total RNA for hd alternate splice variants was
performed using exon-specific primers and RT-PCR. Total RNA
was collected from vegetative cells and at 6-hour increments
during development using the Qiagen RNeasy kit followed by on-
column DNase digestion (Qiagen). The hd transcript was detected
using the Qiagen One-Step RT-PCR kit as per the manufacturer’s
recommendations using primer pairs listed in Table S2.
Conventional and fluorescence microscopy
Growing cells were harvested and deposited into Lab-tek
chambered cover glass (8 well) at 16105 cells/cm2 and allowed
to grow overnight in HL-5 at 21uC. For F-actin staining, the
media was aspirated and cells were fixed with 4% formaldehyde in
PDF buffer (20 mM KCl, 11 mM K2HPO4, 13.2 mM KH2PO4,
1 mM CaCl2, 2.5 mM MgSO4, pH 6.4) at room temperature for
15 minutes, permeabilized with 0.025% TX-100 in PDF buffer for
15 minutes, followed by a brief wash in PDF buffer. Cellular F-
actin was stained by incubating the fixed cells with Texas-Red-
conjugated phalloidin (Molecular Probes, Eugene, OR) at a
concentration suggested by the manufacturer for 25 minutes at
room temperature and washed three times with PBS prior to
viewing. To assess the effects of nutrient removal, the HL-5 was
aspirated and replaced with KK2 buffer (16.5 mM KH2PO4 and
3.8 mMK2HPO4). After starving cells for 1 hr, the cells were fixed
and processed for F-actin staining as described above. Nuclei were
stained with Hoechst 33342. Images were taken on an inverted
NIKON microscope TE2000 (NIKON Instruments, Dallas, TX)
with either 46, 206, 406 objectives or a 636 1.4 NA PlanFluor
oil immersion objective and Quantix camera (Roper Scientific,
AZ) controlled by NIS Elements and processed with Adobe
Photoshop software (Adobe, San Jose, CA).
Spore viability assays
The viability of wild-type and hd2 spores were assayed by
harvesting approximately 26108 cells and plating onto 10 cm non-
nutrient 1.5% agar plates (KK2 buffer pH 6.4). Spores from
mature fruiting bodies were harvested using sterile pipette tips
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containing 10 mL of spore buffer (40 mM KH2PO4, 20 mM KCl,
2.5 mM MgCl2), washed twice by centrifugation at 12,500 g for
2 minutes at room temperature and counted with a hemocytom-
eter. Aliquots of 100 spores were heated to 45uC for 10 minutes,
incubated with 0.5% NP40 detergent (Sigma-Aldrich, St Louis,
MO) for 5 minutes or incubated with spore buffer alone for
5 minutes as a control. Spores were washed and plated in triplicate
onto SM-5 agar plates in a suspension of bacteria (either E. coli B/
R or K. aerogenes) and grown for 7 days at 21uC. The viability of
spores was assessed by counting the number of clear plaques
formed on the bacterial lawns for each treatment. Relative
viability was measured as the percentage of hd2 plaques formed
compared to wild-type cells for all conditions.
Submerged-monolayer assay
The submerged-monolayer assay was modified from an assay
described previously [66]. For stalk cell induction, vegetative cells
were washed once with KK2 buffer and three times with stalk
buffer (10 mM morpholineethanesulfonic acid [MES], 2 mM
NaCl, 10 mM KCl, 1 mM CaCl2, 5 mM cAMP and 200 mg of
penicillin-streptomycin per ml, pH 6.2). The cells were then plated
into 24-well tissue culture plates at a density of 104 cells/cm2 and
incubated in the presence or absence of 10–100 nM differentia-
tion-inducing factor (DIF-1). A calcofluor solution (0.01%) was
added to the wells for 5 min., removed and the cells were observed
immediately by microscopy. Only the cells that were vacuolated
and stained by calcofluor were counted as stalk cells [67]. For
spore cell induction, wild-type cells and hd2 cells were washed
once with KK2 buffer and three times with spore buffer (10 mM
MES, 20 mM NaCl, 20 mM KCl, 1 mM CaCl2, 1 mM MgCl2)
and then incubated in spore buffer supplemented with 5–15 mM
8-Br-cAMP for 24 and 48 hours [68] and visualized in bright field
microscopy. Relative sporulation percentage was calculated as
described for the stalk cell assay. Assays were performed three
independent times, each with three replicates.
Development of chimeric mixture of GFP-labeled wild-
type and hd2 cells
In Dictyostelium, chimeras are readily produced by mixing cells of
different genetic backgrounds and allowing them to co-aggregate
to form a chimeric mound [69]. For chimera aggregation,
development and tracing cell lineages, wild-type and hd2 cells
were transfected with pTX-GFP and selected in 10 mg/mL G418.
GFP-marked and unmarked cells were mixed at varying
percentages prior to deposition under buffer or development on
non-nutrient agar as described above.
Electron microscopy (EM)
To examine spores under electron microscopy, greater than
26108 wild-type and huntingtin-null spores were harvested and
resuspended in 2% glutaraldehyde (EM grade) in spore buffer and
incubated for 1–2 hours at 21uC. After this fixation, the spores
were washed in spore buffer and processed for electron microscopy
(EM). Electron micrographs were prepared using the CHGR
Microscopy Core.
Generation of DdHtt (595):GFP reporter construct
Dictyostelium expression vector pTX-GFP was digested with
restriction enzymes SalI and KpnI, releasing its actin15 promoter
and the first 11 codons of the ORF containing an 86His tag [70].
A region of DNA sequence including 595 bp 59 to hd ORF and the
first 42 bp of the ORF was amplified from D. discoideum (AX3)
genomic DNA using forward primer DdHtt_F608+SalI
(59- AATATGTGTCGACCTACAGTTATTAAATAAATTG-
CAATAAAGGTGC-39) and reverse primer DdHtt_R_Pro+KpnI
(59-TCCTCTGTGGTACCTGGTGATGCTGATAATATATC-
TAATCCACG-39). The product was digested with restriction
enzymes SalI and KpnI to facilitate ligation into the vector
upstream and in frame with the GFP ORF sequence. The
resulting vector therefore expresses the first 14 amino acids of hd
fused upstream of GFP, under the control of the predicted
minimal hd promoter sequence. The vector was transformed into
AX3 cells as previously described [71].
Cell–cell adhesion assay
Cell-cell adhesion was assessed as previously described [72].
Briefly, cells were grown axenically to a density of 2–56106
cells/mL, washed twice in K volume of ice cold Soerensen
buffer (SB), resuspended in 0.4 initial volume of SB and
vortexed, then immediately counted in order to adjust the
concentration of cells to 56106 cells/mL. Cells were incubated
in an Erlenmeyer flask at 150 rpm and 21uC and samples were
collected at various time points over a period of 6 hours. For
each collection point, cells were incubated in the presence or
absence of 10 mM EDTA for 30 minutes and fixed with 2%
glutaraldehyde. Single cells were counted using a hemocytom-
eter. All experiments were performed in duplicate and the mean
value for single cells in duplicate samples, expressed as
percentage of total cells was plotted over time.
Osmotic shock
Control (wild-type) or hd2 cells were grown HL-5 and the
medium was replaced with low ionic buffer (KK2), water
(hypotonic) or 400 mM sorbitol in KK2 (hyperosmotic). At various
time points samples were taken, diluted into KK2 phosphate buffer
containing K. aerogenes and plated onto SM agar plates to assay for
viability. Cell lysis upon osmotic shock was also observed visually
by brightfield microscopy. All experiments were performed in
triplicate.
Supporting Information
Figure S1 Comparison of growth rates between wild-type and
hd2 cells. Cells were inoculated into fresh HL-5 medium at an
initial density of 56104 cells/ml and incubated at 21uC with
shaking at 150 rpm on an orbital shaker. Cell counts were
performed every 24 hours, under a microscope, using a hemocy-
tometer. The graph represents the average of the readings of the
four flasks for each strain, at each time-point. Hd2 cells grow with
a doubling-time of ,10 hours compared to the ,12 hours
doubling time of wild-type control cells in suspension culture.
(TIF)
Figure S2 The addition of bivalent cations to the medium
rescues cAMP relay and streaming of hd2 cells. (A) Wild-type and
(B) hd2 cells (16105 cells/cm2) were submerged under KK2 in the
presence of 1 mM CaCl2 and allowed to develop for 6 hours.
Long streams of wild-type cells are seen moving into aggregation
centers (left panel). In the presence of Ca2+, hd2 cells are now
capable of streaming but form much smaller streams (right panel).
(TIF)
Table S1 Primers used for preliminary genomic DNA PCR
screening of hd-null cells. Sequences of primers presented in the 59-
39 direction that were used to initially identify putative hd2 cells.
(DOCX)
Table S2 Primers used to detect the presence of alternatively
spliced hd mRNA transcripts during growth and development.
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Sequences of primers presented in the 59-39 direction that was
used in RT-PCR reactions to detect the presence of alternatively
spliced hd transcripts from wild-type AX3 purified total RNA.
(DOC)
Video S1 Osmoregulation of wild-type Dictyostelium cells during
hypoosmotic conditions. Growth media was replaced with water
and cells were imaged using brightfield microscopy. After 2 hours
in water, images were taken every 20 seconds over a period of
1 hour with a frame rate of 50 msec.
(AVI)
Video S2 Lysis of Dictyostelium hd2 cells during hypoosmotic
conditions. Growth media was replaced with water and cells were
imaged using brightfield microscopy. After 2 hours in water,
images were taken every 20 seconds over a period of 1 hour with a
frame rate of 50 msec.
(AVI)
Video S3 Pulsatile cAMP signaling and chemotactic streaming
of wild-type Dictyostelium cells. Pulsatile signaling of cAMP appears
as dark, periodic propagating waves moving from right to left
across the field of view prior to the onset of chemotactic streaming.
Cells were imaged using brightfield microscopy and images were
captured every 15 seconds over a period of 6 hours. Video is
representative of the time between 5 and 6 hours with a frame rate
of 50 msec.
(AVI)
Video S4 Dictyostelium hd2 cells do not exhibit pulsatile cAMP
signaling or chemotactic streaming into aggregation territories.
Hd2 cells fail to initiate pulsatile waves and consequently do not
stream into aggregation centers. Cells can be seen randomly
colliding to form loose aggregates. Cells were imaged using
brightfield microscopy and images were captured every 15 sec-
onds over a period of 8 hours. Video is representative of the time
between 5 and 6 hours with a frame rate of 50 msec.
(AVI)
Video S5 Rescue of pulsatile cAMP signaling and chemotactic
streaming of Dictyostelium hd2 cells by addition of bivalent cations.
Under KK2 buffer Hd
2 cells fail to initiate pulsatile waves and
consequently do not stream into aggregation centers. However,
addition of 1 mM CaCl2 (shown here) rescues pulsatile signaling
and partially rescues chemotactic streaming. The streams formed
by hd2 cells under these conditions tend to break and are shorter
than that seen with wild-type cells. Cells were imaged using
brightfield microscopy and images were captured every 15 sec-
onds over a period of 6 hours. Video is representative of the time
between 5 and 6 hours with a frame rate of 50 msec.
(AVI)
Video S6 EGTA blocks calcium rescue of hd2 early develop-
ment. Dictyostelium hd2 cells do not exhibit pulsatile cAMP
signaling or chemotactic streaming into aggregation territories
when incubated with 1 mM CaCl2 in the presence of 1 mM
EGTA. Hd2 cells failed to initiate pulsatile waves and conse-
quently do not stream into aggregation centers, become rounded
and can be seen randomly colliding. Cells were imaged using
brightfield microscopy and images were captured every 15 sec-
onds over a period of 8 hours. Video is representative of the time
between 5 and 6 hours with a frame rate of 50 msec.
(AVI)
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